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Nanoparticles (NPs) are promising tools for a broad range of clinical applications, 
including therapeutic purposes. The surfaces of NPs can be modified for targeted 
therapy and a controlled drug release can be achieved with NPs as drug carriers, 
which is particularly desirable in the treatment of cancer to reduce side effects. 
However, their biosafety is still of concern due to toxic effects exhibited by NPs. 
Furthermore, upon administration, NPs will unavoidably come into contact with blood 
serum proteins and cells of the innate immune system, which is the body’s first line of 
defence. This can result in unwanted clearance of NPs by phagocytic cells such as 
macrophages, thus reducing their therapeutic efficacy. Here, we aimed to investigate 
the intracellular fate and toxicity of starch coated fluorescent iron oxide nanoparticles 
(IONPs) in mouse macrophages by using immunohistochemistry and microscopy 
techniques. We show that different protein corona compositions on the surface of 
IONPs can influence their uptake and also show that IONPs can enter cells through 
more than one endocytic pathway, including macropinocytosis, by using different sized 
fluorescent dextran molecules as endocytic markers. Through cytokine profiling using 
qPCR and transcriptome profiling using RNA-sequencing, we investigated the cellular 
immunotoxicity of IONPs by identifying particular biomarkers and genes which are 
involved in inflammatory processes. IONP toxicity was studied in vivo using zebrafish 
(Danio rerio) embryos as animal models following microinjections of IONPs. 
Biodistribution of IONPs was studied with confocal microscopy. Macrophages were 
labelled by microinjecting a high molecular weight dextran to investigate uptake of 
IONPs by macrophages in vivo, which was low. IONPs accumulated mostly in the 
pericardium and liver at 5dpf and overall a low mortality rate was recorded. 
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1.1 Nanomedicine: An Overview 
Delivering therapeutic compounds to a target site is often a major problem in the 
treatment of many diseases. This can be characterised by factors such as poor 
biodistribution, limited effectiveness and lack of selectivity. However, these drawbacks 
can be surpassed by controlling drug delivery to the target sites. Nanoparticles (NPs) 
are defined as materials with overall dimensions on the nanoscale range, with a size 
range of 1nm – 100nm. Due to their small size, NPs exhibit unique biological and 
physiochemical properties which make them desirable for biomedical applications and 
are thus being explored as drug and gene therapy delivery vehicles. The application 
of nanotechnology, first described by Professor Noro Taniguchi in 1974 (Kreuter, 
2007), in medical research, in the treatment, prevention and diagnosis of diseases can 
be referred to as nanomedicine. In short, nanomedicine is defined as the application 
of nanotechnology to medicine. The main purpose of using NPs in the treatment of 
diseases as drug delivery vehicles is to deliver the intended drug specifically to the 
target cells in order to avoid numerous side effects that arise from the damage caused 
to normal and healthy tissues of the body.  
 
Although the study of NPs in the treatment of diseases has made significant 
contributions to the field of nanomedicine, there are only a handful of NP-conjugated 
drugs approved for clinical use, in cancer therapeutics and other diseases. This is 
because several factors and limitations have to be considered when engineering NPs 
for drug delivery. NPs used for medical applications have to be biocompatible and 
non-toxic. Undesirable effects of NPs heavily depend on their shape, hydrodynamic 
size, surface chemistry, dosage, mode of administration, residence time in the 
bloodstream and reaction with the immune system (Alkilany & Murphy, 2010; 
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Wahajuddin & Arora, 2012). Furthermore, there are more physiological barriers that 
can be encountered by NPs upon administration in the bloodstream, thus making the 
engineering and tailoring of NPs for drug delivery even more challenging. These 
barriers and potential solutions to overcome those limitations are summarised below 






NPs are being extensively studied by scientists across the globe for the diagnosis, 
prevention and treatment of diseases, including therapeutic interventions. 
Furthermore, NPs have also been investigated to merge their therapeutic and 
diagnostic properties, using only one nanomedicine formulation and these 
formulations are known as nanotheranostics (Rizzo et al., 2013). These 
nanotheranostics can be used to generate useful data on pharmacokinetics, including 
drug delivery, release and efficacy and can be indicative of the possibilities of using 
NPs in personalised medicine (Rizzo et al., 2013). Nanomedicine is proving to be a 
useful concept in deciphering the pathophysiology of a number of diseases and will 
Figure 1.1. Physiological barriers and restrictions encountered by nanotherapeutics. This image 
provides a summary of the barriers and limitations encountered by therapeutic NPs, along with some 
strategies that can be investigated and explored to overcome these barriers when engineering NPs 
intended for drug delivery. Image from Kievit & Zhang, 2011. 
 4 
be highly beneficial to patients by improving their lifespan and quality of life. The use 
of nanomedicines have a number of advantages over the use of standard and 
conventional drugs (Ventola, 2012). Nanomedicines, especially NPs loaded with a 
drug of interest, are likely to have longer circulation times than conventional drugs as 
NPs have reduced hepatic degradation and excretion. The volume of drug distribution 
of the nanomedicines will also be reduced and hence there will be less of the drug in 
healthy tissues, leading to reduced side effects in patients. Using nanomedicines, 
which specifically target the diseased tissue, will also improve site-specific drug 
delivery, which means that the drug will accumulate more in the pathological site, thus 
improving the therapeutic index (Bala Tannan et al., 2020).  
 
1.2 Current examples of nanoparticles in drug delivery 
NPs have come a long way in the diagnosis and treatment of many diseases, including 
cancer, where patients would benefit greatly from targeted therapy. For example: a 
‘hybrid’ micellar NP with multifunctional properties has been recently developed. It 
contains metal NPs useful in MRI detection, quantum dots for fluorescent imaging, 
polyethylene glycol (PEG) for increased circulation times, the tumour-specific F3 
peptide for targeting and doxorubicin as the therapeutic agent (Jain et al., 2012). The 
‘hybrid’ NP formulation showed to be efficient in a mouse model that was implanted 
with human breast cancer cells (Park et al., 2008). An important evidence of the 
potential function of gold NPs (GNPs) as a drug delivery mechanism was the use of 5 
nm GNPs covalently bound to cetuximab, a monoclonal anti-epidermal growth factor 
receptor (EGFR) antibody, as a targeted therapy and gemcitabine (an anti-metabolite) 
as a therapeutic payload investigated in pancreatic cancer (Patra et al., 2010). EGFR 
is overexpressed in about 60% of pancreatic cancers and the combination of 
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cetuximab and gemcitabine was investigated in phase II trials for pancreatic cancer. 
The GNP-cetuximab-gemcitabine nanocomplex was found to be superior to the use 
of the agents alone or in combination in vitro and in vivo (Jain, Hirst and O’Sullivan, 
2012). 
 
NPs, liposomes, polymers, antibodies and micelles have all been investigated as 
carrier materials in the field of nanotherapeutics. An example of a nanotherapeutic 
being studied is for the delivery of paclitaxel (taxol). The study of poly(lactic-co-glycolic 
acid) (PGLA) NPs in the paclitaxel formulation showed an increase in cytotoxicity to 
cancer cells as well as an effective therapeutic method in vivo using male rat models 
(Win and Feng, 2006).  
In comparison to standard diagnostics methods, there are not many diagnostic 
imaging methods that are currently using nanomedicine formulations 
(nanodiagnostics). One example of clinical studies using nanodiagnostics is the usage 
of Resovist-like iron oxide NPs (IONPs) in the observation of macrophage activity in 
atherosclerosis, injected cancer vaccines, lymph node metastases and neural stem 
cells (Rizzo et al., 2013).  
 
The development of nanotechnology in surgery is still under extensive study but as 
surgical procedures are becoming less invasive, nanotechnology and its application 
to surgical procedures has immense potential (Singh and Singh, 2013).  
Other than diagnostic and therapeutic purposes, NPs have made significant advances 
in the development of vaccine formulations. The use of NPs in vaccines can be more 
favourable than conventional vaccines since a number of parameters such as shape, 
solubility, size and surface chemistry can be precisely controlled (Al-Halifa et al., 
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2019). For example, a recently developed vaccine against SARS-CoV-2 by BioNtech 
and Pfizer used NPs as the delivery vehicles to intravenously administer an mRNA-
based vaccine (Polack et al., 2020). 
 
1.3 Nanotherapeutics in cancer and other diseases 
Nanomedicine as an alternative treatment for cell-based therapeutics is proving to be 
an effective strategy that is more specific than conventional drugs in a range of 
diseases such as neurological diseases (for example: multiple sclerosis, Parkinson’s 
disease, Alzheimer’s disease), diabetes and cancer (M Samarasinghe et al., 2012). 
PGLA NPs are being broadly studied as drug delivery vehicles in the treatment of 
neurological disorders as they are able to cross the blood brain barrier generating 
promising results (Semete et al., 2010). In addition, PGLA NPs have also shown no 
signs of cytotoxicity. They are eliminated from the body by first undergoing hydrolysis 
forming compounds that are metabolised by the citric acid cycle (Semete et al., 2010). 
 
The concept of personalised medicine has received a lot of attention, especially in the 
treatment of cancer. Similar to how every individual is unique, the cancerous lesions 
are also unique to the patients and each one will be different in terms of disease onset, 
progression and treatment efficacy. These can be useful factors to exploit for better 
clinical management of the disease. Personalised medicine is an individualised 
therapy, which is designed after considering the unique disease profiles of each 
patient. Through personalised medicine, clinicians can make fairly accurate 
predictions on the progression of the disease, effectiveness of therapy and the 
patient’s chances of relapse, all with a maximum therapeutic index and minimal toxicity 
for the patient (Jackson and Chester, 2015). With advances in sequencing 
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technologies and completion of the Human Genome Project in 2003, techniques such 
as genome sequencing, transcriptomic analysis and proteomic analysis are being 
increasingly used with the aim of identifying specific mutations, biomarkers or 
pathways associated with a disease to be used as predictive tools for the development 
of effective treatment plans (Krzyszczyk et al., 2018). This is particularly useful in the 
treatment of cancer. For example, a recent study showed that whole-genome 
sequencing of a prostate cancer patient revealed that his cancer was driven by a 
specific mutation and this provided important information for potential future 
treatments using a personalised medicine approach (Armstrong et al., 2021).  Due to 
their current limitations in developing the formulation, only a few personalised 
medicines have been clinically tested, the best example being the identification of the 
oestrogen receptor (ER) in breast cancer treatment (Ellsworth et al., 2010). These 
drawbacks mainly include the high failure rate of personalised medicine and identifying 
valid biomarkers (Liu, 2012). Some therapeutic NPs in the form of liposomes that have 
been clinically approved for cancer treatment are doxil, myocet and liposomal 
doxorubicin, which were also the first kind of nanotherapeutics to be clinically 
approved (Shi et al., 2016). NPs have also been conjugated with ligands specific to 
the patient with the intention of targeting specific cancer cells in order to have a better 
treatment efficacy; an example is αvβ3-targeted paramagnetic NPs to identify 
angiogenesis sites of melanoma tumours in a non-invasive manner (Schmieder et al., 
2005).  
 
Iron oxide nanoparticles (IONPs), due to their magnetic properties, have proven to be 
useful for magnetic resonance imaging and have been used to monitor cells following 
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transplants, including neural cells, stem cells as well as bone marrow cells (M 
Samarasinghe, K Kanwar and R Kanwar, 2012).  
Nanomedicine formulations can also be used in regenerative medicine, where the 
primary focus lies in restoring and maintaining the normal functions of cells, tissues, 
the extracellular matrix and even organs that have previously been damaged (Engel 
et al., 2008). Diseases such as osteoporosis, Parkinson’s disease, spine injuries, 
Alzheimer’s disease as well as cancer can benefit from regenerative medicine. 
Regenerative medicine research is still at an early stage and there are two main 
strategies that scientists are working on. The first one involves using 3D scaffolds to 
expand stem cells collected from the patient, which are first expanded in vitro and then 
implanted back into the patient; and the second method is the development of NPs 
that would send multiple signals to the stem cells in the patient which would 
subsequently induce the regeneration of the damaged tissue (Engel et al., 2008). 
 
1.4 Iron Oxide Nanoparticles 
Iron oxide nanoparticles (IONPs) are widely desirable for their magnetic and catalytic 
properties. Magnetic NPs have very unique properties such as high magnetic 
susceptibility, low Curie temperature, superparamagnetic and high coercivity (Wu et 
al., 2008). Magnetic NPs are also used in many bioapplications such as detection of 
biological materials, magnetic bioseparation, clinical diagnosis and therapeutics (Wu, 
He and Jiang, 2008). For example: IONPs are useful in magnetic fluid hyperthermia 
treatment (MFH), which is used in the treatment of cancers by specifically heating the 
area of malignancy, changing the physiology of the cells and inducing apoptosis 
(Hildebrandt, 2002).  
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Novel drug delivery vehicles are also being developed using magnetic IONPs and the 
help of an external magnetic field to target the NPs to a particular site as a strategy in 
the development of superparamagnetic iron oxide NPs (SPIONs) (Wahajuddin and 
Arora, 2012). Delivering anticancer drugs with functionalised SPIONs to a specific 
target site is an area of high interest in the development of cancer treatment strategies; 
for example: SPION-induced hyperthermia has been used for the localised killing of 
cancer cells (Wahajuddin and Arora, 2012).  
The biological applications of magnetic IONPs require the iron to be in an aqueous 
salt environment. In order to prevent oxidisation of the iron in this environment, a gold 
coating on the IONPs can be used, which will however affect their magnetic properties.  
 
The magnetic properties, including large surface area to volume ratio, of IONPs make 
them one of the most favourable and promising drug delivery vehicles. SPIONs are 
one of the easiest formulations to produce and have proved to have the least toxicity 
(Wahajuddin and Arora, 2012). The ability to control magnetic NPs externally by using 
a magnet is another promising targeting mechanism. Carcinomas that are close to the 
surface of the skin are highly likely to benefit from magnetic targeting therapy. Despite 
being so promising, there are only a handful of magnetic NPs used in drug delivery on 
the market. This is because there are many limitations and more toxicity issues to 
overcome, before they are clinically safe to be used. Some IONPs that are currently 






Generic Name IONP Coating Blood half-life Stage Reference 
Ferumoxtran-10 Dextran > 24 hours Clinical 
trial 
(Harisinghani et al., 2006) 















2 hours Clinical 
trial 
(Daldrup-Link et al., 2003) 
Ferumoxytol Carboxymethyl
-dextran 
10-14 hours Clinically 
approved 
(Muehe et al., 2016) 
Nanotherm Aminosilane - Clinically 
approved 
in Europe 





In this thesis, 100nm spherical magnetic IONPs with a starch coating were used in all 
studies with the aim of further understanding their biosafety and toxicity. Although 
many studies have emphasized on the promising nature of IONPs for therapeutic 
purposes, only a few IONP formulations as mentioned in the table above have been 
approved for clinical use, suggesting a big gap between paradigm and end-use of 
IONPs in drug delivery. Despite IONPs being chemically inert (Vallabani and Singh, 
Table 1.1. Magnetic Iron Oxide Nanoparticles applications in nanomedicine. This table summarises 
some IONPs that are currently clinically approved or that are still in the clinical trials phase. Most of the 
formulations mentioned above are most commonly used as contrast agents such as for lymph node 
imaging, liver imaging and macrophage imaging. Nanotherm was approved in 2010 in Europe only for 
glioblastoma therapy. At the time of writing, the literature suggests that the Nanotherm therapy system may 
soon receive FDA approval in the US for the treatment of prostate cancer. 
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2018), there is a need for further studies investigating toxicity of IONPs and their 
interactions with the immune system in order to develop strategies where maximum 
therapeutic efficiency is obtained. Currently, all approved IONP formulations are iron 
oxide-carbohydrate based or colloids using small spherical iron oxide-carbohydrate 
NPs (Soetaert et al., 2020), emphasizing the potential of spherical NPs. Furthermore, 
the presence of a carbohydrate coating provides stability to the IONP core with the 
aim of slowing down the release of Fe in blood or biological media (Auerbach and 
Ballard, 2010). Other than shape and outer shell coating, the size of IONPs also play 
a role in determining the bioavailability hence therapeutic efficiency of IONPs.  One 
study has shown that for intracellular drug delivery, the favourable particle size for 
IONPs is between 10nm – 100nm as these provide the longest blood circulation times 
(Turrina, Berensmeier and Schwaminger, 2021). Thus, through the studies carried out 
in this thesis, we aim to contribute to the existing literature by understanding 
intracellular behaviour and toxicity of 100nm starch coated spherical IONPs. 
 
1.5 Nanoparticles and the immune system 
The immune system is an interactive and intricate network consisting of mainly cells 
and cytokines. Being the body’s first line of defence, the immune system has the 
primary task of detecting foreign substances to protect the host whilst preserving the 
integrity of the body. Abnormal functioning of the immune system will result in 
infections, immunodeficiency disorders, autoimmune diseases and can even result in 
the formation of tumours. The immune system has two different subsystems: the 
innate immune system and the adaptive immune system. 
The innate immune system is usually the first response triggered upon exposure to a 
foreign substance and phagocytic macrophages will recognise and bind to the 
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receptors of the foreign substances, which will induce the production of cytokines 







The above figure provides an overview of the cells of the innate immune system and 
the role they play in innate immunity. Innate immune cells such as monocytes can be 
activated and differentiate into phagocytic cells such as macrophages and dendritic 
cells. The activated macrophages will also secrete chemokines, which are proteins 
that will attract other phagocytes from the bloodstream such as neutrophils and 
monocytes as they have chemokine receptors on their surface (Charles A Janeway et 
al., 2001).  Cytokines and chemokines are produced by activated macrophages upon 
exposure to foreign substances, which is the first part of the inflammation process. It 
can also trigger complement activation. Complement consists of proteins that will be 
Figure 1.2. Overview of innate immune cells. This figure shows the different innate immune cells and 
their role in the host’s immune defence mechanism. The first and main cells involved in the innate 
immune system are macrophages, which are differentiated from their precursors; monocytes. Cells of 
the innate immune system such as macrophages and dendritic cells can activate B cells (of the adaptive 
immune) system through antigen presentation and recognition, thus bridging the link between innate 
and adaptive immunity. Image from: Chaudhry, 2016. 
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cleaved into smaller peptides to coat the surface of the foreign substance to be 





The above figure shows an overview of the 3 pathways of the complement system. 
Regardless of how they are activated, all 3 pathways lead to the formation of the 
enzyme C3 convertase, which is crucial for the cleavage of other proteases and 
convertases in order to be able perform specific functions in the clearance of 
pathogens (figure 1.3). The complement system can be activated through three 
different pathways: classical pathway, alternative pathway and lectin pathway (figure 
1.3). The classical pathway involves the complement C1 protein complex, whose 
production is initiated by antigen-antibody immune complexes (Noris and Remuzzi, 
Figure 1.3. Complement pathway activation. This figure illustrates the three different pathways 
through which the complement system can be activated: the classical pathway, mannose-binding 
lectin pathway and alternative pathway. Although they are activated differently, all three pathway 
activations converge up to the formation of complement protein C3. Image from: Chaudhry, 2016. 
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2013). When C1q molecules bind to the antigen-antibody immune complexes, 
conformational changes occur in the C1q molecules, which leads to activation and 
cleavage of other proteases and convertases; for example C1q cleaves C4 and C2 
into classical pathway convertase, C4bC2a, which further cleaves C3 convertases into 
C3a and C3b (Nesargikar et al., 2012). The alternative pathway is not stimulated by 
antibody-antigen complexes but by lipids, carbohydrates and proteins found on the 
surface of foreign substances and pathogens (Sarma and Ward, 2011). The 
alternative pathway is usually constantly active at a low level in the body and involves 
the protein convertase C3 that undergoes hydrolysis to form C3b, which then coats 
the surface of the foreign pathogens (Merle et al., 2015). 
The lectin pathway bears many similarities to the classical pathways, except for the 
initial activation stimuli. Instead of C1q in the classical pathway, the lectin pathway is 
activated when mannose binding lectin (MBL) or ficolin bind to specific carbohydrate 
patterns on the surface of foreign pathogens (Sarma and Ward, 2011). MBL-
associated serine proteases (MASP), similar to C1 in the classical pathway, cleave C2 
and C4 forming C3 convertase, which is further cleaved into C3a and C3b (Nesargikar, 
Spiller and Chavez, 2012).  
Studies have shown that carbon nanotubes can trigger complement activation via the 
classical and alternative pathways in a human monocytic cell line, although higher 
activation via the classical pathway was observed, which may depend on the coating 
of the carbon nanotubes (Pondman et al., 2014). The activation of complement also 
showed an increased uptake by phagocytic cells.  
The innate immune system of a host provides immediate defence against foreign 
substances and in contrast to the adaptive immune system, does not provide long-
lasting immunity. The adaptive immune system provides long-lasting immunity against 
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infections and diseases by developing an immunological memory through the 
differentiation of activated B lymphocytes into memory cells. Activation of the adaptive 
immune system to some extent depends on the innate immune response as it is the 
first inflammatory response in the body. The adaptive immune system is usually 
activated a few days after the innate immune response if the innate immune system 
was unable to destroy all the pathogens. The adaptive immune response is much more 
specific to a particular pathogen (Chaplin, 2010). There are two main types of adaptive 
immune responses: humoral immunity, which is antibody-mediated (depends on B 
lymphocytes/cells) and cell-mediated immunity, which depends on T 
lymphocytes/cells (figure 1.4). The figure below provides an overview of the cells 
involved in adaptive immunity and how they differentiate into specialised cells to 







During humoral immunity, activated B cells secrete immunoglobulins which are 
specific to the foreign antigen (Chaplin, 2010). The presence of these antigens is 
responsible for the production of the antibodies. When the antibodies bind to the 
antigens, the pathogen becomes inactivated because the antibody-antigen binding 
has blocked their ability to bind to host cell receptors (Charles A Janeway et al., 2001). 
The binding of antibodies to the antigens on the pathogen’s surface also act as 
Figure 1.4. Adaptive immune system overview. This image shows a summary of the 
adaptive immune system, the cells involved and the responses triggered. The two main 
cells of adaptive immunity are B lymphocytes and T lymphocytes, which can differentiated 
into different cells and they all play important roles in the clearance of pathogens from the 
body as well as the development of an immunological memory against specific pathogens. 
Image from: Chaudhry, 2016. 
 17 
‘markers’ to make it easier for the pathogens to be ingested and destroyed by 
phagocytes; this process is called opsonisation.  
 
During cell-mediated immunity, the main cells involved are the T lymphocytes that will 
either kill the infected cells directly or will help macrophages to phagocytose the 
infected cell. Cytotoxic T cells (CD8+ T cells) will directly kill the infected cells that 
display the foreign antigen on the surface of a host cell (example: a host cell infected 
with a virus) (Alberts et al., 2002). Helper T cells (CD4+ T cells) can help in activating 
B cells to produce antibodies as well as help to activate cytotoxic T cells to directly kill 
infected cells (Alberts et al., 2002) (figure 1.4).  
When engineered NPs are administered to the body, there is a high probability that 
they will encounter the immune system and subsequently trigger an immune response 
with both wings of the immune system; the innate and adaptive immune response. 
The immune response activated will depend on the physiochemical properties of the 
NPs (Kononenko et al., 2015). Other than the complement system, NPs can also 
activate the mononuclear phagocyte system (MPS) to some extent, which leads to 
their ingestion by phagocytes (Gustafson et al., 2015). The phagocytes, being the 
body’s ‘professional eaters’, may try to engulf the NPs and eliminate them as they 
normally would upon exposure to microbes, as described above.  
 
Understanding these factors and how they may disturb the host’s immune system is 
important in the study of toxicology and development of nanotherapeutics. Many 
studies have shown that the body’s exposure to NPs can activate the complement 
system and trigger inflammatory or allergic reactions (Szebeni, 2014). Although NPs 
are known to be potentially toxic for the body, engineering the NPs and their properties 
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may result in either evading the immune system or intentionally targeting the immune 
system (Dobrovolskaia et al., 2016). 
For example: nanoliposomes can been modified to have different effects on the 
immune system. The literature shows two main types of nanoliposome formulations 
that elicit different immune responses: one that stimulates an immune response to an 
antigen inside the nanoliposome and the second formulation incorporates a polymer 
coat on the nanoliposome in order to avoid being recognised by the immune system 
(Zolnik et al., 2010). A handful of liposome-based drug carriers have been approved 
for the treatment of cancer and some infections, while more liposome-based 
formulations are being investigated for therapeutic vaccines (Zolnik et al., 2010). 
 
The past few decades have shown tremendous advances in the understanding of 
interactions between NPs and the immune system, however a number of questions 
on the interactions and how they can be exploited remain unanswered. Understanding 
physiochemical properties of NPs and their modifications is also crucial to determine 
the effects they will have on the immune system.  
 
1.6 Macrophages and other phagocytes 
Phagocytes or phagocytic cells are important cells of the immune system that protect 
the body against foreign substances by ingesting the foreign substances and 
eliminating them through a process called phagocytosis. Phagocytosis is a unique 
phenomenon of the immune system for clearing foreign pathogens. Phagocytosis is 
not only important for the killing of foreign pathogens but also important for the removal 
of apoptotic cells and cellular debris from necrosis. A number of targets, ligands and 
phagocytic receptors are recognised by phagocytic cells to initiate the process of 
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phagocytosis. Aside from phagocytosis, macrophages can also help in initiating the 
activation of the adaptive immune system as they are important antigen-presenting 
cells, which are recognised by T cells.  
Phagocytes can be classified into two classes; ‘professional’ or ‘non-professional’ 
phagocytes and these are determined by the efficacy of phagocytosis. Professional 
phagocytes include monocytes, macrophages, neutrophils, dendritic cells, mast cells 
whereas non-professional phagocytes include epithelial cells (Aderem and Underhill, 
1999).  
 
The main phagocytes described in this chapter are macrophages, which are blood 
cells formed in the bone marrow. Monocytes are macrophage precursors and upon 
differentiation, they become activated macrophages upon encounter with pathogens 
and cytokines (Mosser and Edwards, 2008). Activated macrophages can be polarised 
into two types of macrophages: classically activated macrophages (M1 macrophages) 
through the secretion of IFN-γ and alternatively activated macrophages (M2 
macrophages) through the secretion of IL-4 (Martinez and Gordon, 2014). M1 
macrophages display pro-inflammatory characteristics and mainly function in 
pathogen-killing, whereas M2 macrophages are involved in tissue repair through cell 
proliferation (Orecchioni et al., 2019).  
As mentioned previously, macrophages are professional phagocytes of the immune 
system and can detect foreign bodies through specific ligand-receptor interactions 
such as toll-like receptors (TLRs) and pattern recognition receptors (PRRs) (Richards 
and Endres, 2014). These interactions and activation of the receptors are the driving 
force for the foreign bodies to be engulfed by the macrophages (Karavitis and Kovacs, 
2011). Receptor activation leads to the formation of a phagosome in the macrophage. 
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The phagosome ultimately fuses with late endosomes and finally with lysosomes 
forming a hybrid-like organelle called a phagolysosome through a series of fission and 
fusion events (Aderem and Underhill, 1999). In the phagolysosomes, an environment 
with already limited nutrition, enzymes, reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) will degrade and kill the pathogen (Slauch, 2011). 
 
Neutrophils are another type of phagocytic cells, which are also found in the 
bloodstream and are important for protecting the body against foreign substances and 
in wound healing. Neutrophils are one of the first immune cells to be recruited at sites 
of acute inflammation through chemotaxis, where they can eliminate foreign 
pathogens through different mechanisms including phagocytosis, degranulation (this 
involves the secretion of anti-microbial solutes) and the formation of neutrophil 
extracellular traps (Mayadas, Cullere and Lowell, 2014). These traps are made up of 
chromatin and proteins and act as a ‘net’ to trap pathogens for elimination as well as 
preventing the spread of foreign pathogens by acting as a barrier. At the same time 
neutrophils  are able to secrete cytokines, which recruit and activate other phagocytes 
(Kolaczkowska and Kubes, 2013). Neutrophils are able to recognise and ingest foreign 
pathogens when they are opsonised by antibodies and can eliminate and kill 
pathogens through their oxidative burst mechanism.  
 
Dendritic cells (DCs) are also classified as important phagocytes, however unlike other 
phagocytes, dendritic cells do not have the primary function of phagocytosis but they 
are very effective antigen-presenting cells. They are also known as professional 
antigen-presenting cells (APCs). DCs are mainly responsible to alert the immune 
system of invading pathogens by processing antigens from foreign pathogens and 
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presenting them on their cell surface to be recognised by T lymphocytes, which are 
then activated (Savina and Amigorena, 2007). DCs are able to present the processed 
antigens through two receptors: MHC class I and MHC class II molecules which are 
present on the surface of DCs. Activation of T lymphocytes initiates the adaptive 
immune response and the body’s immunological memory as described in section 1.5.   
 
1.7 Nanoparticle Uptake Mechanisms 
Since NPs have been discovered as being able to be internalised by cells, they have 
been the prime focus of many scientists for target therapies. Nanomedicines 
encounter a number of obstacles before being internalised by cells, thus the most 
efficient mechanism to get the NPs across the cell and plasma membrane has to be 
identified for specific nanomedicines, particularly those intended for intracellular 
targeting. The plasma membrane maintains a complex integrity due to its important 
role in cell-cell communications, cell division and cell adhesion (Kraft, 2013). To a 
certain extent, these functions of the plasma membrane are carefully regulated by the 
process of endocytosis (Kumari, MG and Mayor, 2010). During endocytosis part of the 
plasma membrane invaginates and new intracellular vesicles are formed translocating 
substances, such as proteins, extracellular fluids and lipids, across the plasma 
membrane and into the cell (Saheki and De Camilli, 2012). Different types of 
substances (proteins, fluids, etc.) will be internalised into the cells through different 






Endocytosis can be classified into two main types: phagocytosis and pinocytosis. 
Pinocytosis, which is internalisation of mostly fluids, can be further categorised into 
four sub-types: clathrin-mediated endocytosis, caveolae-mediated endocytosis, 
clathrin/caveolae-independent endocytosis and macropinocytosis. All these pathways 
are not present in every cell type but the endocytosis pathway will have a major role 
in the intracellular fate and trafficking of internalised particles. However, in all endocytic 
pathways, there are important intracellular organelles that play crucial roles, which 
include early endosomes, late endosomes and lysosomes. Early endosomes are 
thought of as sorting organelles, where internalised particles or substances are sorted 
to be either degraded in the lysosome/late endosomes, to be transported back to the 
trans-Golgi network or if they are to undergo recycling back to the plasma membrane 
(Jovic et al., 2010). Examples of proteins specific to early endosomes are Rab5 and 
Rab4, which are small GTP-binding proteins.  
Figure 1.5. Endocytic pathways at the plasma membrane . The above figure shows the different 
endocytic pathways through which various substances including NPs can be internalised. Physical and 
chemical properties of particles, molecules or protein determine the mechanism of endocytosis.  Image 
from: Chou et al., 2011. 
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Late endosomes are mainly involved in the recycling and degradation (delivery to 
lysosomes) of the internalised substances. Recycling can either be in the form of direct 
recycling to the plasma membrane or indirect recycling through recycling endosomes 
(Scott et al., 2014). Late endosomes also mediate the transport of lysosomal 
components between lysosomes and the trans-Golgi network (Huotari and Helenius, 
2011).  Examples of proteins localised to late endosomes are Rab 7, Rab 9 and Rab 
11. Lysosomes are membrane-bound organelles that receive substances that are to 
be degraded from the early/late endosomes. To help in the degradation of the 
substances, lysosomes constantly maintain a low pH and contain acid hydrolases, 
which are involved in the hydrolysis and hence, degradation of the substances (Luzio 
et al., 2007).  
 
Clathrin-mediated endocytosis (CME) is one of the most studied endocytosis 
pathways in eukaryotic cells and is important for the uptake of nutrients, membrane 
recycling, and intracellular signalling (Kirchhausen, 2000). Over fifty different proteins 
are required to regulate the formation of vesicles at the plasma membrane (Popova et 
al., 2013). The participation of all these proteins causes a slight dip to be formed at 
the surface of the plasma membrane, following which a spherical clathrin-coated 
vesicle is formed (Macro et al., 2012). To release the clathrin-coated vesicle from the 
plasma membrane, specific proteins, called dynamins assemble around the neck of 
the vesicle in a ring-like structure (Traub & Bonifacino, 2013; Popova et al., 2013). 
Once released from the plasma membrane, the clathrin coat on the vesicle is removed 
by auxilins and chaperons such as Hsc70 (Yameen et al., 2014). The uncoated vesicle 
can now fuse with early endosomes where the content may be degraded or recycled 
back to the plasma membrane. CME is the main endocytic pathway for receptor-
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mediated uptake of NPs (Yameen et al., 2014). The uptake mechanism of NPs is 
highly dependent on the physical properties of the NPs such as size, surface charge 
and shape. Certain NPs, particularly ones that are made from polylactic-co-
polyethylene glycol, with sizes approximately 100nm were shown to be taken into the 
cell through CME (Harush-Frenkel et al., 2007). Furthermore, PGLA NPs have also 
been shown to mainly take the CME pathway of internalisation (Vasir and 
Labhasetwar, 2008). However, there have been no studies yet that show a direct link 
between 100nm sized NPs (of different coatings) and CME. 
 
Clathrin-independent endocytosis (CIE) is another endocytic pathway that plays a role 
in processes such as cell polarisation, plasma membrane repair, intracellular 
signalling and cell spreading (Sandvig et al., 2008). CIE does not require the coating 
on the vesicle that is required for CME. CIE does involve vesicle formation on the 
surface of the plasma membrane that is mainly dependent on the presence of actin 
and actin-associated proteins (Mayor and Pagano, 2007). CIE can be further classified 
into three sub-types, which are categorised by the type of proteins involved: RhoA-
dependent CIE, Cdc42-dependent CIE and Arf-6-dependent CIE (Mayor et al., 2014). 
Following vesicle formation, the cargos that enter the cell are delivered to early 
endosomes first and following the sorting process, they are transported to the 
lysosomes or late endosomes to be degraded or recycled back to the plasma 
membrane (Hansen and Nichols, 2009). Specific NPs, particularly self-branched and 
trisaccharide-substituted (glycosylated) chitosan oligomers (SBTCO) NPs, have been 
shown to be mainly endocytosed through CIE pathways (Garaiova et al., 2012).  
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Caveolae-mediated endocytosis involves structures called caveolae. Caveolae play a 
part in many processes including protein endocytosis, signal transduction and 
cholesterol homeostasis (Parton and Simons, 2007). Caveolae are small plasma 
membrane invaginations (of 50-100nm) and are present in a number of cells and 
tissues including fibroblasts, endothelial cells, smooth muscle cells and adipocytes 
(Cohen et al., 2004). Caveolae are coated mainly by caveolins; particularly Cav1, 
Cav2 and Cav3 (Parton and Simons, 2007). Other proteins that coat the caveolae are 
known as cavins and they also contribute to the formation of caveolae (Parton and del 
Pozo, 2013). Caveolin proteins have the ability to oligomerise and this process is 
important in the generation of the endocytic vesicle (Cohen et al., 2004). The 
internalised material is transported to caveosomes before being sorted to lysosomes, 
the Golgi apparatus or the endoplasmic reticulum, depending on the endocytosed 
material (Kiss and Botos, 2009). 
 
Macropinocytosis is the fourth endocytic pathway classified under pinocytosis. 
Macropinocytosis is an actin-dependent endocytic pathway and involves the formation 
of large vesicles called macropinosomes (Lim and Gleeson, 2011). Macropinocytosis 
is generally the preferred uptake route of larger substances such as bacteria, viruses, 
apoptotic cell fragments and large amounts of extracellular fluids (Zeineddine and 
Yerbury, 2015). Macropinocytosis mainly internalises large substances and fluids, 
generating vesicles >1m in diameter whereas phagocytosis involves the uptake of 
particles that are >0.5m in diameter (Cardelli, 2001). Macropinocytosis also plays an 
important part in the process of antigen presentation of MHC class II molecules 
(Sallusto et al., 1995). Macropinocytosis is mainly triggered by growth factors but it 
can also be triggered by particles such as apoptotic bodies, bacteria, viruses and 
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necrotic cells (Zeineddine and Yerbury, 2015). The formation of the macropinosome 
vesicle is promoted by actin polymerisation and actin-mediated ruffling, which occurs 
following the activation of receptor tyrosine kinases such as epidermal growth factor 
receptors (Kerr and Teasdale, 2009). Once the macropinosomes are formed 
containing the trapped solute and soluble substances, the macropinosomes undergo 
a maturation process (Lim and Gleeson, 2011). The maturation involves extensive 
tubulation of the macropinosomes, which then become more spherical as they migrate 
centripetally towards the late endosomes/lysosomes (Lim and Gleeson, 2011). The 
contents of the macropinosomes are then either recycled back to the plasma 
membrane or degraded in the late endosomes/lysosomes.  
 
Phagocytosis (described in section 1.4) is a type of endocytosis specific for foreign 
pathogens, which are translocated across the cell membrane and into the phagosome. 
The uptake of NPs by macrophages through phagocytosis requires attractive forces, 
which can be in the form of electrostatic forces, Van der Waals forces, 
hydrophobic/hydrophilic forces or ionic forces, and occurs between the NPs and cell 
surface (Weissleder et al., 2014). NP uptake by phagocytosis can also occur through 
receptor mediated recognition of opsonins that are present on the surface of the NPs 
(Weissleder, Nahrendorf and Pittet, 2014). Different drug delivery particle shapes have 
been investigated for their ability to inhibit phagocytosis and the results have shown 
that phagocytosis can be reduced or even inhibited by using more elongated drug 
delivery particles made with high aspect ratios (Champion and Mitragotri, 2009).  
 
Many particles that are of small micron sizes are able to be internalised into cells via 
micropinocytosis (Gratton et al., 2008). NPs can be endocytosed into macrophages 
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as well as in cancer cells through micropinocytosis; these are the two main types of 
cells that have the highest uptake of NPs (Weissleder et al., 2014). However, most of 
the literature suggests that in principle NPs are internalised into cells through the many 
different endocytic pathways. Understanding these uptake pathways and the ability to 
control the endocytic pathway taken by NPs is important in mediating their intracellular 
fate and the biological response that the NPs will trigger, which will also help in 
understanding the overall physiological effect in response to NPs.  
 
1.8 Nanoparticle uptake by macrophages 
Macrophages, as described in section 1.6, have very important functions in protecting 
the host against foreign bodies and NPs are endocytosed by macrophages, due to 
their naturally high endocytic activity. As a result of this, NPs are common tools used 
in the imaging and study of macrophages.  
Macrophages can recognise opsonised particles and specific surface and biological 
patterns that are most likely to be present on the surface of NPs, which will determine 
their fate (Etheridge et al., 2013). However, how the phagocytes interact with the 
surface of the NPs, which determines their endocytic pathway, intracellular fate and 
removal, is not clearly understood (Gustafson et al., 2015). NPs are mostly recognised 
by macrophages through the proteins that are adsorbed on their surface. Exploiting 
this recognition will help tremendously in the making of NPs for therapeutic purposes 
as they may remain in the circulation for longer (Dobrovolskaia et al., 2008). An 
example of these protein recognitions is the positively charged collagen domains of 
the scavenger receptors on the surface of macrophages that have been shown to 
facilitate internalisation of negatively charged nanomaterials (Gustafson et al., 2015). 
NP surface size and shape can contribute to changes in the conformation of adsorbed 
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proteins; for example: lysozymes are small enzymes that have been shown to adsorb 
to silica NPs of almost any size (Gustafson et al., 2015). Bovine serum albumin (BSA) 
on the other hand adsorbs to NPs especially those with rough surfaces; for example: 
a study showed that with an increase in BSA adsorption, there was a decrease in 
cellular uptake of rough gold NPs compared to smooth gold NPs (Albanese et al., 
2010). These protein adsorptions on the surface of NPs may form specific patterns 
that contribute to their recognition by macrophages.  
 
Macrophage surface receptors such as TLRs, Fc receptors, mannose receptors and 
scavenger receptors play an important role in the uptake of NPs (Gustafson et al., 
2015). TLRs are important receptors of the innate immune system and are involved in 
the detection of ‘foreign’ material through the recognition of PAMPS (pathogen 
associated molecular patterns) and a study investigating the involvement of TLRs in 
titanium dioxide (TiO2) NP uptake has found that TLR4 in particular played a role in 
the uptake of TiO2 NPs in human cell lines and triggered an inflammation response 
(Chen, Kanehira and Taniguchi, 2013). Fc receptors are cell surface receptors for the 
Fc part of immunoglobulin and have a major role in linking the innate and adaptive 
immune responses by binding to the Fc portion of the antibodies (Nimmerjahn and 
Ravetch, 2007). A study identified that NP surfaces adsorbed with Fc molecules 
increased the cellular uptake of these particles more than the endocytosis of molecular 
IgG (Vllasaliu et al., 2012). Mannose receptors are glycoprotein endocytic receptors 
that binds to carbohydrate domains of microbes and endogenous ligands (Pawde et 
al., 2020). Jain et al., 2008 demonstrated that gelatine NP surface deposited with 
mannose significantly increased the uptake of the NPs compared to the unmodified 
gelatine NPs. Scavenger receptors are PRRs and they can recognise and bind to a 
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number of ligands such as pathogens, lipoproteins and foreign particles which are 
negatively charged (Shannahan, Bai and Brown, 2015). Upon binding to these ligands, 
cellular uptake is promoted and pro-inflammatory responses can also be induced 
(Shannahan, Bai and Brown, 2015). 
 
NPs that have been tailored to specifically target Fc receptors and mannose receptors 
were shown to be internalised quicker than those targeting scavenger receptors 
(Taylor et al., 2005), suggesting that these two receptors are more effective in the 
endocytosis of NPs. Macrophages are also able to internalise NPs without bound 
serum proteins, which further suggests that the four receptors mentioned above can 
independently recognise the NPs without the help of protein coating, unless it is a non-
specific endocytic pathway such as macropinocytosis (Dutta et al., 2007). 
Understanding the interactions between surface receptors on macrophages and NPs 
is crucial in the engineering of NPs for drug delivery or other therapeutic purposes.  
 
1.9 Intracellular trafficking of NPs 
After endocytosis and uptake of NPs across the plasma membrane, their intracellular 
trafficking determines their intracellular fate in the cell, which in turn determines the 
therapeutic efficacy and cellular toxicity of NPs (Peñaloza et al., 2017). Once 
internalised, the NPs will first come into contact with membrane-bound early 
endosomes, which are intracellular vesicles that bud off the plasma membrane 









Endosomes formed at the plasma membrane are key players in controlling recycling 
and degradation of internalised molecules/particles and thus endosomes can be 
classified into early endosomes, late endosomes or recycling endosomes (Scott, 
Vacca and Gruenberg, 2014) (see figure 1.6 above for summary).  
 
Early endosomes carry cargo molecules/particles internalised from extracellular 
surroundings through endocytosis and the main function of early endosomes is to then 
Figure 1.6. Overview of intracellular trafficking of endocytosed material. 
The above figure shows an overview of the intracellular trafficking of 
internalised cargo molecules and particular proteins involved in the trafficking 
at each stage. Vesicles with the cargo molecule bud off from the plasma 
membrane to fuse with early endosomes, with the involvement of particular 
proteins such as Rab5-GTP, PI3P Kinase and EEA1. Recycling endosomes 
are formed through fission of early endosomes and carry cargo molecules to 
be recycled back to the plasma membrane. Early endosomes give rise to late 
endosomes through maturation and differentiation, which can deliver cargo 
molecules to lysosomes or alternatively fuse with lysosomes for the ultimate 
purpose of degradation. During the maturation of early endosomes, proteins 
can also be transported back and forth to the trans-Golgi network. Reference 
and image from: Kaur & Lakkaraju, 2018. 
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sort those cargo molecules/particles either into recycling compartments to be taken 
back to the plasma membrane or into degradative compartments such as the 
lysosomes where the cargo molecule/particle is degraded (Kaur and Lakkaraju, 2018). 
Through the fission of early endosomes into smaller recycling endosomes, certain 
cargo molecules such as ligands, lipids and plasma membrane proteins are 
transported back to the plasma membrane by these recycling endosomes (Kaur and 
Lakkaraju, 2018). Recycling endosomes are likely to traffic cargo molecules to be 
recycled to the plasma membrane via different trafficking pathways depending on the 
individual cargo molecule in the vesicle and much about the mechanisms regulating 
these pathways is yet to be understood but a number of these may operate via 
microtubule-based pathways (Goldenring, 2015).  
 
Late endosomes are formed by the differentiation and maturation of early endosomes 
which can transport the molecule/particle to the lysosomes where they are degraded 
(Huotari and Helenius, 2011). Late endosomes can also fuse with lysosomes to form 
endolysosomes where the enclosed molecules/particles are degraded by hydrolytic 
enzymes (Foroozandeh and Aziz, 2018).  Lysosomes are acidic organelles where 
degradation of proteins, lipids and polysaccharides occur in a cell, although some NPs 
are able to evade the endosome before lysosomal degradation by being released into 
the cytoplasm, which is a feature particularly of interest in cytosolic drug delivery 
(Martens et al., 2014). One study investigated the intracellular trafficking of different 
sized polystyrene NPs (Sandin et al., 2012). The study found that small NPs (40nm) 
are trafficked through Rab5 and are quickly transferred to late endosomes (Rab9) 
before finally localising to lysosomes (using Rab7 as a marker). They also showed 
that larger sized NPs (100nm) are also trafficked through the same endosomes but at 
 32 
a slower rate than the smaller NPs. Due to a lack of sufficient colocalisation of NPs, 
with Rab 11 (a marker for recycling endosomes), Sandin et al. (2012) also reported 
that the recycling of NPs to the plasma membrane is unlikely, although some NPs 
manage to access the recycling endosomes. Other studies using Silica NPs have 
observed similar fate and trafficking patterns of NPs in lymphoid and myeloid cells 
(Sola et al., 2021). The current literature contains gaps for the studies of intracellular 
trafficking of IONPs and further studies need to be carried out to broaden the 
understanding of the trafficking of IONPs, particularly if they are to be used for 
intracellular targeting.  
 
Autophagy is another degradation pathway in cells which can contribute to the 
intracellular fate of NPs and this pathway can also be a result of toxic effects induced  
NPs (Wang et al., 2017). Autophagy is a process mediated by an organelle called 
autophagosome, during which components of the cytoplasm are targeted for 
degradation by lysosomes and recycled (Wang et al., 2017). Thus, studying the 
intracellular fate of NPs is especially important if the NPs are intended to be used as 
drug delivery vehicles and depending on whether they are recycled or degraded can 
bring their therapeutic efficiency and cytotoxicity into question.  
 
1.10 Biomarkers of Nanoparticle immunotoxicity 
Toxic effects of NPs differ between different types of NPs, particularly depending on 
physical and chemical properties, as mentioned previously. Regardless of these 
characteristics, upon administration, NPs will undoubtedly encounter components of 
the immune system, especially the innate immune system as it is the host’s first line 
of defence against ‘foreign’ material. NPs can interact with the innate immune system 
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to either enhance the immune response, triggering a pro-inflammatory response, or 
suppress the immune response resulting in an anti-inflammatory response (Elsabahy 
and Wooley, 2013). Depending on their intended purpose, NPs can be designed to 
specifically induce proinflammatory or anti-inflammatory responses in the body, 
however, concerns arise when administered NPs interact with the immune system in 
an undesirable way, resulting in unwanted pathologies such as hypersensitivity 
reactions and inflammation (figure 1.7) (Zolnik et al., 2010). Furthermore, the 
inflammation response against NPs can significantly alter the residence times of NPs 
in the body, which can in turn affect their bioavailability and therapeutic efficacy. For 
example, one study showed that human properdin opsonised carbon nanotubes 
generated a high pro-inflammatory response and an increased uptake in human 
macrophages, suggesting that the clearance of NPs by the immune system can  be 
influenced by the local synthesis of complement proteins, regardless of whether there 
is activation of the complement system (Kouser et al., 2018). 
 
Immunosuppressive effects exhibited by NPs can be favourable for a decreased risk 
of autoimmune reactions but on the other hand a suppressed immune system can be 
favourable for the growth of cancerous cells (Ngobili and Daniele, 2016). A study 
investigating the immunosuppressive effects of carbon nanotubes (CNTs) showed that 
administration of CNTs through inhalation suppressed the function of B cells, 
increased Transforming growth factor (TGF)-β secretion, and triggered the secretion 
of the anti-inflammatory cytokine IL-10, leading to immunosuppressive effects 
(Mitchell et al., 2009). On the other end of the spectrum, unintended 
immunostimulatory effects exhibited by NPs can result in the development of 
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autoimmune reactions such hypersensitivity reactions or more severe reactions such 






Cytokines are powerful tools in immunotoxicity studies and can be used as biomarkers 
to study pro-inflammatory and anti-inflammatory effects of NPs. Cytokines give a good 
indication of immunomodulatory effects and NP inflammation-mediated toxicity 
(Elsabahy and Wooley, 2013). Furthermore, some studies showed that heating the 
tissue with magnetic IONPs, under the appropriate conditions can further enhance the 
Figure 1.7. Interactions of nanoparticles with the immune system. The 
above image shows the different effects that can occur upon nanoparticle 
interaction with the immune system, which are important factors to be 
considered during the development of nanotherapeutics. Administered NPs 
can either enhance or suppress normal immune function, which can result in 
unwanted effects and pathologies. Image from: Zolnik et al., 2010. 
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immune response which benefits cancer treatment (Grauer et al., 2019). Cytokines 
are small pleiotropic proteins secreted by immune cells during an immune response 
and secretion of pro-inflammatory cytokines results in immune cell activation and 
production of other inflammatory cytokines whereas secretion of anti-inflammatory 
cytokines counteracts the action of pro-inflammatory cytokines, suppressing the 
immune response (Kany, Vollrath and Relja, 2019). Some studies reported that IONPs 
can interact with immune cells in vitro and increase oxidative stress, thus inducing 
apoptosis (Dobrovolskaia, Germolec and Weaver, 2009). Currently, the 
biodistribution, metabolism and excretion of NPs is still not fully understood, mainly 
owing to the lack of successful techniques and methods to measure NPs in tissues. 
However, multiple studies have reported the frequent accumulation of various NP 
types in unwanted organs (Ganapathy, Moghe and Roth, 2015). Furthermore, studies 
have provided evidence that show metal NPs can cause sub-lethal effects in zebrafish 
including oxidative stress, respiratory toxicity and disturbances to trace elements in 
tissues (BJ and RD, 2011). 
 
Activated macrophages are one of the main immune cells which secrete cytokines. 
Upon exposure to a pathogen or ‘danger signal’ they act as a communicating 
mechanism to link the innate and adaptive immune system (Arango Duque and 
Descoteaux, 2014). Some of the pro-inflammatory cytokines secreted by 
macrophages are IL-1, TNF (tumour necrosis factor), IL-6, IL-12 and IL-12 (Arango 
Duque and Descoteaux, 2014). One study investigated the interactions of 5-8nm 
magnetite NPs and immune cells in mouse models and reported a dose-dependent 
increase of pro-inflammatory cytokines IL-6, IL-1 and TNF- in the blood (Park et al., 
2010). TNF is one of the pleiotropic cytokines, which means it can act on different 
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signalling pathways and is known to be involved in apoptosis, activation of stress-
activated protein kinases and NF-B activation (Zhang and An, 2007). In vitro and in 
vivo studies have shown that NF-B activation and pro-inflammatory cytokine 
production (such as IL-8, IL-6, TNF- and IL-1β) were triggered by carbon nanotubes 
and metallic NPs (Pujalté et al., 2011). Other studies have shown that complement 
deposited carbon nanotubes downregulated TNF- and IL-1β, and upregulated IL-12 
levels in a human monocytic cell line (Pondman et al., 2016). The same study also 
identified IL-10, which is a potent anti-inflammatory cytokine, to mediate a key role in 
the immunomodulatory effects during NP interaction with immune cells.  
Overexpression of pro-inflammatory cytokines can lead to inflammation related 
pathologies, for instance, normal secretion of IL-6 is important during inflammation by 
promoting the differentiation and development of T cells, however abnormal IL-6 
upregulation is linked to many inflammatory diseases such as Crohn’s disease and 
rheumatoid arthritis (Nishimoto and Kishimoto, 2004). Moreover, overexpression of 
pro-inflammatory cytokines such as IL-1β, TNF- and IL-6 are involved in pathological 
and neuropathic pain (Zhang and An, 2007). Additionally, one study showed that 
aberrant IL-8 expression is involved in acute lung injury (Allen and Kurdowska, 2014). 
Anti-inflammatory cytokines are immunosuppressive and control the actions of pro-
inflammatory cytokines. Some examples of potent anti-inflammatory cytokines are IL-
10, IL-4, IL-11, IL-13 and IL-1 receptor antagonist (Opal and DePalo, 2000). IL-10 is 
the most potent of them and can suppress the effects of pro-inflammatory cytokines 
such as IL-1, IL-6 and TNF- (Gibson et al., 2013). TGF-β also has anti-inflammatory 
effects by suppressing cytokine functions such as IL-1, IL-6, IL-2 and TNF- and also 
acts as an antagonist for the production of nitric oxide in macrophages, which is 
increased in neuropathic pain (Echeverry et al., 2009). 
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Hence, an effective immune response is carefully regulated by the intricate network of 
cytokines. Abnormal cytokine expression levels can lead to diseases, including 
autoimmune reactions and tumour progression. Thus, studying the effects of 
nanoparticle exposure on cytokine expression levels is a key part of immunotoxicity 
studies of NPs.  
 
1.11 Transcriptome profiling to assess nanoparticle toxicity 
A transcriptome consists of all RNAs transcribed by cells or tissues at a particular 
physiological condition or developmental stage (Yang et al., 2020). High-throughput 
sequencing (HTS) technologies such as RNA sequencing or microarray technologies 
can be used to understand diseases at a molecular level and identify pathways 
affected following treatments by analysing gene transcription levels (Yang et al., 
2020). Identifying the molecular responses to NP exposure is a powerful approach 
which can contribute to the understanding of toxic effects exhibited by NPs and can 
also open new premises for the development of targeted therapies. For example, 
through RNA sequencing a study has shown that high doses of silicon dioxide NPs 
inhibited the transcription of specific genes that may be involved in neurotoxicity and 
apoptosis (Sun et al., 2017). Another study used RNA sequencing to study the toxicity 
of iron sulphide NPs in adult zebrafish and identified that exposure to iron sulphide 
NPs caused significant changes in gene expression in the liver cells relating to 
inflammatory responses, oxidative stress, detoxification and DNA damage/repair 
(Zheng, Lu and Zhao, 2018).  
 
Other than toxicity, transcriptome profiling can also be used to identify pathways 
activated in the cellular uptake of NPs. For example, through RNA sequencing, a study 
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identified that nanosilicates were taken up by human mesenchymal stem cells through 
clathrin-mediated endocytosis (Carrow et al., 2018a). Furthermore, other studies 
identified that gold NPs triggered oxidative stress, which lead to physical damage of 
neurons and lack of cell-to-cell communication, thus identifying the neurotoxicity of 
gold NPs through the use of RNA sequencing (Mo et al., 2020). Transcriptome profiling 
allows researchers to identify changes at the base level and it can provide good 
indication of toxicity of NPs on a wider range of pathways, which can be translated to 
pathological conditions. Moreover, identifying changes in gene expression can provide 
great insights into identifying new strategies for therapeutic and diagnostic targets. 
Hence, transcriptome profiling is a useful tool in studying the toxicity of NPs at a 
molecular level. 
 
1.12 Animal models to study nanoparticle toxicity 
Several animal models are used to assess toxicity of NPs on a physiological level, the 
most common models being mice, rats and zebrafish (Danio rerio). The literature 
shows that zebrafish have traditionally been for aquatic toxicity testing and in the last 
decade, zebrafish have been characterised as established animal models to study NP 
toxicity (Chakraborty et al., 2016).  In addition, nowadays many countries are adopting 
the “Three R’s” principle in animal research, which stand for Replacement, Reduction 
and Refinement, encouraging the use of alternative animal models (Tonelli et al., 
2020). Thus, zebrafish are becoming increasingly popular for toxicity studies both in 
the embryonic and adult stage, each of them having special and desirable 
characteristics for research purposes. Some advantages of using zebrafish in 
research are their small size, embryo transparency, quick development, high 
reproducibility and low maintenance costs compared to other animal models (Strähle 
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et al., 2012). Furthermore, zebrafish embryos are desirable replacements for the study 
of early developmental stages since the embryos are likely to suffer less pain or even 
no pain at all (Strähle et al., 2012). Additionally, following gene mapping in zebrafish, 
it was found that the zebrafish genome displays approximately 75% similarity with the 
human genome which makes zebrafish an even more desirable animal model 
(Chakraborty et al., 2016a).  
 
Toxicity in zebrafish can be studied through hatching analysis, malformations of 
embryos, behavioural studies, immunotoxicity, genotoxicity, breeding patterns and 
measurement of mortality rate (Cassar et al., 2020). Moreover, zebrafish 
embryos/larvae lack adaptive immunity for the first 4 weeks and solely rely on their 
innate immune system during early development (Trede et al., 2004), making them 
particularly attractive models to immunologists. Thus, zebrafish as an animal model 





The aim of this thesis is to study the intracellular fate and toxicity of IONPs. We are 
particularly interested in the intracellular trafficking of IONPs in macrophages and the 
innate immune responses triggered by IONPs following uptake by macrophages. 
Furthermore, zebrafish (danio rerio) embryos we used as in vivo models to assess the 
biodistribution and toxicity of IONPs. We also aimed to label macrophages in vivo to 
study IONP distribution and uptake by macrophages in zebrafish. We hypothesise that 
IONPs behave differently when a protein corona is adsorbed to their surface compared 
















All buffers and solutions in this section were prepared as stated below, unless 
otherwise specified. 
Magnetic iron oxide nanoparticles (IONPs) 
Product code: nano-screenMAG-D/R, purchased from the manufacturer Chemicell. 
IONPs stock concentration: 25 mg/ml (in aqueous dispersion). Particle size: 100nm. 
Phosphate Buffer Saline (PBS) (ThermoScientific) 
PBS was prepared using OxoidTM Phosphate Buffered Saline Tablets (Dulbecco A) 
diluted in dH2O. 
Permeabilisation buffer for immunohistochemistry 
20mM HEPES, 300mM Sucrose, 50mM Sodium chloride, 3mM Magnesium chloride, 
0.5% Triton X-100 and Sodium azide. 
Saponin buffer for immunohistochemistry 
0.5% BSA (Bovine Serum Albumin), 0.1% Saponin and Sodium azide. 
DGVB++ buffer 
2.5 mM Sodium barbital, 71 mM NaCl, 0.15 mM CaCl2, 0.5 mM MgCl2, 2.5% w/v 
Glucose and 0.1% w/v Gelatin. 
EGTA Buffer 
2.5 mM Sodium barbital, 71 mM NaCl, 7 mM MgCl2, 10 mM EGTA, 2.5% w/v Glucose 
and 0.1% w/v Gelatin.  
Live cell imaging medium 
140 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2 and 20mM HEPES (pH 7.4). 
E3 medium (zebrafish embryos) 
5.0 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl and 0.33 mM MgSO4. 
Mowiol Mounting Solution 
 43 
4.3 mM Mowiol 4-88 (Sigma Aldrich), 0.2M Tris (pH 8.5) and 0.02% Sodium azide. 
SDS acrylamide gel (separating layer) 
12% acrylamide mix (37:1), 0.375M Tris (pH = 8.8), 0.1% SDS, 0.1% ammonium 
persulfate, 0.001% TEMED and dH2O.  
SDS acrylamide gel (stacking layer) 
3.75% acrylamide mix (37:1), 0.125M Tris (pH=8.8), 0.1% SDS, 0.1% ammonium 
persulfate, 0.1% TEMED and dH2O. 
SDS loading buffer 
50mM Tris (pH=6.8), 100mM dithiothreitol, 2% SDS, 0.1% bromophenol blue and 10% 
glycerol. 
Running buffer 
25mM Tris (pH=8.3), 192mM Glycine and 0.1% SDS. 
Transfer buffer 
25mM Tris (pH=8.3), 192mM Glycine and 20% w/v methanol. 
Enhanced Chemiluminescence Solution 
0.1M Tris, pH=8.8 (solution A), 90mM Coumaric acid (solution A), 250mM Luminol 
(solution A), 0.1M Tris, pH=8.8 (solution B) and 30% hydrogen peroxide (solution B). 
 
2.2 Cell Culture 
The cells studied in this thesis are RAW 264.7 cells. RAW 264.7 is a mouse 
monocytic/macrophage cell line derived from the tumour of a male mouse 
intraperitoneal injected with Abselon Leukaemia Virus (A-MuLV). RAW cells are 
established models of macrophages are of particular interest in this thesis due to their 
ability to perform phagocytosis and pinocytosis. RAW cells are phenotypically and 
functionally stable, and it is a well characterised cell line with regards to macrophage-
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mediated immune, metabolic and phagocytic functions (Taciak et al., 2018). RAW 
cells were grown in cell culture flasks in a humidified incubator of 5% CO2 at 37C. 
RAW cells were cultured in RPMI 1640 medium (Biosera) and were passaged by 
scraping off adhered cells using a cell scraper once the cells were 70 - 80% confluent. 
RPMI cell culture media contained 1% stable glutamine (2mM), 10% FCS (Foetal Calf 
Serum) and 1% Pen Strep (Penicillin 100 U/ml and Streptomycin 100g/ml, 
antibiotics). Experiments were performed with the cell line for up to 30 passages, since 
the efficacy is likely to decrease beyond that point. 
 
2.3 Preparation of cells 
The cells were passaged when they were about 80% confluent and counted using a 
haemocytometer. Once counted, approximately 30,000 cells per well (60,000 cells/ml) 
were seeded in 24-well tissue culture plates and each well contained a 13mm coverslip 
for immunofluorescence staining. The cells were allowed to adhere and grow for 24 
hours before the addition of IONPs. Prior to the addition of IONPs, the cell medium 
was changed to serum-free medium (FCS absent) containing 1% Pen Strep. Serum-
free medium was used in order to eliminate serum proteins in the cell culture medium 
as a variable in the study of the uptake of IONPs by the cells.  
 
2.4 Preparation and Addition of  Nanoparticles 
From a stock concentration of 25 mg/ml, the IONPs were diluted appropriately to 
obtain a final concentration of 10 g/ml. Studies have shown that using lower IONP 
(size range 15-30nm) concentrations (25-200 g/ml) maintained >95% cell viability for 
prolonged exposure times when compared to high IONP concentrations (300-500 
g/ml) (Naqvi et al., 2010).  The study by Naqvi et al. concluded that using a low 
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optimum concentration of IONPs avoids ROS-induced cell injury and death as the 
damage caused to cells is both time- and concentration-dependent. For all in vitro 
experiments in this thesis, a concentration of 10 g/ml was used after testing for the 
optimal concentration where cell viability is maintained after 24 hours of IONP 
exposure and where IONPs are clearly visible under the microscope. Additionally, due 
to long-term IONP supply shortages from the manufacturer at the time when 
experiments were performed, the amount of IONPs available had to be carefully 
managed. The IONPs used in this thesis are commercially available, consisting of a 
magnetite core, which is first covered by a lipophilic fluorescence dye, followed by a 
second layer enveloping the particle with a hydrophilic polysaccharide matrix (starch) 
(Manufacturer: Chemicell) (Figure 2.1). In addition to low toxicity, spherical magnetite 
NPs provide a high surface area for adsorption and for surface modifications using 
molecules or drugs for targeted delivery (Natarajan et al., 2019). Furthermore, due to 
their magnetic properties, they can be controlled and separated using an external 
magnetic field. In this thesis, IONPs with a 100nm diameter were used for all 
experiments. For intracellular drug delivery, the favourable particle size for IONPs is 
between 10nm – 100nm as these provide the longest blood circulation times (Turrina, 
Berensmeier and Schwaminger, 2021). To confirm the 100nm size of the particles 
stated by the manufacturer and for further characterisation of IONPs, TEM 
(transmission electron microscopy) and DLS (dynamic light scattering) techniques can 







Surface coatings on particles increase their biocompatibility and stability in 
bioenvironments, allowing for better targeted delivery and increased therapeutic 
efficacy. Additionally, due to strong magnetic attractions between particles, iron oxide 
particles with no surface coatings have an increased tendency of forming aggregates, 
resulting in large clusters, which are then cleared from the body by phagocytic cells 
(Xia et al., 2012). Furthermore, high concentrations of local Fe ions from Fe dissolution 
poses additional toxicity concerns for organisms, which can be avoided by the use of 
surface coatings (Ali et al., 2016). Due to their non-toxic nature, polysaccharides are 
often used as surface coatings to prevent the formation of particle aggregates as well 
as increasing particle stability and providing a high sorption capacity, making them 
favourable for targeted drug delivery (Stolyar et al., 2021).  
 
To help in understanding the uptake and intracellular fate of IONPs, ‘naked’ and serum 
deposited IONPs were added to the cells to compare uptake patterns. For the serum 
protein coating, IONPs were diluted in complete serum (no addition of other buffers) 
and the ‘naked’ IONPs were diluted in PBS only (Phosphate-Buffered Saline). The 
samples were briefly vortexed and incubated for 1 hour at 37C on a shaker. After 1 
Figure 2.1. Structure of iron oxide 
nanoparticles. This image shows the composition 
of the nanoparticle, with a magnetite core, a layer 
of lipophilic fluorescence dye and a second layer 
of a polysaccharide matrix. Image taken 
manufacturer website (Chemicell) 
Magnetite core 
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hour, the IONPs were washed three times with PBS to remove any excess proteins or 
ions from the solution using the following steps: Sterile PBS was added to both 
Eppendorf tubes in a 1:1 ratio of the volume present in the Eppendorf tube. The 
Eppendorf tubes were briefly vortexed and then centrifuged at 13,000 rcf for 3 minutes 
using a microcentrifuge (Fisher Scientific AccuSpin Micro R Centrifuge). The tubes 
were then placed on a magnetic rack for about one minute before carefully removing 
the supernatant, without disturbing the pelleted IONPs. The first step is repeated, 
keeping the volume of PBS added consistent. The tubes were briefly vortexed and 
centrifuged for 3 minutes, then placing them again on a magnetic rack for a minute. 
The supernatant is carefully removed and the same amount of PBS is added once 
more to both tubes. Both tubes were vortexed and then ultrasonicated in a sonicator 
water bath (Transonic T460, Camlab) for 15-20 minutes to disperse the IONPs evenly 
throughout the PBS solution. After the first few experiments, the sonication method 
was changed to using an ultrasonic sonicator probe (MSE Soniprep 150 Sonicator, 
amplitude = 26) for better dispersion of IONPs in the solution. 
Once the IONPs were washed and sonicated, they were added to the 24-well plate 
containing the cells and a magnet (Neodymium magnets) was placed underneath the 
wells to pull the IONPs to the bottom of the wells. The magnet was used to eliminate 
the NPs settling time as an influencing factor when studying uptake and percentage 
uptake as the IONPs take about 11 – 16 hours to naturally reach the bottom of the 
plate where the cells are growing (Figure 3.4). 
The main time points studied were 1 hour, 2 hours, 4 hours and 24 hours after the 
addition of IONPs. After 1 hour, the medium in the wells was removed and the wells 
were washed twice with PBS. The coverslips, with the cells adhered onto them, were 
transferred to a fresh 24-well plate to be fixed. The cells were fixed for 10 minutes at 
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room temperature using 4% PFA (paraformaldehyde) in PBS. To make 4% PFA, 
paraformaldehyde (TAAB Laboratories) was dissolved in PBS by heating the mixture 
to 70C, the pH was then adjusted to 7 using NaOH, following which the mixture was 
filtered and aliquoted. 
After fixing, the cells were washed three times with PBS and stored at 4C ready for 
immunofluorescence staining. The same process was repeated to fix the cells at the 
remaining time points. The cells were then stained on the same day or within the next 
five days.  
 
2.5 Immunofluorescence Staining 
Indirect immunofluorescence was used to detect the antigens of interest. Cell 
membranes were permeabilised using permeabilisation buffer with Triton X-100 for 5 
minutes on ice. However, Triton X-100 is a non-selective detergent, which can also 
extract proteins along with the lipids (Jamur and Oliver, 2010). Alternatively, other 
buffers such as saponin buffer can be used at room temperature throughout the 
staining protocol as saponin is a selective buffer which interacts with membrane 
cholesterol forming temporary reversible holes in the membrane (Medepalli et al., 
2013). If Triton X-100 is used as a permeabilising agent, the buffer used for the rest of 
the protocol is 5% BSA in PBS or 5% FCS in PBS. If saponin is being used as a 
permeabilisation agent, the permeabilisation step can be omitted, thus starting directly 
with the blocking step. The 24-well plate containing the fixed coverslips were blocked 
with a blocking solution comprising of 5% BSA in PBS (if Triton X-100 was used) or 
saponin buffer, depending on the antibody used. Blocking of the coverslips prevents 
any non-specific binding of the antibodies. After blocking, the coverslips were 
transferred to an incubation chamber at room temperature which contained moist 
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The primary antibodies used were diluted accordingly in the buffer used. The 
mastermix was then pipetted onto each coverslip (30 l per coverslip) and left to 
incubate at room temperature in the incubation chamber for 30 minutes.  
After the primary antibody incubation, the coverslips were transferred back into their 
respective wells to be washed in the buffer for 30 minutes.  
The mastermix for the secondary antibodies was prepared similar to the primary 
antibodies. The coverslips were transferred again into the incubation chamber to be 
incubated with the secondary antibodies for 30 minutes. The incubation for the 
Moist pieces of tissue




Figure 2.2. Incubation chamber set up. The above shows an 
illustration of the incubation chamber set up during 
immunofluorescence staining. Coverslips were placed on a 
piece of parafilm before adding the antibody mastermix. Moist 
pieces of tissue paper were placed at both ends and a lid was 
placed on top of the chamber to prevent drying out of 
coverslips. 
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secondary antibodies was carried out at room temperature in the dark to avoid any 
fluorophore bleaching due to the fluorescently labelled antibodies being light sensitive.  
 
The coverslips were transferred back into the wells to be washed; the washes were 
also carried out in the dark for 30 minutes. The buffer was changed at regular time 
intervals for clearer images under the microscope. After the last wash, the coverslips 
were ready to be mounted onto slides. A drop of Vectashield Mounting Medium (Vector 
Laboratories) was added onto each coverslip before carefully placing a cover glass 
onto the coverslips. The slides were imaged using a Leica DM4000 Fluorescence 
microscope (LAS software) and Nikon Eclipse TE2000-S Confocal microscope (EZ-



















Lectin - Invitrogen 
Anti-Rab7 1:200 Late 
endosomes 
Primary Mouse Abcam 
Anti-Rab5 1:200 Early 
endosomes 
Primary Rabbit Abcam 
Anti-
SOD2/MnSOD 
1:200 Mitochondria Primary Rabbit Abcam 
Anti-Syntaxin 6 1:200 Golgi 
apparatus 
Primary Mouse BD 
Transduction 
Labs 
Anti-Caveolin-1 1:100 Caveoli  Primary Mouse BD 
Transduction 
Labs 
Anti-ERp72 1:100 Endoplasmic 
reticulum 
Primary Rabbit Cell 
Signalling 
Technology 
Anti-Rab9 1:100 Late 
endosomes 
Primary Rabbit Abcam 
Hoechst 33342 1:10000 Nucleic acid - - Invitrogen 




1:100 - Secondary Goat ThermoFisher 
Scientific 




1:100 - Secondary Goat ThermoFisher 
Scientific 
Alexa Fluor 488 
anti-rabbit 
1:100 - Secondary Goat ThermoFisher 
Scientific 
Alexa Fluor 546 
anti-rabbit 
1:100 - Secondary Goat ThermoFisher 
Scientific 
Figure 2.3. Table of antibodies used in immunofluorescence staining. This table shows all 
antibodies used in this thesis, along with dilution factors and manufacturers. Ex=excitation, 
EM=emission. 
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2.5.1 Colocalisation quantification 
 
Following organelle staining as described above, the images obtained from 
microscopy were analysed using the open source software Fiji ImageJ 
(https://imagej.net/Fiji) and quantified by manual counting. An example of 
colocalisation quantification between human serum deposited IONPs and caveolae is 
shown in the table below. Quantification for 1 hour time point is given as an example 
below, all time points were analysed in the same way. The table includes data from 
two experimental repeats. All colocalisation quantifications in chapter 3 were carried 


























17.02.17 - 1h - 002 19 7 36.84 0 0 
17.02.17 - 1h - 005 10 3 30.00 0 0 
17.02.17 - 1h - 007 16 5 31.25 0 0 
17.02.17 - 1h - 009 13 5 98.46 0 0 
17.02.17 - 1h - 011 22 7 31.82 0 0 
13.03.17 - 1h - 002 9 6 66.67 0 0 
13.03.17 - 1h - ph002 7 3 42.86 0 0 
13.03.17 - 1h - 004 11 4 36.36 1 9.09 
13.03.17 - 1h - 006 8 4 50.00 0 0 
13.03.17 - 1h - 008 11 6 54.55 1 9.09 




Figure 2.4. Table layout for organelle quantification. This table shows how colocalisation was 
quantified following organelle staining in chapter 3. The table shows data for the 1 hour time point of 
two independent experiments. First, the total number of cells in each image was counted. The number 
of cells which have internalised IONPs are then counted. The number of cells with colocalisation 
between IONPs and caveolae was also counted. To determine % of cells containing IONPs: B/A*100. 
To calculate % of cells with colocalisation: D/A*100. All graphs were plotted as an average percentage 
of each time point. Graphs were plotted using GraphPad Prism. 
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For all colocalisation quantification purposes, multiple images were taken per slide so 
that the quantification was carried out using at least 5 different fields of view per 
experiment for each time point. Experiments were carried out at least twice and 
average percentage colocalisation values were used to plot the graphs, using 
standard deviation as error bars. Colocalisation was visually identified as an overlay 
of both colours (red for IONPs and green for protein/organelle of interest) through the 
microscope lens of the Leica DM4000 microscope. Confocal microscopy was also 
used to take z-stack images of samples to confirm colocalisation, where strong 
colocalisation was seen using the Leica DM4000 microscope. Alternatively, Fiji 
ImageJ could be used to measure fluorescence or pixel intensity to quantify 
colocalisation from composite images, however, background noise and cross-staining 
need to be taken into account when using this method to avoid false positive results.  
 
2.6 Veronal buffers 
Two veronal buffers, DGVB++ and EGTA buffer, were used during IONP preparation 
in order to compare IONP uptake pattern in the cell line when the classical pathway 
was triggered versus the alternative pathway of the innate immune system. With the 
use of DGVB++ buffer, we aim to measure deposition of serum components associated 
with the classical pathway. Even though the buffer is able to activate all three pathways 
(classical, alternative and lectin pathways), the classical pathway can be activated with 
a lower serum concentration compared to the other two pathways (Moreno-Indias et 
al., 2012a). DGVB++ buffer contains both Mg2+ and Ca2+ ions which are essential to 
activate the classical pathway because this pathway contains a calcium-dependent 
step. On the other hand, the EGTA buffer does not contain Ca2+ ions and hence only 
the alternative pathway can be activated, thus only components of the alternative 
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pathway will be deposited on the IONPs through the use of this buffer. During IONP 
preparations for serum-coating, both buffers were diluted in a 1:1 ratio with the serum 
used. The steps for deposition were the same as described in section 2.4. Details of 




Approximately 60,000 cells/ml were seeded in a 24-well plate set up with 13mm 
coverslips and the IONPs were prepared and added to the cells as described 
previously. The IONPs were left to incubate with the cells at 37C for 24 hours before 
adding green LysoTracker (Cell Signalling Techonology, #8783) to separate wells in 
the plate. LysoTracker is a cell permeable dye which stains acidic compartments 
(lysosomes) in live cells. The concentration of lysotracker used per well was 100nM. 
Following addition, LysoTracker was left to incubate with the cells at 37C for 15 
minutes, after which the cells were washed three times using warm PBS. The cells 
were then mounted onto slides using imaging medium (section 2.1, materials), without 
fixing. The live cells were imaged immediately under the Leica microscope.  
 
2.8 Dextran: a marker for fluid phase endocytosis 
Dextrans are polysaccharides and are made of chains of varying lengths and one of 
their many uses is as a fluid-phase marker. Dextrans have high water solubility and 
behave as Newtonian fluids (Xu et al., 2009).  
Cells were seeded as described in section 2.3 in a 24-well tissue culture plate, 24 
hours prior to adding the IONPs and dextran. The IONPs were prepared as described 
previously and the FITC labelled dextran (Mr = 20,000, 40,000 (Sigma) and 70,000 
(Invitrogen)) was prepared to a concentration of 100mg/ml in PBS. The dextran was 
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further diluted to obtain a final concentration of 100g/ml in each well. The dextran 
was added to the wells at the same time as the addition of IONPs. After incubation at 
37C, cells were washed with PBS and fixed at time points 1 hour, 2 hours, 4 hours 
and 24 hours using 4% PFA. Once fixed, the cells were stained with Hoechst 33342 
to reveal DNA and the nucleus and imaged under the Leica fluorescence microscope 
and Nikon confocal microscope.  
 
2.9 Western Blotting 
Western blot experiments were carried out to measure the level of C3 protein 
adsorption to the IONPs after 1 hour incubation with human serum vs. overnight 
incubation with the aim of increasing time efficiency for zebrafish embryo 
microinjections. IONPs were incubated with human serum as described in 2.4, 
following which they were run on an SDS gel as described below. After incubation with 
the sera and washing with PBS, IONPs were pelleted and resuspended in SDS sample 
buffer. Before loading on the SDS gel, samples were boiled on a heat block for 5 
minutes and centrifuged for 3 minutes at 13,000 RPM using a microcentrifuge. The 
samples were then loaded onto a 12% SDS acrylamide gel (section 2.1, materials), 
along with 5l of a protein marker, ‘colour plus’ (New England BioLabs). The gel was 
run on a mini-PROTEAN electrophoresis tank (BioRad) for 1 hour at constant current 
(25mA). Once the proteins had run to the bottom of the gel after approximately 1 hour, 
the membrane ‘sandwich’ for protein transfer onto a nitrocellulose membrane was 







The assembled membrane ‘sandwich’, an ice pack and a magnetic stirrer were added 
to the tank along with 1X transfer buffer. The transfer was run for 1 hour at constant 
voltage (100V). Since the transfer was run at a very high current, the ice pack and 
magnetic stirrer were added to avoid any overheating.  
After the transfer, 5% ponceau-S in acetic acid (Sigma Life Sciences) was added to 
the nitrocellulose membrane in a petri dish for 3 minutes to check for the presence of 
protein bands on the membrane. Once the protein bands were visible, the ponceau-S 
was washed off with deionised water followed by PBS containing 0.1% Tween 20 
(PBS-Tween) (two 5 minute washes). 
 
After ponceau-S staining, the nitrocellulose membrane was blocked for 1 hour at room 
temperature with 5% milk powder in PBS-Tween on an orbital shaker. The 
nitrocellulose membrane was then washed twice with PBS-Tween (5 minute each) 
and the primary antibody was prepared according to its dilution in 5% milk and was 
then added onto the nitrocellulose membrane overnight at 4C on an orbital shaker.  
Figure 2.7. Order of assembled membrane ‘sandwich’. After the 
SDS acrylamide gel was dismantled following the run, the membrane 
‘sandwich’ was prepared as shown above. The sponges, filter papers 
and nitrocellulose membrane were pre-soaked in 1X transfer buffer 
prior to assembly. Image from: abcam. 
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Following overnight incubation, the membrane was washed at room temperature with 
PBS-Tween (two 5 minute washes) and kept in PBS-Tween until it was developed. 
ECL (enhanced chemiluminescence) solutions were prepared and incubated with the 
nitrocellulose membrane for one minute at room temperature immediately before 
developing the membrane onto a film in a dark room.  
 
2.10 Quantitative RT PCR 
Quantitative RT PCR (qPCR) was used to measure mRNA expression levels of 
cytokines in response to IONP exposure. The cells were first grown in T75 flasks to 
80-90% confluency and then starved in serum-free medium for 2 hours prior to the 
addition of IONPs. IONPs were prepared as described in section 2.4, complete media 
was removed from the flask, cells washed with PBS before addition of serum-free 
media and IONPs were then added to the flasks containing the cells for 2 hours. 
Following the 2 hour incubation with IONPs at 37C, the cells were washed and 
scraped off the flasks for counting. A maximum of 1 x 107 cells (counted using a 
haemocytometer) were harvested and spun down into a pellet.  The supernatant was 
carefully removed and total RNA was extracted from the pelleted cells using the 
Qiagen RNeasy Mini Kit (#74104). RNA extraction was carried out as per the protocol 





Figure 2.8. Schematic representation of total RNA extraction protocol (Qiagen). Pelleted cells were 
lysed and homogenised followed by the addition of ethanol to precipitate nucleic acids. After a series of 
washes and spins, the total RNA was eluted using RNase free water. Images obtained and adapted from: 
Qiagen. 
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Total RNA extracted was kept on ice at all times and the OD (optical density) was 
measured at absorbance wavelength 260/280 using a NanoDrop (2000/2000c 
spectrophotometer, ThermoFisher Scientific)  to assess the purity of RNA. The RNA 
was aliquoted and stored at -80C. 
To convert the extracted RNA to cDNA, reverse transcriptase was performed using 
the High-Capacity RNA-to-cDNATM Kit (ThermoFisher Scientific). Reactions were 
prepared in Eppendorf PCR tubes as per the manufacturer’s instructions (up to 2g of 
total RNA was used per 20l reaction). Thermocycler (TETRAD2 Peltier Thermal 
Cycler, BioRad) settings were as follows: 37C for 60 minutes, 95C for 5 minutes and 
4C hold (as per protocol in the kit). cDNA was stored at -20C until needed. 
The cDNA was then used as a template for amplification by qPCR. On the day of 
qPCR, a mastermix was first prepared containing SYBR green PCR mastermix, 
forward primer, reverse primer and RNase free water. From the mastermix prepared, 
9l was pipetted into each well of a 96 well microplate. At the end, 1l of cDNA was 
added to the respective wells. Negative control wells contained 1l of RNase free 
water instead of cDNA. Each well contained the following: 
SYBR Green Mastermix 




Forward primer 0.5l 
Reverse primer 0.5l 
H2O (RNase Free) 3l 
cDNA 1l 
Total per well 10l 
 
 
Figure 2.9.Contents of each well in a 96 well microplate. All relevant wells contained the above, 
with the exception of negative controls which contain 1l of RNase free water instead of cDNA. Plates 
and all reagents were kept on ice at all times. 
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The table below lists all the primer sequences used in this thesis for qPCR reactions. 
Targets Forward primer (5’ to 3’) Reverse primer (5’ to 3’) 
TNF-α CTGTAGCCCACGTCGTAGC TTGAGATCCATGCCGTTG 
IL-1β TGTAATGAAAGACGGCACACC TCTTCTTTGGGTATTGCTTGG 
IFN-α GGACTTTGGATTCCCGCAGGAGAAG GCTGCATCAGACAGCCTTGCAGGTC 
IFN-β AACCTCACCTACAGGGCGGACTTCA TCCCACGTCAATCTTTCCTCTTGCTTT 
IL-6 GAGGATACCACTCCCAACAGACC AAGTGCATCATCGTTGTTCATACA 
IL-8 CAAGGCTGGTCCATGCTCC TGCTATCACTTCCTTTCTGTTGC 
TGF-β1 CAAGGGCTACCATGCCAACT GTACTGTGTGTCCAGGCTCCAA 
IL-10 ATTTGAATTCCCTGGGTGAGAAG CACAGGGGAGAAATCGATGACA 
NF-Kb1 GAAATTCCTGATCCAGACAAAAAC ATCACTTCAATGGCCTCTGTGTAG  
NLRP3 AGAAGAGACCACGGCAGAAG CCTTGGACCAGGTTCAGTGT 
IL-12 p40 CAGAAGCTAACCATCTCCTGGTTTG TCCGGAGTAATTTGGTGCTTCACAC 




The loaded 96 well microplate is then run on a QuantStudio 7 Flex Real-Time PCR 
machine for DNA amplification. The run settings were set as recommended by the 
SYBR green mastermix manufacturer and were as follows: Initial denaturation: 95C 
for 5 minutes. PCR cycle: Denaturation: 95C for 10 seconds, Annealing and 
extension: 60C for 30 seconds. Repeat: PCR cycles were repeated 40 times. 
 
Using the QuantStudio 7 manufacturer’s software, the amplification curve results were 
converted to excel files containing the CT values for each gene of each well. The CT 
value refers to that particular value where the fluorescence signal crosses the 
threshold line on the amplification curve. The data was then analysed using the 2-CT 
Figure 2.10. Primer sequences used in qPCR reactions. Primers were purchased in powder form 
from ThermoFisher. Primers were diluted in RNase free water to a stock solution of 100M and were 
further diluted to a working stock of 10M. Primers were stored at  -20C and thawed on ice before 
use. 
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method (Rao et al., 2013) to reveal fold change in gene expression, normalised 
against the CT values of the housekeeping gene (18s rRNA). Graphs of fold change 
in gene expression and log10 of relative expression was plotted (chapter 4) using 
GraphPad Prism.  
 
2.11 RNA Sequencing and Transcriptome analysis 
Cells were cultured, IONPs were prepared and incubated with cells in the same way 
as in the previous section, 2.11. Following incubation with IONPs, cells were counted 
and pelleted. Total RNA was extracted from the pelleted cells using the Qiagen 
RNeasy Mini Kit and the enclosed protocol was followed for RNA extraction in the 
same way as previously mentioned (2.11). The OD of the extracted total RNA was 
measured at absorbance wavelength 260/280 using the NanoDrop and the RNA was 
aliquoted and stored at -80C until samples were sent for RNA sequencing. RNA 
sequencing and standard RNA sequencing analysis, as described later, was 
performed by a company called Genewiz using the Illumina NovaSeq platform. 









On completion of sequencing, the data files are generated in an FASTQ-format, which 
contains the reads generated from the sequencing platform. The raw data obtained 
can carry errors, thus the data must be quality checked to filter out possible errors, 
indicated by low quality scores in the FASTQ files and data trimming was performed 
to remove low quality bases. Before carrying out differential gene expression analysis, 
Figure 2.11. Overview of RNA sequencing. From total RNA extracted from 
a biological sample, desired RNA molecules are isolated. This can be done 
by three different methods as seen in the figure. In this case, poly-A-selection 
was used to select for RNA species, which enriches for mRNA species. The 
isolated RNA species is then converted to cDNA which is ready for 
sequencing following PCR amplification. Reference and image from: Kukurba 
and Montgomery, 2015.  
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the reads obtained from RNA sequencing should be aligned to the reference genome, 
following which mapped reads are assembled into transcripts. Hit counts were then 
generated to assign the reads to specific genes or exons. Differential gene expression 
analysis was performed using DeSeq2 platform to compare gene hit counts and 
identify differentially expressed genes, which were narrowed down to significant 
differentially expressed genes by using a cut-off p-value of 0.05. To generate p-values 
and log2 fold changes, the Walt test was used. Genes with a p-value<0.05 and 
absolute log2 fold change >1 were called as differentially expressed genes (DEGs). 
Gene ontology analysis was carried out to cluster significant DEGs by their gene 
ontology and the enrichment of gene ontology terms was tested using Fisher exact 
test (GeneSCF v1.1-p2). Raw FASTQ files, data quality control, trimming, mapping, 






Figure 2.12. Bioinformatics analysis workflow. This workflow summarises 
the steps and analyses carried out by Genewiz, from quality report, FASTQ 
files, data QC, trimming & mapping, analysis hit counts for differential gene 
expression to gene ontology analysis. Image from: Genewiz.  
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From significant differentially expressed genes, gene ontology enrichment analysis 
was further carried out to identify genes relating to the pathways of immune processes. 






The gene names were entered onto the retrieve/ID mapping tool, the organism 
reference was set to Mus Musculus and the mapped results were generated and 
narrowed down as shown in the figure below. 
Figure 2.13. Gene enrichment ontology analysis. Significant 
DEGs were used to identify genes relating to specific pathways by 






Once the list of gene names related to immune system processes were identified 
through UniProt, they were retrieved from our list of previously identified significant 
DEGs (p-value <0.05). The genes with the most significance relating to immune 
system processes were selected and discussed in chapter 4, along with specific genes 
involved in innate immune responses in particular. Graphs showing upregulation and 
downregulation of discussed genes in chapter 4 were plotted using GraphPad Prism 
and heatmaps were generated using the MeV software. 
 
 
2.12 Microinjections in zebrafish (Danio rerio) embryos 
2.12.1 Zebrafish breeding and husbandry 
Healthy adult male and female zebrafish (Wild-type, AB strain) are separated by using 
a tank with a removable divider in the late afternoon the day before the eggs are to be 
collected. Zebrafish are photoperiodic and will start breeding the next day at dawn. 
1 2
Figure 2.14. Gene enrichment ontology analysis. Once the 
mapping results was generated, the results were viewed by gene 
ontology pathways and ‘immune system process’ pathway was 
identified under biological processes. The results were then 
exported from UniProt in a microsoft excel sheet. 
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They are kept in a carefully monitored room with a 14 hour light to 10 hour dark cycle 
and the water temperature is kept around 28C (pH 6.2-7.5). In the morning, the divider 
is removed from the tank to allow spawning to begin. Once spawning has stopped, the 
eggs are collected into petri dishes and kept in E3 medium thereafter. The E3 medium 
was made as a 50X stock (section 2.1) and diluted to 1X solution when needed. A 
small amount of methylene blue can be added to the 1X solution as fungicide. The 
media should be stored at 4C and 1X E3 solution should be warmed to 28C before 
use on eggs or embryos. Once the eggs are collected, they are sorted under the 
microscope and any unfertilised or malformed eggs are removed. The healthy eggs 
are kept in a 28C incubator until they are ready to be injected.  
 
2.12.2Nanoparticle preparations for zebrafish embryos microinjections 
The IONPs were incubated, washed and sonicated in the same manner as described 
in section 2.4 with the only difference being the concentration of IONPs used. The 
serum-deposited IONPs were coated with human serum proteins while the ‘naked’ 
IONPs were incubated in PBS only. Following some preliminary experiments, the best 
concentrations to be used where there is good IONP visibility whilst being non-lethal 
(>90% survival rate) to the embryos were 500g/ml and 1000g/ml (5l was loaded 
into the needle and a final volume of 2nl was injected into the duct of Cuvier in each 
embryo at 2dpf, as described further later). 2-3l of phenol red solution (Life 
Technologies) was added to each Eppendorf tube before the solution was loaded in 
the needles (described in section 2.9.3). Phenol red is used for ease of visibility during 
microinjections to confirm that the site of injection in the embryos is as accurate as 
possible every time.  
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2.12.3 Needle Preparation 
The needles were made from glass capillaries using the P-97 Flaming/BrownTM 
Micropipette Puller (Sutter Instrument Company). The settings on the machine were 
adjusted as required (Heat-358, Pull-60, Velocity-80, Time-200). If the needles have 
a long shank, they are more likely to break during microinjections whereas if the 
needles have a short shank, they are more likely to damage the embryos despite being 
more sturdy.   
Once the needles are made, they need to be prepared for injection. Using an extra-
long pipette tip, the needle is carefully filled with the solution to be injected. The needle 
is then secured in a micromanipulator and the injection pressure is adjusted on the 
attached pneumatic pump to prevent any medium from flowing back into the needle.  
A very small bit of the needle tip is broken off to allow the solution to flow out of the 
needle and this is done by placing the tip in a small petri dish containing mineral oil 
(Sigma). A calibration micrometer slide is placed under the petri dish and using the 
highest magnification on a dissecting microscope (RS PRO Stereo Microscope), the 
tip of the needle is carefully broken off using clean tweezers. The size of the solution 
dot flowing out of the needle with each press of the injection foot pedal should be 
corresponding to the 0.15mm dot on the calibration slide, which translates to a volume 
of 2nl. If the droplet is slightly off the correct size, the injection pressure can be slightly 
adjusted to change the volume ejected from the needle. Once calibrated, the needle 
is ready for microinjections in embryos.  
 
2.12.4 Zebrafish embryo microinjections (nanoparticles) 
The zebrafish embryos were injected at 2 days post fertilisation (dpf) because they 
were developed enough to successfully locate the site of injection but not too 
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developed where they have a lot of pigment cells on their skin which would make the 
skin too tough to penetrate with the needle as well as making the site of injection 
harder to locate. The IONPs were injected in the duct of Cuvier (figure 2.4) which 
serves as a vein leading into the heart’s sinus venosus and also collects all venous 
blood (Pontes et al., 2017).  
 
 
Figure 2.5. Microinjections in the duct of Cuvier. This series of images shows zebrafish embryo 
microinjections in the duct of Cuvier, which delivers the sample injected into the systemic circulation. 
Phenol red can be seen distributed in the circulation following injection in the last image.  
 
Before microinjections, if they are not naturally hatched already, the embryos have to 
be carefully dechorionated using tweezers. Only healthy-looking embryos were 
chosen and placed on an agarose mould and 200g/ml buffered tricaine 
methanesulfonate (MS222, Sigma Aldrich) was added dropwise to the agarose mould 
until the embryos were sedated. The embryos were left in MS222 for no longer than 
45 minutes whilst the microinjections took place. Once sedated, the embryos were 
arranged and positioned to lie on their right side so that the duct of Cuvier is more 
accessible. The embryos are then injected and immediately placed back into E3 
medium to reverse the anaesthesia. Once injected, the zebrafish embryos were 
monitored for any malformation or unusual swimming behaviours and imaged up until 
5dpf. 







2.12.5 Zebrafish embryo microinjections (dextran) 
Dextran (Fluorescein isothiocyanate-dextran, MW = 2,000,000, Manufacturer: Sigma 
Aldrich) was injected in zebrafish embryos with the aim that macrophages in the 
embryos will phagocytose the dextran and when IONPs are injected two days later, 
we would be able to study the biodistribution of IONPs in relation to macrophages. 
The dextran was prepared at a stock concentration of 25mg/ml and diluted 1:2 to a 
final concentration of 12.5mg/ml in sterile PBS. 2-3l of phenol red was added for ease 
of visualisation during microinjections. A final dextran volume of 2nl was injected in 
each embryo since volumes of 2-3nl were found to be optimal for yolk sac and 
blastomere microinjections (England and Adams, 2011). Dextran was injected 
Figure 2.6. 2dpf embryo straight after IONP microinjection. 
The above images show sedated embryos immediately after 
IONPs were injected into the duct of Cuvier. Phenol red can be 
seen to monitor immediate systemic delivery of injected IONPs. 
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separately into two sites; one is injecting directly into the yolk sac at the 1-cell stage 
and the second is injecting into a peripheral blastomere at the 16 cell stage on the day 
of fertilisation. The needle preparation and calibration were done in the exact same 
way as mentioned before but at 0dpf the embryos did not need any sedation. They 
were placed in agarose gels that were prepared using microinjection moulds (World 
Precision Instruments). The width and design of the moulds are the ideal size for 
zebrafish embryos and allow them to align and stay in place during microinjections. 
Once injected, the embryos were transferred back into E3 medium and placed in a 
28C incubator, ready to be injected with IONPs at 2dpf.  
 
2.12.6 Zebrafish embryo fixing and imaging 
For live imaging of the embryos, the embryos were sedated using MS222 and 
mounted onto slides (single depression concave microscope slides) using 3% 
methylcellulose (Sigma Aldrich) in E3 to keep the embryos in place. The embryos were 
imaged on the Leica Microscope (DMi8) using the LAS software. Following imaging, 
the embryos were placed back into E3 medium to dissolve the methylcellulose and 
reverse the anaesthesia. The selected embryos were then transferred to a 24-well 
plate and fixed with 4% PFA overnight for further imaging.  
 
Once fixed, the embryos were stained using Hoechst 33342 (1:10,000 dilution) 
overnight at 4C to stain the nucleic acid in cells for ease of visualisation under the 
microscopes. The fixed embryos were imaged on the Leica DM4000 Microscope to 
locate the distribution of IONPs at a lower magnification (X20) and these identified 
areas were imaged at a higher magnification using confocal microscopy. The embryos 
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were mounted on slides using 3% methylcellulose, similar to live imaging of the 
embryos.  
 
The embryos were also imaged using the Nikon Eclipse TE2000-S Confocal 
Microscope, which takes images in a z-stack from top to bottom of the specimen. The 
best way found to successfully mount and image the zebrafish embryo through 
confocal microscopy was the use of Mowiol Mounting Solution (see section 2.1, 
materials) as the mounting medium. Mowiol is a liquid when mounted and solidifies 
after several hours at room temperature. Before oil immersion lenses are to be used, 
the Mowiol mounting medium should be allowed to harden in the dark overnight or at 
37C for about 20 minutes.  
 
2.12.7 Ethical Implications of using zebrafish embryos 
Since all research carried out in zebrafish embryos were performed for no longer than 
5 days post fertilisation, according to current legislations, no project license was 
required. Zebrafish embryos are considered to be protected animals after 5 days post 
fertilisation, following which a project license and personal license are required to carry 
out any further research under regulated procedures. The place of work at Brunel 
University London holds an establishment license, under which all zebrafish breeding 
and husbandry were performed. Furthermore, I hold a personal license (PIL), which 
helped with understanding all legislation and ethics associated with animal research.  
 
2.13. Statistical Analyses 
All graphs presented in this thesis were designed using Prism (GraphPad Software 
Inc.). Heatmaps for the bioinformatics analyses were designed using MeV software. 
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Variability in all data was determined by calculating the standard deviation (using 
Microsoft Excel), denoted by error bars on graphs. ANOVA tests with a post-Tukey or 
Sinak test (as recommended by Prism based on the data sets being analysed) were 
carried out to determine significance when comparing multiple data sets. Results were 
deemed significant with a p-value <0.05. All statistical tests were performed using 









3. Intracellular Localisation of Iron Oxide 




It is widely known that NPs have the ability to encapsulate and transport therapeutic 
components to be delivered to targeted cells. Intricately orchestrated by their nano-
size, controlled drug delivery properties, surface charge and stability, NPs can cross 
biological barriers, such as cell membranes, and enter target cells to carry out their 
designed function. In spite of their desirable therapeutic purposes, NPs can also 
negatively affect the cells and cause unwanted adverse effects. A fundamental aspect 
of determining their end effect is to study the pathways that NPs use to enter cells and 
where they localise intracellularly. To achieve maximum therapeutic efficiency, the 
safe entry of drug delivery carriers into the targeted cells is of significant importance 
and coupled with their intracellular fate and localisation, will subsequently impact their 
cytotoxicity (Foroozandeh and Aziz, 2018).  
The intracellular uptake routes of NPs will heavily depend on their size and surface 
charge, which can be engineered to suit the intended therapeutic function. These 
physical and chemical properties play a role in determining whether the NPs will be 
endocytosed via pinocytosis or phagocytosis (described in section 1.7). For example: 
a study used endocytic pathway inhibitors to show that 1µm particles were found to 
be endocytosed by phagocytosis and macropinocytosis whereas smaller NPs of 40nm 
were endocytosed by phagocytosis and macropinocytosis as well as clathrin-mediated 
endocytic pathways in mouse macrophages (Kuhn et al., 2014). Another study also 
showed through the use of endocytic pathway inhibitors that 359nm modified chitosan 
NPs were endocytosed by more than one mechanism simultaneously in HeLa cells, 
suggesting that uptake mechanisms vary in different cell lines and that surface 
modification can also play a major role in the endocytic pathway (Nam et al., 2009). 
Furthermore, a study showed that identical gold NPs (10nm) had different uptake 
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mechanisms in healthy cells compared to cancer cells, further suggesting that different 
cell types behave differently when exposed to NPs (Saha et al., 2013). As described 
in chapter 1.9, once internalised, NPs are subject to intracellular vesicle trafficking 
from early to late endosomes before being very likely degraded in the lysosomes.  The 
figure below gives an overview of intracellular trafficking pathways and the Rab 
GTPases that are involved in the intracellular trafficking of cargo molecules/particles, 
some of which will be encountered later in this chapter. Rab GTPases are a subfamily 
of Ras-like GTPases (Shi, Shi and Xu, 2017) and play important roles in the 
intracellular trafficking of vesicles from the moment they bud off the donor membrane 










Figure 3.1. Overview of intracellular vesicle trafficking and related Rab 
GTPases. The above image shows intracellular trafficking pathways of 
internalised particles. For example, Rab5 is important in the formation of 
early endosomes at the plasma membrane. Early endosomes mature to 
become late endosomes, which can carry cargo to lysosomes for 
degradation or fuse with lysosomes (mediated by Rab7) to form 
endolysosomes. Orange broken arrows show the Rab proteins that facilitate 
that particular transport/trafficking pathway. ER: Endoplasmic reticulum, 
TGN: trans-Golgi network, GLUT4: glucose transporter type 4. Image from: 
Shi, Shi, & Xu, 2017. 
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This thesis chapter studies the intracellular localisation of iron oxide nanoparticles 
(IONPs) through organelle staining following the incubation of IONPs with mouse 







We also investigated the differences in cellular uptake when the IONPs were 
deposited with serum proteins compared to ‘naked’/unmodified IONPs. This is 
because IONPs intended for therapeutic uses will encounter serum proteins in the 
bloodstream, especially when administered intravenously. Blood plasma contains high 
levels of proteins, red blood cells, white blood cells and platelets in suspension. Serum 
is the fluid that remains after clots from whole blood are removed. Serum/plasma is a 
protein-rich solution with a protein concentration of approximately 60-80 mg/ml, where 
50-60% of proteins are albumins and the remaining 40% are globulins (of which 10-
20% are IgG) (Leeman et al., 2018). The interaction of IONPs and serum proteins in 
vivo can lead to the formation of a ‘protein corona’ on the IONP surface, which can 
Rab 9
Figure 3.2. Overview of organelles studied in this 
chapter. The organelles stained through 
immunofluorescence and studied through microscopy 
are circled in blue. These include the early 
endosomes, late endosomes, lysosomes, 
mitochondria, trans-Golgi network and the 
endoplasmic reticulum. This pathway was chosen to 
be studied because this is the expected intracellular 
trafficking route of most NPs.  Image from: Shi, Shi, & 
Xu, 2017. 
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alter its fate and decrease therapeutic efficiency by promoting its recognition by 
phagocytes (Oh et al., 2018). It has been reported that the deposition of serum 
proteins on NPs can activate the complement pathway, particularly via the alternative 
pathway (Moghimi and Simberg, 2017). In this study, we also investigate the 
differences seen in the cellular uptake of IONPs when the classical and alternative 
pathways of the complement system is favoured over another through the use of 
specific veronal buffers. Finally, fluorescent dextrans were used as markers of 
endocytosis. Different sized dextrans are commonly used to study endocytic pathways 
of various molecules, for example 10kDa dextrans are preferred to study fluid-phase 
endocytosis, including macropinocytosis and micropinocytosis whereas 70kDa 
dextrans are used mainly for studying macropinocytosis (Li et al., 2015).  Li et al. 
(2015) investigated the effect of different sized dextrans on endocytic pathways in 
HeLa cells and macrophage-like cells, and concluded that dextran 70 is a better probe 
to study macropinocytosis whereas smaller dextrans such as dextran 10 are better for 
the study of general fluid-phase endocytic pathways. Current literature shows that 
multiple studies have used fluorescent dextran as a marker of fluid-phase endocytosis, 
including a study by Iversen et al. (2012) who used dextran to investigate the uptake 
route of conjugated quantum dot NPs (approximately 30nm in diameter) and found 
that they are internalised by a macropinocytosis-like mechanism in HeLa cells (Iversen 
et al., 2012). Thus, through the use of different-sized dextrans, we aim to investigate 
the uptake pathways of starch coated IONPs (100nm diameter). 
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Aim & Hypothesis 
The aim of this chapter is to investigate the intracellular uptake, trafficking and 
endocytic pathways of IONPs in mouse macrophages, following the formation of a 
protein corona. We hypothesize that IONPs with a protein corona will behave 
differently, especially uptake patterns, when compared to IONPs with no protein 
corona over a 24 hour time course. Furthermore, we hypothesize that different protein 






3.2 Results Using Human Serum 
Mouse macrophages were incubated with human-serum deposited IONPs and ‘naked’ 
IONPs. To study the difference in uptake and their intracellular localisation, cellular 
organelles were labelled with fluorescent antibodies and the co-localisation with 
IONPs was observed with fluorescence microscopy. The table below summarises the 
results (Table 3.1). 
 
Organelle Stained Colocalisation 
Early endosome No 
Late endosome Little to none 
Mitochondria No 
Golgi apparatus No 
Caveolae Little to none 





Three dextran sizes (molecular weights 20,000, 40,000 and 70,000) were used as 
endocytic markers and co-localisation was seen with all dextrans, with the strongest 
co-localisation seen with dextran 70,000. 
  
Table 3.1. Organelles stained in this part of the chapter. The table lists all organelles in murine 
RAW264.7 macrophages that were stained following incubation with IONPs. IONPs were first incubated 
with human serum proteins before being added to the cells. The cells were fixed with 4% PFA at time 
points 1h, 2h, 4h and 24h. After fixing, immunofluorescence staining was carried out and the cells were 
imaged with a Leica DM4000 microscope using LAS software. Lysosome staining was done in live cells 
using Alexa488 LysoTracker and imaged using the same equipment. 
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3.2.1 Nanoparticle uptake over a 24h time course (serum-deposited) 
To have an initial understanding of the uptake pattern of IONPs at varying time points, 
the surface of fluorescently labelled starch coated IONPs (568nm excitation (red 
fluorescence) was deposited with complete human serum and incubated with mouse 
macrophages (RAW264.7). The cells were cultured on glass cover slips overnight and 
fixed 15 minutes, 30 minutes, 1 hour, 2 hours, 4 hours and 24 hours after exposure to 
IONPs. After fixation, the plasma membrane was stained using FITC labelled Wheat 
Germ Agglutinin (WGA), a lectin which specifically binds to N-acetyl-D-glucosamine 
and Sialic acid residues and Hoechst 33342 was used to label DNA and stain the 






10 m  
15 mins 30 mins 1 hour 
2 hours 4 hours 24 hours 
Figure 3.3. Uptake of serum deposited IONPs in RAW 264.7 cells over a 24h time course. The 
images show RAW 264.7 cells incubated with the fluorescently labelled IONPs for the indicated time 
points before fixation with 4% PFA and staining with FITC labelled WGA lectin to label the plasma 
membrane (green). Hoechst 3342 was used to label DNA (blue) and IONPs can be seen as red 
clusters (arrows). Cells were imaged on Leica DM4000 microscope using LAS software. Scale bar = 
10m. 
  
10 m  10 m  10 m  
10 m  10 m  
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Figure 3.3 demonstrates uptake in murine RAW 264.7 cells following incubation with 
human serum deposited IONPs. The results show some IONP uptake after 2 hours 
and 4 hours, however, after 24 hours, the cells appear to be almost saturated with 
IONPs. The earlier uptake seen varied between experiments where more IONP 
uptake was seen at 2 hours and 4 hours compared to the above results.   
 
This was narrowed down to these possibilities:  
1. Since the RAW cells used for the experiments had been in cell culture for over 
10 weeks and thus had gone through at least 20 passages, the phenotype and 
functional stability of the cells might have been affected. For subsequent 
experiments, the cells were not used if they had gone through more than 15 
passages in order not to influence data reliability. 
2. The human serum used in this experiment had undergone several freeze-thaw 
cycles, which could have led protein instability/activity. 
3. The nanoparticle settling time has to be taken into account, which was about 
11-16 hours. During the initial experiments (results in section 3.2.1 and 3.2.2), 
no magnet was used to help the IONPs settle immediately to the bottom of the 
wells after addition. From section 3.2.3 onwards, a strong magnet was held 
against the the bottom of the 24-well plate for IONPs to immediately settle in 








3.2.2 Nanoparticle Uptake – Serum-deposited vs ‘Naked’  
Once the uptake pattern of serum-deposited IONPs at specific time points was 
established, the uptake of serum deposited fluorescently (488nm) labelled IONPs was 
compared to the uptake of ‘naked’ IONPs at the same time points. The plasma 
membrane was stained using fluorescently labelled WGA lectin and Hoechst 33342 











The above images (Figure 3.5) show the uptake of serum deposited IONPs in RAW 
cells after 1 hour, 2 hours, 4 hours and 24 hours. Similar to the previous results, the 
same uptake pattern is seen, with most uptake seen after 24 hours. The noticeable 
difference is that at 24 hours, ‘naked’ IONPs show less uptake compared to serum-





1 hour 2 hours 4 hours 24 hours
10 m  
Figure 3.5. Uptake of serum-deposited IONPs vs. ‘naked’ IONPs. The images show uptake patterns in murine 
RAW264.7 macrophages seen at 1h, 2h, 4h and 24h comparing serum-deposited IONPs and ‘naked’ IONPs. The 
plasma membrane was stained with TRITC labelled WGA (red), Hoechst 33342 was used to stain the nucleus (blue) 
and IONPs can be seen in green (arrows), which appear yellow inside the cells due to the red WGA staining on the 
cell surface. At 24 hours, more serum-deposited IONPs were seen in the macrophages compared to ‘naked’ IONPs. 
Cells were incubated with IONPs, fixed at the indicated time points and stained. Cells were imaged on Leica DM4000 
microscope using LAS software. 
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Since IONPs were incubated with starved (serum-free medium) RAW cells, this 
suggests that human serum derived proteins, which are absent from samples with the 
‘naked’ IONPs, have a key role in mediating the uptake of IONPs and very likely act 
as opsonins to favour endocytosis. Furthermore, after 24 hours cells incubated with 
‘naked’ IONPs show a change in cell morphology, indicating signs of stress, even 
though in both cases (serum-deposited and ‘naked’), the cells were serum-starved. 
However, similar to the previous experiment described in 3.2.1, the settling time of the 
IONPs has to be taken into consideration as no magnet was used to enhance  
interaction between cells and IONPs.  
 
As part of preliminary studies,  IONP settling time  was determined by adding serum-
deposited and ‘naked’ IONPs to live cells in a petri dish. The settling was followed 
through live cell imaging on a Nikon inverted microscope with a heated stage using 
NIS-Elements software. The results below indicate that serum deposited IONPs settle 
to the bottom of the dish slightly faster than ‘naked’ IONPs. For all future experiments, 
strong magnets were used to help the IONPs settle immediately to the bottom of the 









3.2.3 Early Endosome Staining 
Early endosomes are the first ‘sorting stations’ for internalised particles. Rab 5 belongs 
to the Rab superfamily of small GTPases and plays a key role in controlling many 
endocytic processes including invagination at the plasma membrane, signalling and 
endosomal fusion (Stone et al., 2007). Activated Rab 5 recruits its effectors at the 
plasma membrane and is an important regulator of vesicular trafficking during early 
endocytosis (Zerial and McBride, 2001). During the early endocytic pathway, Rab 5 
mediates clathrin-coated vesicle transport from the plasma membrane to early 
endosomes and also mediates early endosome fusion (Zerial and McBride, 2001). 
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Figure 3.4. Investigating IONPs settling time over a 24-hour time period. IONPs were added to RAW cells in a 
petri dish, immediately followed by live cell imaging. The images show a faster settling time for serum-deposited 
IONPs compared to ‘naked’ IONPs. From 11 hours onwards, the cells seem to have internalised the IONPs. Thus, 
to avoid discrepancies regarding IONPs settling time in relation to uptake patterns, strong magnets were used 
during experiments to immediately pull IONPs to the bottom of the dish. The cells were imaged live using an inverted 




The images below show Rab 5 antibody staining, used as an early endosomal marker, 









Since it was observed during initial experiments that there was no IONP uptake at time 
points 15 and 30 minutes, the two first time points were omitted henceforth. The time 
points at which cells were fixed were 1 hour, 2 hours, 4 hours and 24 hours following 
the addition of IONPs.  Prior to IONP incubation with cells, the IONPs were sonicated 
using a sonication probe rather than an ultrasonic water bath to avoid ‘clusters’ seen 
in earlier experiments and to achieve a better dispersion of IONPs. The results show 
some uptake as early as 1 hour, incrementally increasing until 24 hours (Figure 3.5) 
but no colocalisation with early endosomes (Rab 5) was observed. These results 
10 m  
Figure 3.5.Early endosome staining. The images show early endosome staining in murine RAW 264.7 
macrophages following addition of serum-deposited IONPs and ‘naked’ IONPs. IONPs were coated with serum for 
1 hour at 37C on a shaker, following which they were washed in PBS and sonicated before being added to the cells. 
The IONPs were left to incubate with the cells at 37C and fixed using 4% PFA at specific time points, followed by 
immunofluorescence staining. Anti-Rab5 antibodies were used as early endosome marker (green), Hoechst 33342 
was used to label the nucleus (blue). Uptake of IONPs (red) inside macrophages can be seen at early time points. 
No colocalisation between IONPs and Rab5 is seen. Two independent experiments were carried out and 
representative images are displayed. Cells were imaged on a Leica DM4000 microscope using LAS software. 
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suggest that either IONPs are not present in early endosomes at these specific time 
points or that their concentration in these organelles is too low for detection. 
The results show consistency in the uptake pattern of serum-deposited and ‘naked’ 
IONPs, where lower uptake is seen with ‘naked’ IONPs.  
 
 
3.2.4 Late Endosome Staining 
Rab 7, like Rab 5, is also a member of the Rab superfamily of small GTPases. Rab 7 
associates with the effector protein RIPL to regulate membrane trafficking from early 
to late endosomes and lysosomes (Jordens et al., 2001). Rab 7 also contributes to the 
regulation of growth factor receptor endocytic trafficking and degradation as well as in 
the maturation of phagosomes (Ceresa and Bahr, 2006).  
In figure 3.6 below, anti-Rab7 antibodies were used as late endosomal marker, 
Hoechst 33342 was used to label DNA.  
 
 
Figure 3.6. Late endosome staining. The images show late endosome staining in murine RAW 264.7 macrophages 
following addition of serum-deposited IONPs and ‘naked’ IONPs. IONPs were coated with serum for 1 hour at 37C 
on a shaker, following which they were washed in PBS and sonicated before being added to the cells. The IONPs 
were left to incubate with the cells at 37C and fixed using 4% PFA at specific time points, followed by 
immunofluorescence staining. Anti-Rab7 antibodies were used as late endosome marker (green), the nucleus was 
labelled with Hoechst 33342 (blue). Uptake of IONPs (red, yellow arrows) inside macrophages can be seen at early 
time points. Results show little colocalisation between IONPs and Rab7 (purple arrows). Two independent 
experiments were carried out and representative images are displayed. Cells were imaged on a Leica DM4000 
microscope using LAS software. 
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From the above results (figure 3.7), no statistically significant colocalisation between 
IONPs and late endosomes (Rab 7 staining) with either serum-deposited IONPs nor 
‘naked’ IONPs was observed, suggesting that the IONPs are not present in high 
amounts in the late endosomes at the time points investigated. The data shows little 
to no evidence of IONP presence in late endosomes of murine RAW264.7 
macrophages within the first 24 hours of exposure. It is thus unlikely that for the IONPs 
accumulate in these organelles before either recycling back to the plasma membrane 
or forward movement into lysosomes for degradation within the time investigated. It is 
possible, however, that most IONPs have already been trafficked to degradative 
organelles at 24 hours. These results suggest that the resident time within late 































Figure 3.7. Late endosome staining quantification. The graph shows the average uptake of 
serum deposited and ‘naked’ IONPs in RAW264.7 macrophages. Average uptake was determined 
by calculating the % of cells that contained IONPs. Some colocalisation was seen at 24 hours in 
both IONPs conditions. Colocalisation was calculated from the number of cells where colocalisation 
was seen out of total number of cells. Error bars represent standard deviation. See chapter 2 
(methods) for in depth detail of how the analysis was done. Two independent experiments were 
carried out and the graph was plotted using GraphPad Prism. A two-way ANOVA test was performed 
using GraphPad Prism. Statistical significance was found between the two 1h samples and the two 
2h samples, as shown. Statistical significance was also found for uptake between all samples, 
except for 2h vs 4h (serum-deposited IONPs) and 1h vs 2h (‘naked’ IONPs). Some of the highest 
significance is shown on the graph. No statistical significance was found for colocalisation of IONPs. 








endosomes is low and that no significant accumulation occurs. However, an 
alternative hypothesis is that IONPs take an alternative route to be trafficked 
intracellularly following endocytosis. 
 
3.2.5 Mitochondrial Staining 
Mitochondria are important intracellular organelles with the major task of providing 
energy to the cells through the production of adenosine triphosphate (ATP). However, 
mitochondria have many other functions including mediating cell death in a cascade 
of events orchestrated by apoptogenic proteins (Salnikov et al., 2007). Furthermore, 
increased membrane permeability of the mitochondria to macromolecules is an 
important contributing factor to the cell’s apoptotic and necrotic death (Friedman and 
Nunnari, 2014). Some studies have shown that NPs such as gold NPs can localise to 
the mitochondria and mitochondria-targeting NPs such as modified titanium dioxide 
NPs were successfully retained in the mitochondria (Wongrakpanich et al., 2014). NPs 
targeting mitochondria are also studied as therapeutic agents in treatment of 
mitochondrial diseases (Pathak, Kolishetti and Dhar, 2015). Hence, we investigated 
whether IONPs had the ability to localise to mitochondria. 
The images below show mitochondrial staining in murine RAW 264.7 cells using an 
antibody directed against mitochondrial superoxide dismutase (SOD2) and detection 










Following staining for early and late endosome, the next organelle investigated was 
mitochondria. The data and images obtained showed no colocalisation between 
mitochondria and serum deposited IONPs or ‘naked’ IONPs, suggesting the absence 
of IONPs in mitochondria (figure 3.8). 
 
3.2.6 Golgi Staining 
 
The Golgi apparatus is an intracellular organelle which acts as ‘sorting station’ for 
newly synthesised proteins but also receives proteins and lipids that are retrogradely 
transported after endocytosis (Cooper, 2000). This is an alternative pathway for 









Figure 3.8. Mitochondria staining. The images show mitochondrial staining in murine RAW264.7 macrophages 
following addition of serum-deposited IONPs and ‘naked’ IONPs. IONPs were coated with serum for 1 hour at 37C 
on a shaker, following which they were washed in PBS and sonicated before being added to the cells. The IONPs 
were left to incubate with the cells at 37C and fixed using 4% PFA at specific time points, followed by 
immunofluorescence staining. Mitochondria were stained with an anti-SOD2 antibody (green), the nucleus was 
stained with Hoechst 33342 (blue). No colocalisation between IONPs (red, yellow arrows) and mitochondria was 
observed. Two independent experiments were carried out and representative images are displayed. Cells were 
imaged on a Leica DM4000 microscope using LAS software. 
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lysosomes (Yameen et al., 2014). In the images below (figure 3.9), the Golgi apparatus 
has been stained with an antibody directed against syntaxin 6 and detection with an 









The images above (Figure 3.9) show no colocalisation between the Golgi apparatus 
and serum deposited NPs nor ‘naked’ IONPs. This indicates that IONPs were not 
present in the Golgi apparatus or trafficked from late endosomes to the Golgi 






1 hour 2 hours 4 hours 24 hours
Figure 3.9. Golgi apparatus staining. The images show Golgi staining in murine RAW264.7 macrophages following 
addition of serum-deposited IONPs and ‘naked’ IONPs. IONPs were coated with serum for 1 hour at 37C on a 
shaker, following which they were washed in PBS and sonicated before being added to the cells. The IONPs were 
left to incubate with the cells at 37C and fixed using 4% PFA at specific time points, followed by immunofluorescence 
staining. The Golgi apparatus was stained with an anti-syntaxin 6 antibody (green), the nucleus was stained with 
Hoechst 33342 (blue). No colocalisation between IONPs (red, yellow arrows) and the Golgi was observed. Two 
independent experiments were carried out and representative images are displayed. Cells were imaged on a Leica 
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3.2.7 Caveolae Staining 
Caveolae are 60-80nm wide dips in the plasma membrane containing caveolin. These 
structures can bud from the cell surface and form intracellular vesicles. The function 
of caveolae is still not very well understood, however they are believed to mediate 
uptake of certain particles via receptors that cluster in caveolae (Kiss and Botos, 
2009).  
Caveolins make up the majority of membrane proteins of caveolae and can be 
detected by immunofluorescence staining. The antibody used in this case was 
directed against caveolin 1 and the caveolae can be seen as green punctate dots in 




Figure 3.10. Caveolae staining. The images show caveolae staining in murine RAW 264.7 macrophages following 
addition of serum-deposited IONPs and ‘naked’ IONPs for the indicated times. IONPs were coated with serum for 1 
hour at 37C on a shaker, following which they were washed in PBS and sonicated before being added to the cells. 
The IONPs were left to incubate with the cells at 37C and fixed using 4% PFA at specific time points, followed by 
immunofluorescence staining. Calveolae were stained with an anti-caveolin 1 antibody (green), the nucleus was 
stained with Hoechst 33342 (blue). Some colocalisation between IONPs (red, yellow arrows) and caveolae (punk 
arrows) was observed. Two independent experiments were carried out and representative images are displayed. 
Cells were imaged on a Leica DM4000 microscope using LAS software.  
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The above results (figures 3.10 and 3.11) show that there seems to be some 
colocalisation between caveolae and IONPs. However, it should be noted that the 
same amount of colocalisation was not seen in all experimental repeats. Overall, the 
amount of colocalisation seen was not significant but it does indicate that some IONPs 
might have been present in the caveolae and some IONPs may have trafficked across 
the plasma membrane through caveolae-mediated endocytosis. Particularly, 
statistical significance was found for colocalisation between 1 hour and 24 hours for 
serum-deposited IONPs. This result may suggest that serum-deposited IONPs take 
longer to internalised and trafficked when compared to ‘naked’ IONPs. IONPs 
investigated here are 100nm and studies have shown that particles as large as 500nm 
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Figure 3.11. Caveolae staining quantification. The graph shows the average uptake of serum 
deposited and ‘naked’ IONPs. Average uptake was determined by calculating the % of cells that 
contained IONPs. Some colocalisation was seen at all investigated time points in both IONPs 
conditions. Colocalisation was calculated from the number of cells where colocalisation was seen out 
of total number of cells. Error bars represent standard deviation. See chapter 2 (methods) for in depth 
detail of how the analysis was done. Although at the earlier time points, there seem to be a higher 
percentage colocalisation, most colocalisation was seen in one experimental repeat whereas less 
colocalisation was seen in the second experimental repeat. Two independent experiments were carried 
out and the graph was plotted using GraphPad Prism. A two-way ANOVA test was performed using 
GraphPad Prism. Comparing serum-deposited vs ‘naked’ samples for each time point, statistical 
significance was found for the 1h, 2h and 4h samples only, as shown. Comparing all time points against 
each other per treatment condition, statistical significance was found between all samples except for: 
1h vs 2h (‘naked’ IONPs), 1h vs 4h (‘naked’ IONPs) and 2h vs 4h (‘naked’ IONPs). Statistical 







can be internalised through caveolae-mediated pathway of endocytosis (Rejman et 
al., 2004). Thus, our results above may indicate differences in endocytic times when 
there is a protein corona present, compared to no protein corona on the IONPs. The 
data above is based on two experimental repeats and should be repeated to confirm 
our results seen, in particular the differences in endocytic times. 
 
3.2.7 Endoplasmic Reticulum Staining 
The endoplasmic reticulum is a key organelle, which is involved in the synthesis of 
proteins as well as transport of proteins and it is the largest organelle of a cell (Schwarz 
and Blower, 2016). Some NPs can escape lysosomal degradation through the 
retrograde trafficking pathway where cargo molecules in the early endosomes are 
trafficked to the endoplasmic reticulum and Golgi apparatus (Yameen et al., 2014). 
Thus, it was deemed important to investigate possible localisation of IONPs in the 
endoplasmic reticulum. In the images below (figure 3.12), the ER was stained with an 
antibody directed against ERp72 and detection with an Alexa488 labelled secondary 
antibody. 
 







The results for colocalisation between IONPs and the endoplasmic reticulum (figure 
3.12) were negative, implying  that IONPs are not trafficked to the ER during the first 
24 hours, thus the theory of retrograde trafficking pathway of IONPs in this case is 
unlikely. 
 
3.2.8 Dextran as marker for fluid phase endocytosis 
Dextran is a hydrophilic and non-digestible carbohydrate that is commercially available 
in different molecular sizes (Wang et al., 2014). Fluid phase markers such as dextran 
can help in the study of the endocytic capacity and uptake pathways of NPs. 
Experiments with different sized dextrans have a key role in differentiating cellular 





1 hour 2 hours 4 hours 24 hours
Figure 3.12. Endoplasmic reticulum staining. The images show endoplasmic reticulum staining in murine RAW 
264.7 macrophages following addition of serum-deposited IONPs and ‘naked’ IONPs for the indicated times. IONPs 
were coated with serum for 1 hour at 37C on a shaker, following which they were washed in PBS and sonicated 
before being added to the cells. The IONPs were left to incubate with the cells at 37C and fixed using 4% PFA at 
specific time points, followed by immunofluorescence staining. The ER was stained with an anti ERp72 antibody 
(green), the nucleus was stained with Hoechst 33342 (blue). No colocalisation between IONPs (red, yellow arrows) 
and ER was observed. Two independent experiments were carried out and representative images are displayed. 
Cells were imaged on a Leica DM4000 microscope using LAS software.  
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amounts of fluids in macropinosomes but less so in pinosomes. Fluorescently labelled 
dextran is one of the most convenient fluid phase markers, especially for pulse-chase 
experiments. Different sized dextrans can be internalised through different endocytic 
pathways and studies have shown that smaller dextran molecules (such as 
MW=10,000 Da) are more suitable to study fluid-phase endocytosis whereas larger 
dextran molecules (such as MW=70,000) are more suited to study macropinocytosis 
(Li et al., 2015). Here, we investigate 3 different sizes of dextrans, MW=20,000, 40,000 
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Figure 3.13. Uptake of IONPs and FITC-labelled dextran (MW=20,000). The images show colocalization (yellow) 
between IONPs (red) and dextran (green). Significant colocalisation is seen at 24 hours (arrows). IONPs were 
coated with serum for 1 hour at 37C on a shaker, following which they were washed in PBS and sonicated before 
being added to the cells together with the dextran. The IONPs and dextran were left to incubate with the cells at 
37C and fixed using 4% PFA at specific time points, followed by immunofluorescence staining. Plasma membrane 
is stained with Alexafluor350 conjugated WGA (blue). The cells were imaged using the Nikon Eclipse TE2000-S 
Confocal Microscope (EZ-C1 software), x60 oil lens. The graph shows the corresponding quantification of 
colocalisation (see chapter 2 for details). Error bars represent standard deviation. A two-way ANOVA test was 
performed using GraphPad Prism. Comparing serum-deposited vs ‘naked’ samples for each time point, statistical 
significance was not found for uptake. Comparing both time points against each other (4h vs 24h) per treatment 
condition, statistical significance was found for uptake of both samples. Statistical significance was found for 
colocalisation, as shown on graph. 
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Serum-deposited and ‘naked IONPs show colocalisation with FITC-labelled dextran 
20,000 after 24 hours (figure 3.13). Dextran conjugates are internalised by cells 
through fluid phase endocytosis, into the endosomal maturation pathway to finally 
accumulate in lysosomes (Fernando et al., 2010). The colocalisation seen between 
dextran and serum deposited IONPs suggests that the IONPs have been internalised 








Less colocalisation is seen here (figure 3.14) compared to the dextran 20,000 (figure 
3.13) which strongly indicates that dextran 40,000 is trafficked across the plasma 





































Figure 3.14. Uptake of IONPs and FITC-labelled dextran (MW=40,000). The images show colocalisation between 
IONPs and dextran in murine RAW264.7 macrophages. IONPs were coated with serum for 1 hour at 37C on a 
shaker, following which they were washed in PBS and sonicated before being added to the cells together with the 
dextran. The IONPs and dextran were left to incubate with the cells at 37C and fixed using 4% PFA at specific time 
points, followed by immunofluorescence staining. Plasma membrane is stained with Alexafluor350 conjugated WGA 
(blue). The cells were imaged using the Nikon Eclipse TE2000-S Confocal Microscope (EZ-C1 software), x60 oil 
lens. The graph shows the corresponding quantification of colocalisation (see chapter 2 for details). Error bars 
represent standard deviation. A two-way ANOVA test was performed using GraphPad Prism. Comparing serum-
deposited vs ‘naked’ samples for each time point, statistical significance was not found for uptake. Comparing both 
time points against each other (4h vs 24h) per treatment condition, statistical significance (*) was found for uptake 
of both samples. Statistical significance was found for colocalisation, as shown on graph. 
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colocalisation can be seen with serum-deposited IONPs which indicates that the 
presence of serum proteins on the IONP surface enhanced their uptake through the 
same mechanism as dextran 40,000 when compared to ‘naked’ IONPs sample. As 
stated before, larger dextran molecules are likely to be internalised through 









The result with dextran 70,000 (figure 3.14) demonstrated strong colocalisation 






































Figure 3.14. Uptake of IONPs and FITC-labelled dextran (MW=70,000). The images show colocalisation between 
IONPs and dextran in murine RAW264.7 macrophages. Strong colocalisation is seen at 24 hours (yellow, arrows), 
for both IONP samples. IONPs were coated with serum for 1 hour at 37C on a shaker, following which they were 
washed in PBS and sonicated before being added to the cells together with the dextran. The IONPs and dextran 
were left to incubate with the cells at 37C and fixed using 4% PFA at specific time points, followed by 
immunofluorescence staining.   Plasma membrane was stained with Alexafluor350 conjugated WGA (blue). The 
cells were imaged using the Nikon Eclipse TE2000-S Confocal Microscope (EZ-C1 software), x60 oil lens. The 
graph shows the corresponding quantification of colocalisation (see chapter 2 for details). Error bars represent 
standard deviation. A two-way ANOVA test was performed using GraphPad Prism. Comparing serum-deposited vs 
‘naked’ samples for each time point, statistical significance was not found for uptake. Comparing both time points 
against each other (4h vs 24h) per treatment condition, statistical significance (*) was found for uptake of both 
samples. Statistical significance was found for colocalisation, as shown on graph. 
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provides concrete evidence that IONPs(100nm) are mainly endocytosed via 
macropinocytosis. With the results seen with dextran 20,000, it is possible that some 
IONPs are also endocytosed via fluid-phase endocytosis indicating that IONPs are 
taken up through a range of endocytic pathways. 
 
3.1.9 LysoTracker  
LysoTracker is a fluorescent dye used to visualise lysosomes. The LysoTracker dye 
is a small highly soluble molecule that accumulates in acidic compartments such as 
the lysosomes (Fogel et al., 2012). Penetration of the dye into the lysosomes is not a 
concern as they are taken up through diffusion and get trapped in the acidic 
environment of the lysosomes and endosomes.  
The images below (figure 3.15) show live cell images of RAW 264.7 cells incubated 
with serum deposited and ‘naked’ IONPs for 24 hours before the addition of the 
LysoTracker dye for 15 minutes, which is seen in green. The cells were imaged live 
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Serum-deposited IONPs ‘naked’ IONPs 
Figure 3.15. Live cell imaging of cells incubated for 24 hours with 
IONPs and 15 minutes with lysotracker. RAW cells were incubated 
with IONPs for 24 hours, following which the lysotracker dye was added 
for 15 minutes and imaged immediately. The image on the left shows 
serum deposited IONPs in red and the image on the right shows ‘naked’ 
IONPs in red. The lysotracker dye can be seen in green. The bright field 
channel on the Leica DM-4000 microscope was used to visualise cell 
morphology. 
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Strong colocalisation of IONPs with the LysoTracker dye was seen in both cases; 
serum deposited and ‘naked’ IONPs (figure 3.15).  These results show that IONPs are 
present in an acidic organelle after 24 hours, most likely for degradation. However, 
trafficking of NPs to the lysosomes as a final destination can be exploited to make 
them a favourable drug delivery vehicle to deliver drugs specifically to lysosomes 
where the low pH can be employed to release their content.  
 
 
3.3 Results Using Mouse Serum 
This section will show results of IONP uptake in the mouse macrophage cell line RAW 
264.7, after preincubation with mouse serum instead of human serum (section 3.2). 
This was to investigate if the results seen in section 3.2 were due to activation of the 
murine macrophage cell line upon exposure to human serum. Furthermore, by using 
different veronal buffers, we aim to study the differences in complement activation via 
classical and alternative pathway where one is favoured over the other (see figure 
3.16).  
All protocols and incubations were carried out in the same way, with one exception; 
the mouse serum used to coat the surface of the IONPs was either diluted in DGVB++ 
buffer to favour complement activation via the classical pathway or diluted in EGTA 
buffer to favour complement activation via the alternative pathway. An initial 
experiment comparing uptake of IONPs, using human serum and mouse serum, was 
carried out before organelles were stained. This was done to compare uptake using 
DGVB++ buffer, EGTA buffer and using undiluted serum (not favouring the activation 





All experiments in section 3.3 were carried out using mouse serum, unless otherwise 
stated. The results from the organelle staining showed similar patterns seen with the 
use of human serum in 3.2, where some colocalisation was seen in late endosomes 
(Rab 7 and Rab 9) and a small amount of colocalisation was also observed with 
caveolin again. The organelle staining is summarised in the table below (table 3.2). 
 
Organelle Stained Colocalisation 
Early endosome No 
Late endosome (Rab9) Yes 
Late endosome (Rab7) Little to none 
Mitochondria No 
Golgi apparatus No 
Caveolae Little to none 
 Table 3.2. Organelles stained in this part of the chapter. The table lists all the organelles that were 
stained following incubation of murine RAW264.7 macrophages with IONPs. IONPs were first incubated 
with mouse serum proteins, following which they were added to the cells. The cells were fixed with 4% 
PFA at time points 1h, 2h, 4h and 24h. After fixation with 4% Paraformaldehyde, immunofluorescence 
staining was carried out and the cells were imaged under the Leica DM4000 microscope using the LAS 
software.  
Figure 3.16. Complement activation pathways. The above image shows 
how the three pathways of complement activation are induced. Although 
they have different triggers, all three pathways lead to the formation of C3 
complement protein. Image from: Noris & Remuzzi, 2013. 
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Dextran was again used as markers of endocytosis and the three sizes used are the 
same; MW= 20,000, 40,000 and 70,000 kDa. 
 
3.3.1 Comparing uptake of IONPs with different sera 
To compare the overall uptake of IONPs preincubated with either human serum or 
mouse serum to form the protein corona, IONPs deposited under both conditions 
(mouse serum and human serum) were incubated with murine RAW 264.7 cells for 2 
and 24 hours and NP uptake compared. The images below (figure 3.17)  show uptake 
at 2 hours (the time point where nanoparticle uptake was first observed) and at 24 








Similar uptake pattern can be seen with both sera, where some uptake can be seen as early 
as 2 hours and maximum IONP uptake is seen at 24 hours. Slightly less IONP uptake was 
seen with the mouse serum compared to human serum which is most likely due to the fact 
that human serum proteins may contain molecules that are recognised as ‘foreign’ by 
macrophages and hence are phagocytosed more readily. However, similar uptake patterns 
using mouse serum proteins shows that, regardless of sera used, IONPs are internalised by 
Figure 3.17. Comparing IONP uptake preadsorbed with either human serum or mouse (serum deposited). 
‘Naked’ IONPs were not used here since we only want to see the difference in serum-deposition on IONPs uptake. 
IONPs were coated with serum for 1 hour at 37C on a shaker, before being washed with PBS and sonicated. The 
IONPs were then added to the cells. The cells were fixed with 4% PFA at the respective time points, followed by 
immunofluorescence staining. The plasma membrane is stained with fluorescently labelled lectin WGA (green). The 
nucleus is stained using Hoechst 33342 (blue). Arrows show IONPs (red) inside macrophages. The cells were imaged 
using Leica DM-4000 microscope and the LAS software. 
 
10 m  10 m  
10 m  10 m  10 m  10 m  
10 m  10 m  10 m  10 m  
 102 
macrophages. This indicated that the results seen so far using human serum are not solely a 
result of using human serum in a murine cell line but dependent on exposure to IONPs.  
 
3.3.2 Nanoparticle Uptake – Classical vs Alternative pathway 
The complement system can be activated via three different pathways: classical 
pathway, alternative pathway and mannose binding lectin pathway. An overview of the 
complement activation pathways is given at the beginning of this section (figure 3.16) 
and is explained in detail in chapter 1.5. The activation of classical and alternative 
pathways can be favoured in vitro through the use of different veronal buffers. 
Complement activation can be induced via the classical pathway using veronal buffer 
DGVB++, containing calcium and magnesium ions which are required for C1q complex 
formation and C2-C4 interactions, respectively (Okroj et al., 2012). Similarly, 
complement can be activated via the alternative pathway using veronal buffer with 
EGTA as a calcium chelating agent and magnesium ions only. The alternative pathway 
is the only one that can proceed in the absence of calcium ion since its activation does 
not involve a calcium-dependent step, unlike the other two pathways (Okroj et al., 
2012). Undiluted serum (not diluted in DGVB++ or EGTA) was also used as comparison 












The above results (figure 3.18) show the uptake of serum-deposited IONPs that were 
incubated in the appropriate buffer to favour the activation of classical pathway or 
alternative pathway. At 24 hours, the overall percentage uptake seen with the use of 
EGTA buffer is lower than that seen with the use of DGVB++. The least amount of 
uptake was seen in the undiluted serum sample, which indicates that the presence of 
Serum deposited in DGVB++ buffer 24h 
Green WGA Red IONPs Merge
Serum deposited in EGTA buffer 24h 
Undiluted serum 24h 
10 µm
Figure 3.18. Uptake of serum-deposited IONPs diluted in DGVB++ , EGTA buffer and undiluted serum in 
murine RAW264.7 macrophages. IONPs (red) were incubated in mouse serum diluted in DGVB++ buffer, EGTA 
buffer as well as undiluted serum (i.e. no buffer added). The pictures show uptake of IONPs after 24 hours. IONPs 
were coated with serum for 1 hour at 37C on a shaker, before being washed with PBS and sonicated. The IONPs 
were then added to the cells. Cells were fixed with 4% PFA and stained with fluorescently labelled lectin WGA 
(green) to reveal the plasma membrane and Hoechst 33342 (blue) to reveal the nucleus. Arrows show IONPs inside 
macrophages. The cells were imaged using Leica DM-4000 microscope and the LAS software. 
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proteins adsorbed onto the IONPs in veronal buffers enhance uptake of IONPs by 







‘naked’ IONPs in DGVB++ buffer 24h 
Green WGA Red IONPs Merge
‘naked; IONPsin EGTA buffer 24h 
PBS only 24h 
10 µm
Figure 3.19. Uptake of ‘naked’ IONPs diluted in DGVB++ and EGTA buffer in murine RAW264.7 macrophages. 
’naked’ IONPs (red) were incubated in DGVB++ buffer, EGTA buffer as well as PBS. The pictures show uptake of 
IONPs after 24 hours. IONPs were coated with serum for 1 hour at 37C on a shaker, before being washed with 
PBS and sonicated. The IONPs were then added to the cells. Cells were fixed with 4% PFA and stained with 
fluorescently labelled lectin WGA (green) to reveal the plasma membrane and Hoechst 33342(blue) to reveal the 
nucleus. Arrows show IONPs inside macrophages. The cells were imaged using Leica DM-4000 microscope and 
the LAS software.  
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‘naked’ IONPs incubated in DGVB++ buffer had a reduced uptake compared to serum-
deposited (figure 3.18), suggesting that the presence of serum protein in DGVB++ 
buffer has a suppressive effect on the uptake of IONPs. 
 
3.3.3 Early endosome staining (Rab 5) 
Rab 5 was used as an early endosome marker and the localisation of IONPs was 
studied in relation to early endosomes. The effect of DGVB++ and EGTA buffers was 
investigated to determine whether the proteins adsorbed on the IONPs in the different 













Figure 3.20. Early endosome staining. Serum-deposited and ’naked’ IONPs (red) were prepared as before (serum 
deposited IONPs with mouse serum + buffer and ‘naked’ IONPs were incubated in the buffer only. The pictures show 
uptake of IONPs at 1h, 2h, 4h and 24 hours in murine RAW264.7 macrophages. IONPs were coated with serum for 1 
hour at 37C on a shaker, before being washed with PBS and sonicated. The IONPs were then added to the cells. 
The cells were fixed with 4% PFA followed by immunofluorescence staining. An anti-Rab5 antibody and a fluorescently 
labelled secondary antibody was used to stain early endosomes (green). DNA was labelled with Hoechst 33342 to 
stain the nucleus (blue). Pink arrows show IONPs inside macrophages and yellow arrows show colocalisation between 
IONPs and Rab 5. The cells were imaged using Leica DM-4000 microscope and the LAS software. 
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The images above (figure 3.20) show some colocalisation between early endosomes 
and IONPs denoted by yellow arrows. Some colocalization can be seen at earlier time 







The results from early endosomal staining show that some IONPs may be present in 
early endosomes at most time points (figure 3.20 and 3.21). Although the percentage 

























































Figure 3.21. Early endosome staining quantification. The graph shows the average uptake of mouse 
serum deposited and ‘naked’ IONPs. Average uptake was determined by calculating the % of cells that 
contained IONPs. Some colocalisation was seen at all investigated time points in both conditions. 
Colocalisation was calculated from the number of cells where colocalisation was seen out of total 
number of cells. Error bars represent standard deviation. See chapter 2 (methods) for in depth detail of 
how the analysis was done. Two independent experiments were carried out and graphs were plotted 
using GraphPad Prism 6. A two-way ANOVA test was carried out using GraphPad Prism to determine 




of cells containing IONP is low, in some of the conditions, almost half of the cells 
displayed colocalisation between early endosomes and IONPs. The colocalisation 
observed was not strong colocalisation (figure 3.21) and the quantification for the 
colocalisation was not statistically significant. Hence, although the images show that 
there may be some early endosomal trafficking of IONPs, it is not possible to make a 
positive colocalisation deduction.  
 
3.3.4 Late endosome staining (Rab 7) 
As mentioned previously, Rab 7 regulates membrane trafficking from early to late 
endosomes as well as lysosomes. Here, we use Rab 7 as a late endosomal marker to 
investigate whether the use of veronal buffers (DGVB++ and EGTA) has a different 

















Figure 3.22. Late endosome staining. Serum-deposited and ’naked’ IONPs (red) were prepared as before (serum 
deposited IONPs with mouse serum + buffer and ‘naked’ IONPs were incubated with the buffer only. The pictures 
show uptake of IONPs at 1h, 2h, 4h and 24 hours in murine RAW264.7 macrophages. IONPs were coated with serum 
for 1 hour at 37C on a shaker, before being washed with PBS and sonicated. The IONPs were then added to the 
cells. The cells were fixed with 4% PFA followed by immunofluorescence staining. Late endosomes were labelled with 
an anti- Rab 7 antibody and a fluorescently labelled secondary antibody (green). The nucleus was labelled with 
Hoechst 33342 (blue). Pink arrows show IONPs inside macrophages and yellow arrows show colocalisation between 
IONPs and Rab 7. The cells were imaged using Leica DM-4000 microscope and the LAS software. 
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The results of the late endosome staining (Rab 7) (figure 3.22-3.23) show 
colocalisation between late endosomes and IONPs. However, the microscopy data 
does not show strong colocalisation between Rab 7 and IONPs, instead there are one 
or two sparsely areas spread out in each cell. The above graph shows how many cells 
had colocalisation out of all the cells that have internalized IONPs. This could either 
mean that not all internalized IONPs were present in late endosomes at the time 





























































Figure 3.23. Late endosome staining quantification. The graph shows the average uptake of serum 
deposited and ‘naked’ IONPs. Average uptake was determined by calculating the % of cells that 
contained IONPs. Some colocalisation was seen at all investigated time points and all conditions. 
Colocalisation was calculated from the number of cells where colocalisation was seen out of total 
number of cells. Error bars represent standard deviation. See chapter 2 (methods) for in depth detail of 
how the analysis was done. Two independent experiments were carried out and graphs were plotted 
using GraphPad Prism 6. A two-way ANOVA test was carried out using GraphPad Prism to determine 











points, or it is also possible that there is insufficient accumulation of IONPs in these 
organelles even at 24 hours. Furthermore, as mentioned in the discussion later, the 
resolution of the microscope used may not allow the visualization of individual IONPs. 
Hence, there is also a probability that individual IONPs were present in the cells and 
organelles, which could not be seen.  
 
3.3.5 Late endosomes (Rab 9) 
From the results seen with the late endosomal marker Rab 7 (figures 3.22 and 3.23), 
limited colocalisation between IONPs and late endosomes was determined. To 
confirm the results another late endosome marker Rab 9 was used. Rab 9 is a member 
of the Ras superfamily of GTPases and is also bound to the membranes of late 
endosomes, similar to Rab 7 (Kucera, Bakke and Progida, 2016). However, the main 
difference between the two is that Rab 7 mediates late endosomal maturation into 
lysosomes whereas Rab 9 mainly mediates the recycling pathway from late 









Serum-deposited IONPs ‘naked’ IONPs
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EGTA buffer
Figure 3.24. Late endosome staining. Serum-deposited and ’naked’ IONPs (red) were prepared as before (serum 
deposited IONPs with mouse serum + buffer and ‘naked’ IONPs were incubated with the buffer only). The pictures 
show uptake of IONPs at 1h, 2h, 4h and 24 hours in murine RAW264.7 macrophages. IONPs were coated with 
serum for 1 hour at 37C on a shaker, before being washed with PBS and sonicated. The IONPs were then added 
to the cells. The cells were fixed with 4% PFA followed by immunofluorescence staining. Late endosomes were 
labelled with an anti- Rab 9 antibody and a fluorescently labelled secondary antibody (green). The nucleus was 
labelled with Hoechst 33342 (blue). Pink arrows show IONPs inside macrophages and yellow arrows show 
colocalisation between IONPs and Rab 7. The cells were imaged using Leica DM-4000 microscope and the LAS 
software. 
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The data obtained with Rab 9 staining (figures 3.24 and 3.25) support the hypothesis 
that IONPs reach late endosomes, especially serum-deposited IONPs. Theoretically, 
due to the function of Rab 9, it is possible that these IONPs are recycled, however 
further studies have to be done to identify if other Rab proteins involved in recycling 
also colocalise with IONPs. The likely end results of this IONP localisation is that 
IONPs are either trafficked to lysosomes or will be recycled to the plasma membrane. 





























































Figure 3.25. Late endosome staining quantification. The graph shows the average uptake of serum 
deposited and ‘naked’ IONPs. Average uptake was determined by calculating the % of cells that 
contained IONPs. Some colocalisation was seen at all investigated time points and conditions. 
Colocalisation was calculated from the number of cells where colocalisation was seen out of total 
number of cells. Colocalisation was seen in most samples, especially serum-deposited IONPs. Error 
bars represent standard deviation. See chapter 2 (methods) for in depth detail of how the analysis was 
done. Two independent experiments were carried out and graphs were plotted using GraphPad Prism 
6. A two-way ANOVA test was carried out using GraphPad Prism to determine statistical significance, 













To distinguish between these possibilities pulse chase experiments need to be 
undertaken. 
 
3.3.6 Mitochondrial Staining (SOD2) 
To study if IONPs localise differently in the mitochondria when mouse serum proteins 
are adsorbed on their surface in the presence of the different veronal buffers, 
mitochondria were stained and colocalization with IONPs investigated. No 
colocalisation was found, similar to the results obtained with human serum (section 
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Figure 3.26. Mitochondrial staining. Serum-deposited and ’naked’ IONPs (red) were prepared as before (serum 
deposited IONPs with mouse serum + buffer and ‘naked’ IONPs were incubated with the buffer only. The pictures 
show uptake of IONPs at 1h, 2h, 4h and 24 hours in murine RAW264.7 macrophages. IONPs were coated with 
serum for 1 hour at 37C on a shaker, before being washed with PBS and sonicated. The IONPs were then added 
to the cells. The cells were fixed with 4% PFA followed by immunofluorescence staining. Mitochondria were labelled 
with an anti- SOD2 antibody and a fluorescently labelled secondary antibody (green). The nucleus was labelled with 
Hoechst 33342 (blue). Pink arrows show IONPs inside macrophages, no colocalisation with mitochondria is seen.  
The cells were imaged using Leica DM-4000 microscope and the LAS software. 
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3.3.7 Golgi apparatus staining (Syntaxin 6) 
To check for presence of IONPs in the Golgi apparatus, the Golgi apparatus was 
stained using anti-syntaxin-6 antibodies. The results (figure 3.27) show limited 
colocalisation between the Golgi and serum deposited IONPs, independent of the 
buffers  used. However, only two cells showed colocalisation with IONPs and these 
observations could not be verified in further experiments suggesting that IONPs are 




Figure 3.26. Golgi apparatus staining. Serum-deposited and ’naked’ IONPs (red) were prepared as before 
(serum deposited IONPs with mouse serum + buffer and ‘naked’ IONPs were incubated with the buffer only. The 
pictures show uptake of IONPs at 1h, 2h, 4h and 24 hours in murine RAW264.7 macrophages. IONPs were 
coated with serum for 1 hour at 37C on a shaker, before being washed with PBS and sonicated. The IONPs 
were then added to the cells. The cells were fixed with 4% PFA followed by immunofluorescence staining. Golgi 
apparatus were labelled with an anti-syntaxin 6 antibody and a fluorescently labelled secondary antibody (green). 
The nucleus was labelled with Hoechst 33342 (blue). Pink arrows show IONPs inside macrophages, limited 
colocalization between IONPs and Golgi is seen (yellow arrows).  The cells were imaged using Leica DM-4000 
microscope and the LAS software. 
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3.3.8 Caveolae staining (Caveolin 1) 
Caveolae, as described previously (section 3.2.7), play an important role at the plasma 
membrane in receptor-mediated endocytosis. To investigate differences in possible 
uptake mechanisms when using IONPs deposited with serum proteins in presence of 
the two different veronal buffers (DGVB++ and EGTA buffers),  caveolin-1 antibody 
was use to stain caveolae and localisation of IONPs was studied through microscopy.  
 
 
Serum-deposited IONPs ‘naked’ IONPs
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Figure 3.27. Caveolae staining. Serum-deposited and ’naked’ IONPs (red) were prepared (serum deposited 
IONPs with mouse serum + buffer and ‘naked’ IONPs with buffer only). IONPs were coated with serum for 1 
hour at 37C on a shaker, before being washed with PBS and sonicated. The IONPs were then added to the 
cells. The cells were fixed with 4% PFA followed by immunofluorescence staining. Caveolae were labelled 
with an anti-caveolin 1 antibody and a fluorescently labelled secondary antibody (green). The nucleus was 
labelled with Hoechst 33342 (blue). Pink arrows show IONPs inside macrophages, limited colocalisation with 
caveolae is seen (yellow arrows). The cells were imaged using Leica DM-4000 microscope and the LAS 
software. 
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Some colocalisation was observed between caveolae and IONPs in approximately 
half of the total number of cells that had taken up IONPs. This suggests that caveolae-
mediated endocytosis may be one of the pathways through which IONPs are 
internalised. Furthermore, ‘naked’ IONPs also colocalised with caveolae, suggesting 
that the ‘protein corona’ deposited on the surface of the IONPs is not the only factor 
in determining caveolin-mediated endocytosis.  




























































Figure 3.28. Caveolae staining quantification. The graph shows the average uptake of serum 
deposited and ‘naked’ IONPs. Average uptake was determined by calculating the % of cells that 
contained IONPs. Some colocalisation was seen at all investigated time points and conditions. 
Colocalisation was calculated from the number of cells where colocalisation was seen out of total 
number of cells. Colocalisation was seen in all samples however is not significant for a positive 
colocalisation result. Error bars represent standard deviation. See chapter 2 (methods) for in depth 
detail of how the analysis was done. Two independent experiments were carried out and graphs were 
plotted using GraphPad Prism. A two-way ANOVA test was carried out using GraphPad Prism to 
determine statistical significance, which are shown on the graph above (Black lines compare uptake for 









3.3.9 Dextran as a marker for fluid phase endocytosis 
To further pursue elucidating the endocytic pathways of IONPs, three molecular 
weight dextrans were used as markers of endocytosis (MW=20,000, 40,000 and 
70,000 Da). Contrary to the results obtained with IONPs deposited with human serum 
proteins (section 3.2.8), little colocalisation was found using mouse serum deposited 
IONPs. The main factor was that less IONP uptake was observed with the mouse 
serum deposited IONPs. Smaller dextran molecules such as dextran 20,000 Da are 
likely to be endocytosed through fluid-phase endocytosis, including micropinocytosis 
and macropinocytosis. The results presented in this section are based on one 
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Figure 3.29. Dextran 20,000 as an endocytic marker. Serum-deposited and ’naked’ IONPs (red) were 
prepared as before (serum deposited IONPs with mouse serum + buffer and ‘naked’ IONPs were 
incubated with the buffer only). The pictures show uptake of IONPs at 1h, 2h, 4h and 24 hours in murine 
RAW264.7 macrophages. IONPs were coated with serum for 1 hour at 37C on a shaker, before being 
washed with PBS and sonicated. The IONPs were then added to the cells together with the dextran. The 
cells were fixed with 4% PFA at specific time points, followed by immunofluorescence staining. FITC 
dextran 20,000 (green) and plasma membrane stained with Alexafluor350 conjugated WGA (blue). Pink 
arrows show IONPs inside macrophages. Yellow arrows show colocalisation. The cells were imaged 
using Leica DM-4000 microscope and the LAS software. 
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The results with dextran 20,000 (figure 3.29) show that there is little colocalisation 
between IONPs and dextran except for mouse serum-deposited IONPs in EGTA 
buffer at 24 hours. This is strikingly different to the data obtained with human serum 
protein coatings on the IONPs (section 3.2.8). This could be due to the fact that there 
is less IONP uptake overall or it could also mean that certain proteins are absent in 
mouse serum which are present in human serum that play a role in stimulating fluid-









The results (figure 3.30) show little colocalisation between IONPs and dextran 40,000 
suggesting that IONPs do not follow the same intracellular uptake mechanisms as 
Serum-deposited IONPs ‘naked’ IONPsDextran 40
DGVB
EGTA
Figure 3.30. Dextran 40,000 as an endocytic marker. Serum-deposited and ’naked’ IONPs (red) 
were prepared as before (serum deposited IONPs with mouse serum + buffer and ‘naked’ IONPs 
were incubated with the buffer only). The pictures show uptake of IONPs at 1h, 2h, 4h and 24 hours 
in murine RAW264.7 macrophages. IONPs were coated with serum for 1 hour at 37C on a shaker, 
before being washed with PBS and sonicated. The IONPs were then added to the cells together 
with the dextran. The cells were fixed with 4% PFA at specific time points, followed by 
immunofluorescence staining. FITC dextran 40,000 (green) and the plasma membrane stained with 
Alexafluor350 conjugated WGA (blue). Pink arrows show IONPs inside macrophages. Some 
colocalisation can be seen as shown by yellow arrows. The cells were imaged using Leica DM-
4000 microscope and the LAS software. 
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these dextran molecules. Similar to the previous experiment (figure 3.29), IONP 
uptake was not high which could also be an explanation for the lack of colocalisation 





Figure 3.31. Dextran 70,000 as an endocytic marker. Serum-deposited and ’naked’ IONPs (red) were 
prepared as before (serum deposited IONPs with mouse serum + buffer and ‘naked’ IONPs were 
incubated with the buffer only). The pictures show uptake of IONPs at 1h, 2h, 4h and 24 hours in murine 
RAW264.7 macrophages. IONPs were coated with serum for 1 hour at 37C on a shaker, before being 
washed with PBS and sonicated. The IONPs were then added to the cells together with the dextran. 
The cells were fixed with 4% PFA at specific time points, followed by immunofluorescence staining. 
FITC dextran 70,000 (green) and the plasma membrane stained with Alexafluor350 conjugated WGA 
(blue). Pink arrows show IONPs inside macrophages. Some colocalisation can be seen as shown by 
yellow arrows. The cells were imaged using Leica DM-4000 microscope and the LAS software. 
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The results (figure 3.31) show some colocalisation with mainly the serum-deposited 
IONPs in EGTA buffer, which further supports the argument that mouse serum 
proteins adsorbed in the presence of EGTA buffer can play a role in determining the 





The aim of this study was to investigate the intracellular fate of IONPs in murine 
macrophages. This was done through organelle staining and microscopy. Different 
sized dextrans were also used as markers of endocytosis to help in the understanding 
uptake mechanisms of IONPs. Overall, the data produced strongly suggests that 
IONPs accumulate in the late endosomes and lysosomes. IONPs showed no 
significant colocalisation with early endosomes, mitochondria, Trans-Golgi network 
and the endoplasmic reticulum. Due to the low percentage of colocalisation between 
IONPs and these organelles observed during screening with conventional microscopy, 
colocalisation was not confirmed using the Nikon Eclipse Confocal microscope but 
images using the Leica DM4000 microscope were analysed. Some colocalisation was 
seen between IONPs and late endosomal protein Rab 9 and strong colocalisation was 
seen with LysoTracker; a pH sensitive dye used to visualise cellular compartments 
with low pH. This provides strong evidence that the IONPs are localised in an acidic 
compartment of the cell, 24 hours after IONP exposure, most likely lysosomes due to 
the limited colocalisation observed with the late endosomes (Rab 7 staining). Other 
studies have shown similar intracellular trafficking patterns. For example: a study 
investigated the intracellular trafficking of different sized polystyrene NPs (Sandin et 
al., 2012). The study found that small NPs (40nm) are trafficked through Rab5 and are 
quickly transferred to late endosomes (Rab9) before finally localising to lysosomes 
(using Rab7 as a marker). They also showed that larger sized NPs (100nm) are also 
trafficked through the same endosomes but at a slower rate than the smaller NPs. 
This could explain why our results showed maximum uptake and colocalisation in late 
endosomes/lysosomes at 24 hours after exposure as the diameter of the IONPs used 
in our studies is 100nm and hence, they are likely to be trafficked at a slower rate due 
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to their size. Although the presence of IONPs in recycling endosomes were not studied 
in this chapter, some studies have shown that very few NPs are able to access the 
recycling endosomes (Sandin et al., 2012), thus decreasing the likelihood that the 
IONPs may be recycled back to the plasma membrane. There is also the possibility 
that some of the IONPs escaped the endolysosomal system and were located in 
clusters in the cytoplasm. If IONPs escape endosomes prior to fusion with lysosomes, 
these IONPs can bypass lysosomal degradation (Behzadi et al., 2017). To investigate 
whether IONPs remain free in the cytoplasm, cytoplasmic markers could be used to 
investigate possible colocalisation.  
To investigate the pathway the IONPs take to enter macrophages, an anti-caveolin 1 
antibody was used to localise caveolae. Some colocalisation was seen with IONPs 
and caveolae, which indicates that these IONPs are being taken up through caveolae 
mediated endocytosis. One reason why more IONPs colocalisation was not seen 
within the caveolae could be the size of the IONPs (100nm). Although caveolae are 
small invaginations with a diameter of about 60-80 nm, they are able to internalise 
molecules of a bigger size, although not as efficiently (Wang et al., 2009). For 
example, a study showed that smaller NPs of size 20-40 nm were endocytosed 5-10 
times more than larger NP sizes of 100nm (Wang et al., 2009). Thus, the size of the 
IONPs used in our experiments could be the reason why stronger colocalisation with 
caveolae was not seen. 
Using dextran molecules as fluid-phase endocytosis markers has helped 
understanding the endocytic pathway of the IONPs. Different molecular weights of 
dextran were used to distinguish the different endocytic pathways as they  will be 
endocytosed via distinctive pathways. Lower molecular weight dextrans are 
endocytosed via classical pinocytosis pathways whereas higher molecular weight 
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dextrans are endocytosed via constitutive macropinocytosis (Li et al., 2015). 
Colocalisation of IONPs with different sized dextran molecules was observed 
indicating that macropinocytosis is likely to be the major endocytic pathway of IONP 
uptake in murine macrophages. This was especially observed with human serum 
deposited IONPs. Although it is not possible to know how many IONPs were 
internalised and colocalised with dextran, the uptake and colocalisation of IONPs can 
be measured using the intracellular area covered  as a measuring parameter and 
quantifying the fluorescence intensity on ImageJ. Other studies have used different 
methods of quantifying colocalisation by using Imaris software (Bitplane), where 
colocalisation within a manually masked region of the cell can be measured (Sandin 
et al., 2012). Nevertheless, some of our results show strong and clear colocalisation 
between IONPs and dextran based on 2 experimental repeats and this finding could 
be further studied and exploited for the targeting of tumour cells. This is of particular 
interest as certain types of tumour cells are known to have increased macropinocytic 
activity, thus NPs entering cells through macropinocytosis could be favourable drug 
delivery in these cells (Desai, Hunter and Kapustin, 2019). 
 
Mouse serum was also used to determine the differential effects seen with the use of 
human serum in a murine cell line. Similar to the results obtained with human serum, 
little to no colocalisation was seen with the early endosomes, mitochondria and the 
Trans-Golgi network. However, with late endosomal marker Rab 7, differences were 
seen in colocalisation between the human serum and mouse serum samples. This 
could indicate the possibility of different trafficking pathways of IONPs due to different 
protein corona compositions of IONPs. More colocalisation was seen with the late 
endosomal marker Rab 9 than other organelles, with the overall percentage of 
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colocalisation being about 40% for serum-deposited IONPs. This shows that the 
presence of a different protein corona can influence the intracellular trafficking of 
IONPs as higher colocalisation percentages are seen between IONPs and late 
endosomes when using mouse serum as the protein coating compared to using 
human serum as the protein coating.  
To distinguish between the different pathways of complement activation, different 
veronal buffers, DGVB++ and DGVB-EGTA, were used to favour adsorption of 
complement components of the classical and alternative pathway respectively. 
Through the use of DGVB++ buffer, we have aimed to adsorb proteins associated with 
the classical pathway of the complement system. Although DGVB++ buffer is able to 
activate all three pathways of the complement system, proteins of the classical 
pathway would be more prevalent since they can be activated at lower serum 
concentrations compared to the others (Moreno-Indias et al., 2012). DGVB++ buffer 
contains both calcium and magnesium ions, both of which are required for C2-C4 
interaction, leading to the formation of C1q complex, an important molecule of the 
innate immune response (Okroj et al., 2012). With the use of EGTA buffer, we aimed 
to adsorb proteins of the alternative pathway because it is the only pathway that can 
be activated without calcium. The results in figures 3.18 and 3.19 show differences 
between the uptake pattern when the classical pathway associated proteins had been 
adsorbed compared to those associated with the alternative pathway. More uptake of 
IONPs was seen with the classical pathway than the alternative pathway. This 
difference in uptake between the two different buffers is most likely due to the different 
proteins adsorbed to the IONPs and may suggest that the presence of EGTA buffer 
can lead to reduced uptake of IONPs, which can be exploited to avoid unwanted 
clearance of IONPs in vivo by the mononuclear phagocytic system (MPS). It is well-
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known that different protein corona compositions can play a major role in influencing 
the uptake of NPs. With in vivo applications of NPs, the formation of a protein corona 
can determine the stability, protein interactions, biodistribution, toxicity and clearance 
from the body by the MPS (Rampado et al., 2020). Thus, it is important to understand 
which protein corona formulations satisfy the most criteria to offer the best therapeutic 
efficacy. Taking this forward, the protein corona when different buffers are used in the 
coating can be analysed by using electrophoresis methods and relating the results to 
the uptake patterns seen in our experiments.  
Different molecular weight dextran molecules were also used to study the endocytic 
pathway of IONPs incubated with mouse serum. These preliminary results differ from 
the results seen with human serum. Less dextran molecules were endocytosed at the 
earlier time points (1 hour, 2 hours and 4 hours) and high levels of endocytosed 
dextran are only seen after 24 hours, especially in the EGTA buffer sample. These 
results again strongly suggest that the IONPs favour macropinocytosis as an 
endocytic route and additionally, the difference in buffers incubated with the IONPs 
may also influence their uptake as different uptake patterns are seen with the two 
different buffers. It is important to also note that protein corona is a dynamic structure 
that is subject to changes over time and this may affect the uptake and intracellular 
fate of IONPs. Since this data was produced by one experimental repeat, it needs to 
be repeated to validate our results. A study investigating the uptake and endocytosis 
of different sized silver NPs showed that the uptake of larger sizes AgNPs (50nm and 
100nm) was reduced when 5-(N-ethyl-N-isopropyl) amiloride was used as a 
macropinocytosis inhibitor, suggesting that macropinocytosis is one of the preferred 
uptake pathways for larger sized NPs (Wu et al., 2019). This correlates to the results 
found in this chapter where macropinocytosis was shown as the likely route for IONP 
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(100nm) endocytosis. The results can be further confirmed by using other methods to 
study endocytic pathways such as the use of specific endocytic inhibitors (Dejonghe 
et al., 2019). Endocytic routes taken by IONPs is by using surface-enhanced Raman 
spectroscopy in combination with endocytic inhibitors, as carried out by a recent study 
where the endocytosis of gold NPs was investigated using this method (Yılmaz and 
Culha, 2021). As another future avenue, molecular techniques such as RNA 
interference (RNAi) and small interfering RNA (siRNA) can be used to investigate and 
assess the role of key proteins involved in the different endocytic pathways of IONPs.  
The data produced so far helps our understanding of the intracellular trafficking and 
intracellular fate of larger sized IONPs in murine macrophages. Through organelle 
staining, we have shown strong evidence of IONPs localising in the endolysosomal 
system. This can be particularly exploited in the development of nanotherapeutics 
targeting low pH organelles. For instance, abnormal function of the lysosome has been 
linked to multiple neurodegenerative diseases and autoimmune diseases (Ma et al., 
2016) and the accumulation of IONPs in lysosomes could be an interesting strategy 
for lysosomal-targeted nanotherapeutics. Furthermore, our data suggests that one of 
the main routes of endocytosis is through macropinocytosis, which, as mentioned 
earlier, can also be exploited to develop strategic targeting of certain tumour cells 
which show increased macropinocytic activity due to growth factor activation. In 
addition, the data presented in this chapter can be further explored and taken forward 
to investigate strategies that can be developed in order to avoid unwanted clearance 
of IONPs by phagocytes, especially with further studies on protein corona 
formulations.  
Some limitations were present in this study which need to be considered when 
planning future work. For example, the resolution of the microscope used (Leica 
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DM4000) may not be very effective for the visualisation of individual IONPs but rather 
are more easily seen when IONPs are present in small clusters. Hence, for 
visualisation of individual IONPs, higher magnifications can be used (such as TEM). 
Furthermore, the use of a sonication probe can affect the integrity of the protein corona 
formed on the IONPs, which can influence their uptake. To assess changes which 
may occur following sonication, the IONP coating and protein corona can be analysed 
by using electrophoresis techniques (Lundqvist et al., 2008).  Lastly, serum starvation 
of cells can downregulate certain endocytic pathways such as clathrin-independent 
endocytosis (Rennick et al., 2021) and although this endocytic pathway was not of 
particular interest in this chapter, since all experiments were performed in serum-free 
media, it is important to acknowledge that serum starvation can play a role in mediating 
endocytosis. All experiments were carried out at least twice and those experiments 
with two experimental repeats should be carried out again to confirm our results, 
however, we believe our current findings so far have built a good foundation for future 





















As engineered NPs are becoming more important in the drug delivery world, their 
toxicity remains a concern. Inevitably, NPs administered via the bloodstream will be in 
direct contact with cells of the innate immune system such as macrophages with the 
increased likelihood of triggering an immune response against the NPs. NPs with 
different surface compositions and properties will interact with the immune system in 
different ways, resulting in a downregulated or upregulated immune response 
(Elsabahy and Wooley, 2013). To understand the immune response against IONPs, 
selected cytokines were used as biomarkers of inflammation. Cytokine responses can 
translate to pathology through fever, muscle pain, headache, nausea and vomiting, 
amongst others (Elsabahy and Wooley, 2013). Several authors have shown the ability 
of a number of metal oxides to be able to trigger cytokine production (Borgognoni et 
al., 2018). One study investigated cytokine secretion by human macrophages 
following exposure to TiO2 NPs (approximate size of 100-120nm). The study found 
that cytokine secretion is concentration dependent where at high NP concentrations, 
IL-1β, IL-6 and IL-10 were secreted whereas at lower NP concentrations, only IL-6 
secretion was found (CF et al., 2015). This secretion of IL-6 may contribute to the 
development of autoimmune diseases as well as the secretion of acute phase proteins 
(CF et al., 2015). Furthermore, other studies have investigated the inflammatory ability 
of TiO2 through the activation of the NLRP3 inflammasome in human macrophages, 
leading to the secretion of IL-1β and IL-1α (Yazdi et al., 2010). NPs Hence, studying 
cytokine expression levels is considered a key step in determining immunotoxicity 
during the development of nanotherapeutics, as well as other biotherapeutics.  
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Pro-inflammatory cytokines, such as TNF-α, IL-6, IL-1β  are released upon immune 
response stimulation and through a series of events, lead to the activation and 
infiltration of immune cells and cytokines, an important process of the host’s defence 
against invading pathogens (Ray, 2016). As much as pro-inflammatory cytokines are 
important, their overexpression can lead to the development of diseases and 
tumorigenesis. Hence, the release of anti-inflammatory cytokines, such as IL-10, IL-
13 and IL-4, is an important protective mechanism against the adverse effects of pro-
inflammatory cytokines by inhibiting or supressing their activity resulting in a 
suppressed immune response (Chatterjee et al., 2014). The delicate balance of pro-
inflammatory and anti-inflammatory cytokine secretion is thus key to an effective 
immune response.  
Quantitative Real-Time PCR was used to detect and measure the expression levels 
of selected pro-inflammatory and anti-inflammatory cytokines in response to 
incubation with IONPs in mouse macrophages. The cytokines initially investigated 
were TNF-α, IL-1β, IFN-α, IFN-β, TGF-β1, IL-6, IL-8, IL-10, NF-κB1, IL-12p40 and 
NLRP3, which are discussed later. Transcriptome sequencing (RNA-sequencing) was 
also carried out to identify differentially expressed genes at the mRNA expression 
level. RNA-sequencing is a highly accurate and precise method of quantifying gene 
expression as well as effective comparisons between experiments. Amongst other 
advantages, RNA-sequencing also allows for specific signalling pathways that are 
upregulated or downregulated to be identified. For example, through transcriptome 
profiling, a study recently identified over 4,000 genes that were differentially expressed 
in response to nanoparticle treatment for 48 hours (Carrow et al., 2018). The same 
study showed that specific signalling pathways such as MAPK (mitogen-activated 
protein kinase) and stress-responsive pathways were upregulated. Through RNA-
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sequencing, we aim to identify differentially expressed genes and upregulated 
pathways relating to immune responses in order to better understand and evaluate 
IONPs-induced toxicity. If IONPs alter gene regulation in any way, this could lead to 
cell death or the development of abnormal cells, which in turn can lead to the 
development of autoimmune diseases, hypersensitivity reactions or the formation of 
tumours. This chapter aims at studying the immunotoxicity of IONPs in mouse 
macrophages, which is a crucial part in establishing their biosafety as drug delivery 
vehicles. We hypothesize that an enhanced immune response will occur with the 
exposure of ‘naked’ IONPs, compared to serum-deposited IONPs and different IONP 
treatments will elicit different responses.   
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4.2 Results 
4.2.1 Using cytokines as biomarkers of inflammation following 
uptake of IONPs by macrophages 
To study if IONPs trigger a pro-inflammatory or anti-inflammatory immune response, 
cytokine expression levels were measured by qPCR. The previous chapter focused 
on the intracellular fate of IONPs following phagocytosis by macrophages and the 
earliest intracellular uptake was seen at 2 hours after the addition of IONPs. Hence, 
cytokine expression levels were measured following a 2 hour incubation period with 
IONPs to understand the initial immune response by macrophages. We also wanted 
to see the difference in innate immune activity when the IONP surface was deposited 
with different sera; human serum and mouse serum as well as differences between 
the activation of classical and alternative pathways by using the same veronal buffers 
used previously (DGVB++ and EGTA buffers). The different conditions used are listed 
in the table below. 
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Serum Veronal Buffer Aim 
1) IONPs incubated in mouse 
serum 
DGVB++ To favour classical pathway 
activation in the presence of 
mouse serum proteins 
2) IONPs incubated in mouse 
serum 
EGTA To favour alternative pathway 
activation in the presence of 
mouse serum proteins 
3) IONPs incubated in human 
serum 
DGVB++ To favour classical pathway 
activation in the presence of 
human serum proteins 
4) IONPs incubated in human 
serum 
EGTA To favour alternative pathway 
activation in the presence of 
human serum proteins 
5) ‘naked’ IONPs DGVB++ To favour classical pathway 
activation in the absence of 
serum proteins 
6) ‘naked’ IONPs EGTA To favour alternative pathway 
activation in the absence of 
serum proteins 
Table 4.1. IONPs incubations in different sera and buffers. The IONPs were incubated under the 
conditions listed in this table. The IONPs were incubated for 1 hour with the serum + buffer. IONPs 
were then washed with PBS before adding to serum-starved cells for 2 hours, following which the RNA 
was extracted. 
 
Reverse transcriptase was carried out on the extracted RNA to produce cDNA 
(described in section 2.10), which served as a template for the gene expression 
studies using qPCR. The amplification results were analysed using the 2-CT method 
(see section 2.10 for details) and the fold change in gene expression results were 











The graph (figure 4.2) shows that in both mouse serum deposited IONP samples (A & 
B), transcriptional expression of all investigated cytokines was minimally changed 
when normalised to the housekeeping gene. In both human serum deposited IONP 
samples (figure 4.2 C & D), expression of some cytokines was elevated, with IL-1β on 
Figure 4.2. Fold difference in gene expression for selected cytokines 
after exposure of serum starved mouse macrophages to IONPs for two 
hours. The graphs show the fold change/difference in gene expression for 
each cytokine investigated after exposure of mouse macrophages for 2 
hours with IONPs pre-incubated with human or mouse sera in DGVB++ or 
DGVB-EGTA buffers. Cells with without IONP addition were used as control 
to normalise the data. The housekeeping gene used was 18s rRNA. Error 
bars show standard deviation. qPCR data of 2 independent experiments 
was analysed with the 2-CT method. A one-way ANOVA test was carried 
out on GraphPad Prism to determine statistical significance. Due to large 
error bars, statistical significance was only obtained between IL-6 and IL-10 
in the ‘naked’ IONP in DGVB++ buffer. Dotted lines were added as a 
minimum threshold to show where significant fold differences may occur. 






average being overexpressed 5 fold. IL-1β is a potent pro-inflammatory cytokine 
mainly secreted by immune cells such as monocytes and macrophages in response 
to the detection of PAMPs (pathogen associated molecular patterns) (Lopez-Castejon 
and Brough, 2011). While it is an important cytokine in the host’s defence mechanism, 
overexpression of IL-1β can induce apoptotic events and its upregulation in cancer 
cells can promote tumour growth (Tu et al., 2008).  
 
Comparing the two ‘naked’ IONP samples (figure 4.2 E & F), the EGTA sample 
showed higher expression (by at least 9 fold) for 4 out of 11 cytokines compared to 
the DGVB++ sample. These cytokines included IL-1β, IL-6, IL-8 and IL-12p40. Along 
with IL-1β, IL-8 and IL-12p40 are pro-inflammatory cytokines and some studies have 
shown that IL-12 can play a role in the production and release of IL-8 (Ethuin et al., 
2001). This seems to correlate with the expression levels of IL-12 and IL-8 seen in the 
above figure 4.2. IL-6 is a pleiotropic cytokine, which can act as both pro-inflammatory 
and anti-inflammatory cytokine, and is usually secreted during infections or cell 
damage (Velazquez-Salinas et al., 2019).  
 
The difference seen between the two ‘naked’ IONPs samples (figure 4.2 E & F) could 
indicate that the DGVB++ buffer containing Ca2+ and Mg2+ ions triggers a lower 
inflammatory response than EGTA buffer, which lacks Ca2+ ions. However, presence 
of mouse serum proteins (B) greatly reduces the inflammatory immune response, 
indicating that the deposition of serum proteins modulates the inflammatory cell 
response. The data also indicates that different serum protein compositions on the 
IONPs has different effect on inflammatory responses, as demonstrated by the 
differences in human serum and mouse serum samples (figure 4.2 A,B,C,D). 
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NLRP3 expression was also increased by at least 2 fold in both ‘naked’ IONPs 
samples (figure 4.2 E & F), with the higher increase seen in ‘naked’ IONPs in EGTA 
buffer (Note: this data is based on two separate experiments done in triplicates. Due 
to error bar size, the experiment should be repeated to confirm these findings. 
However, during RNA-sequencing, NLRP3 was differentially expressed but 
expression was not significantly altered, which corresponds to the findings seen here.  
 
NLRP3 is a protein that upon stimulation, forms and activates the NLRP3 
inflammasome, which plays an important role in innate immunity (Zahid et al., 2019). 
NLRP3 inflammasome activation mediates the release of pro-inflammatory cytokines 
such as IL-1β, and as described previously, pro-inflammatory cytokines are key 
players in response to infections and tissue damage (Kelley et al., 2019). Furthermore, 
aberrant NLRP3 inflammasome activation has been associated with a number of 
diseases including diabetes, inflammatory bowel disease (IBD), certain cardiovascular 
diseases and cancers (Zahid et al., 2019).  
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To compare overall upregulated and downregulated cytokine expression, a log10 





















































































































































































































































































































































































'naked' IONPs in EGTA buffer
Figure 4.3. Log10 values of fold differences for selected cytokines after 
exposure of serum starved mouse macrophages to IONPs for two 
hours.. The graph shows the log10 values of fold change/difference in gene 
expression for each cytokine investigated after exposure of mouse 
macrophages for 2 hours with IONPs pre-incubated with human or mouse 
sera in DGVB++ or DGVB EGTA buffers. Values greater than 1 show an 
upregulation in cytokine expression whereas values less that 1 show a 
downregulation in cytokine expression. Cells with without NP addition were 
used as control to normalise the data. The housekeeping gene used was 
18s rRNA. Error bars show standard deviation. qPCR data of 2 independent 
experiments was analysed with the 2-CT method. A one-way ANOVA test 
was carried out using the log10 values on GraphPad Prism to determine 
statistical significance. Due to large error bars, statistical significance was 







The above graph (figure 4.3) shows an overview and comparison of upregulated 
cytokines and downregulated cytokines for each of the different experimental 
conditions. The ‘naked’ IONP samples incubated in EGTA buffer showed the highest 
upregulation of cytokine expression compared to the other samples, including ‘naked’ 
IONPs in DGVB++ buffer. This suggests that ‘naked’ IONPs in the presence of EGTA 
buffer is more likely to trigger an inflammation reaction since some of the pro-
inflammatory cytokines such as IL-1β, IL-6, TNF-α and IL-12p40 are marginally 
upregulated. However, IONPs incubated in the presence of mouse serum proteins 
diluted in EGTA buffer showed a low inflammatory response suggesting that triggering 
the activation of the alternative pathway in the presence of mouse serum proteins does 
not generate as high of an inflammatory response. Both mouse serum deposited 
IONPs showed the lowest inflammatory response whereas IONPs deposited with 
human serum triggered an inflammatory response with the upregulation of potent pro-
inflammatory markers such as IL-1β. 
Overall, IONPs deposited with mouse serum proteins, irrespective of the buffer used 
to deposit proteins, do not seem to trigger an enhanced immune response, with the 
lowest seen in the EGTA buffer sample (figure 4.3B). In fact, in the serum-deposited 
IONPs in EGTA buffer sample (figure 4.3B), most of the pro-inflammatory cytokines 
are downregulated with the exception of TNF-α. In the absence of serum proteins 
however, ‘naked’ IONPs in EGTA buffer (figure 4.3F) elicited the highest immune 
response, with the upregulation of all pro-inflammatory cytokines investigated. In the 
IONPs deposited in human serum proteins samples (figure 4.3C & D), there is an 
elevation in pro-inflammatory cytokine expression and a downregulation for the anti-
inflammatory cytokine IL-10. This could be due to the fact that some components of 
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human serum proteins may have been recognised as foreign by the mouse 
macrophages.  
 
5.2.2 Investigating the toxicity of IONPs using transcriptome and 
gene expression analysis 
To study the effects of IONPs exposure on gene expression in macrophages, cells 
were incubated for 2 hours with IONPs under different conditions, after which RNA 
was extracted from the cells and sequenced (Company: Genewiz) using Illumina RNA 
sequencing (poly(A) tail).  
The RNA samples sequenced are as follows: 
• Mouse serum deposited IONPs in DGVB++ buffer 
• Mouse serum deposited IONPs in EGTA buffer 
• ‘naked’ IONPs in DGVB++ buffer 
• ‘naked’ IONPs in EGTA buffer 
• No exposure to IONPs (control) 
Following library preparation and sequencing, all samples were compared against 
each other and all genes showing significant differential expression (DEGs) were 
identified. Once a list of DEGs was obtained, gene ontology enrichment analysis was 
carried out using UniProt to filter and extract genes that are involved in immune system 
processes. The method of this analysis is explained in more detail in chapter 2.12.   
 
Mouse serum deposited IONPs 
The two mouse serum deposited samples (DGVB++ and EGTA buffers) were 
compared against each other. The graph (figure 4.4) below shows the results from 
Gene Ontology analysis which denotes specific pathways where the significant DEGs 
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identified are involved in. Gene Ontology terms are organised as a hierarchy of 





The gene ontology analysis showed few pathways where the significant DEGs were 
involved; this was because in this comparison, only two significant DEGs were 
identified. 
 
The two samples showed very little DEGs overall suggesting that mouse serum 
proteins reduce a transcriptional response in mouse macrophages independent of 
complement pathway activation. The volcano plot below (figure 4.5) shows an 
overview of DEGs and significant DEGs in the two samples. 
Figure 4.4. Gene Ontology Analysis Overview. Differentially expressed genes were clustered by their 
gene ontology and the enrichment of gene ontology terms was tested using Fisher exact test 
(GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly enriched with 
an adjusted p-value (P<0.05) in the differentially expressed gene sets. Since only 2 DEGs were 
significant in this case, not many GO terms were identified. The pathways shown above are pathways 



















The two samples compared had two DEGs upregulated (p<0.05) in the mouse serum 
deposited IONPs in EGTA buffer and no downregulated DEGs. The two genes 
identified were CREB5 and HIST1H4J - neither of which relate to immune system 
processes - are described below.  
 
Figure 4.5. Volcano plot showing global transcriptional change.  The graph 
shows all DEGs when the two mouse serum deposited IONPs samples were 
compared. Each data point in the scatter plot represents a gene. The left side of the 
graph shows downregulated genes and the right side of the graph shows 
upregulated genes. Of 13,136 DEGs, only two genes (denoted by red dots) were 
significantly upregulated (p value <0.05). The x-axis shows log2 fold change of each 
gene and the y-axis shows the -log10 of its p-value. Significant p-value was 
considered at p<0.05, i.e. above 1.3 on the -log10 scale, as denoted by green line 
on the plot. 
Mouse serum-deposited IONPs in DGVB++ buffer vs 







CREB5 (cAMP responsive element binding protein 5) is a transcriptional factor and 
functions in cell cycle regulation, growth, proliferation and differentiation (He et al., 
2017). Overexpression of CREB5 by at least 2 fold has been identified in several types 
of cancers such as prostate cancer, ovarian cancer, colorectal cancer and 
hepatocellular carcinomas (Wang et al., 2020, Zhang et al., 2019). HIST1H4J encodes 
for a histone that is replication-dependent and is part of the histone H4 protein family 
(Tessadori et al., 2020). Very little is known of the effects of HIST1H4J upregulation 
however, a recent study by Tessadori et al. (2020) showed that a variant of the 
HIST1H4J gene is related to the development of neurodevelopmental disorders and 
caused severe developmental defects in zebrafish embryos. 
 
































Mouse serum deposited IONPs
Legend
Figure 4.6. Bar chart and heatmap showing significant DEGs.  Graph A shows the Log2 fold 
change of expression for CREB5 and HIST1H4J. Graph B shows a heat map of the upregulation of 
the two significant DEGs, plotted using log2 of expression values. The left column represents mouse 
serum deposited IONPs in DGVB++ buffer and the right column represents the corresponding EGTA 
buffer sample. Mouse serum deposited IONPs in EGTA buffer show the most significant change for 
both genes.  
A B 
Figure 4.7. Table showing summary of genes discussed in this comparison.  The table lists the 
significant DEGs identified in this comparison and the log2 fold change values. 
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DGVB++ buffer: Mouse serum deposited IONPs vs. ‘naked’ IONPs 
To evaluate the effects of mouse serum proteins associated with classical pathway 
activation adsorbed to IONPs, mouse serum deposited IONPs in DGVB++ buffer was 
compared against ‘naked’ IONPs in DGVB++ buffer. The analysis showed some 





The Gene Ontology analysis (figure 4.7) results revealed the several pathways where 




Figure 4.7. Gene Ontology Analysis Overview. Differentially expressed genes were clustered by their 
gene ontology and the enrichment of gene ontology terms was tested using Fisher exact test 
(GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly enriched with 
an adjusted p-value (P<0.05) in the differentially expressed gene sets. Up to 40 GO terms are shown 




















Of the 37 significant DEGs, 25 genes were upregulated and 12 genes were 
downregulated (figure 4.8). Gene ontology enrichment analysis was carried out to 
identify the significant DEGs involved in immune system processes (chapter 2.11). 7 
genes were found to be related to the immune system, 2 of which are downregulated 
and 5 are upregulated (figure 4.9). 
‘naked’ IONPs in DGVB
++
 buffer vs mouse serum-
deposited IONPs in DGVB
++
 buffer 
Figure 4.8. Volcano plot showing global transcriptional change.  The graph shows 
all DEGs when mouse serum deposited sample was compared to the ‘naked’ IONPs in 
DGVB++ buffer. Of 12,805 DEGs, 37 genes were significant (p value <0.05). The red 
dots on the right of the graph show genes that were significantly upregulated and the 
blue dots on the left show genes that were significantly downregulated. The x-axis 
shows log2 fold change of each gene and the y-axis shows the -log10 of its p-value. 
Significant p-value was considered at p<0.05, i.e. above 1.3 on the -log10 scale. Of the 
genes identified relating to immune system processes discussed in the text, the most 









The data shows that TNFSF12, TNFSF13, IL-10, CD5L, and SERPINB9B are 
upregulated while TCIM and ACOD1 are downregulated in the serum deposited 
sample when compared to the ‘naked’ IONPs sample (figure 4.9).  
TNFSF12 (tumour necrosis factor superfamily member 12) is one of the genes that 
encode for TRAIL (TNF-related apoptosis-inducing ligand) proteins, which upon 
activation induces caspase-8 activity, leading to receptor-induced cell death (Wan et 
al., 2018). Hence, TNFSF12 signalling can have some pro-apoptotic effects, 
especially seen in tumour cell lines (Abend, Uldrick and Ziegelbauer, 2010). TNFSF12 
signalling also plays a role in cell proliferation and migration, suggesting that it is 
involved in wound repair, angiogenesis and tumorigenesis (Abend, Uldrick and 
Ziegelbauer, 2010).  
 
Another member of the same family, TNFSF13 (tumour necrosis factor superfamily 
member 13) has be shown to be involved in the progression of several types of 










































































‘naked’ IONPs in 
DGVB++ buffer
Figure 4.9. Bar chart and heatmap showing significant DEGs. Graph A shows the Log2 fold change 
of expression for the significant DEGs. Graph B shows a heat map of the significant upregulated and 
downregulated DEGs, plotted using log2 of expression values. The left column represents mouse 
serum deposited IONPs in DGVB++ buffer sample and the right column represents the corresponding 
EGTA buffer sample. Mouse serum deposited IONPs in EGTA buffer show the highest number of 
upregulated genes. The dotted line represents the threshold value for fold change, where significant 
changes may occur within the cell. Heatmaps show which sample the gene was more upregulated in. 
A B 
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et al., 2014). A study by Qian et al. (2014) found that TNFSF13 was overexpressed in 
some types of lung cancers, with the highest upregulation associated with 
adenocarcinomas. TNFSF13 overexpression was also found in colorectal 
adenocarcinoma fibroblasts (Petty et al., 2009). 
 
IL-10 (interleukin 10) is one of the most potent anti-inflammatory cytokines and plays 
an important role towards limiting the immune response upon exposure to pathogens. 
IL-10 prevents the production of cytokines, chemokines and costimulatory molecules, 
thus reducing host cell damage and autoimmune reactions (Iyer and Cheng, 2012). 
On the other hand, by suppressing immune system functions, IL-10 can contribute to 
the development of cancer as tumours have an increased chance of escaping immune 
surveillance (Wei, Wang and Li, 2020).  
 
CD5L (CD5 molecule-like) is a glycoprotein, mainly secreted by macrophages, and 
when secreted is involved in inflammatory responses (Sanjurjo et al., 2018). A study 
carried out by Sanjurjo et al. (2018) showed that CD5L is similar to IL-10 in the way 
that they both induce M2 macrophage polarisation. CD5L is regarded as an apoptosis 
inhibitor in macrophages and plays an important role in inflammation to maintain 
normal tissue homeostasis (Martinez et al., 2014). Whilst this is an important process 
during inflammation, the occurrence of apoptosis is a crucial part of tumour protection 
and if this function is impaired, the progression of tumours is favoured (Silke and 
Meier, 2013).  
 
SERPINB9B (serine protease inhibitor, clade B, member 9b) is one of the lesser 
studied serpin family member so far, however the serine protease inhibitor superfamily 
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is known to play a role in regulating immune system processes such as apoptosis, 
blood coagulation and complement activation (Kaiserman and Bird, 2010). 
ACOD1 (Aconitate decarboxylase 1) also known as IRG1 (Immunoresponsive gene 
1) is upregulated in macrophages during pro-inflammatory reactions, however its 
exact role and cellular mechanisms remain unexplored (Michelucci et al., 2013, Wu et 
al., 2020).  
 











EGTA buffer: Mouse serum deposited IONPs vs. ‘naked’ IONPs  
Mouse serum deposited IONPs in EGTA buffer were compared against ‘naked’ IONPs 
in EGTA to evaluate the effect of mouse serum proteins associated with alternative 
pathway activation adsorbed on IONPs. The data showed hundreds of significant 
DEGs and gene ontology enrichment analysis was carried out to identify those relating 
to immune system process (figure 4.11).  
Figure 4.10. Table showing summary of genes discussed in this comparison.  The table lists the 






The Gene Ontology analysis results revealed several pathways where the significant 
DEGs in this comparison are involved in (figure 4.11). The most upregulated pathway 
was found to be ‘inflammatory response’, which means one of the conditions 






Figure 4.11. Gene Ontology Analysis Overview. Significantly differentially expressed genes were 
clustered by their gene ontology and the enrichment of gene ontology terms was tested using Fisher 
exact test (GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly 
enriched with an adjusted p-value (P<0.05) in the differentially expressed gene sets. Up to 40 GO terms 
are shown in the above figure. 
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The graph below (figure 4.12) shows an overview of DEGs, including significantly 





















Of 289 significant DEGs, 159 genes were downregulated and 130 were upregulated 
(figure 4.12). Through gene ontology enrichment analysis, 75 DEGs were found to be 
related to immune system processes. Some of the genes which are related to cytokine 
Figure 4.12. Volcano plot showing global transcriptional change.  .  The graph 
shows all DEGs when mouse serum deposited sample was compared to the ‘naked’ 
IONPs in EGTA buffer. Of 13,134 DEGs, 289 genes were significantly (p value <0.05) 
changed. The red dots on the right of the graph show genes that were significantly 
upregulated and the blue dots on the left show genes that were significantly 
downregulated. The x-axis shows log2 fold change of each gene and the y-axis shows 
the -log10 of its p-value. Significant p-value was considered at p<0.05, i.e. above 1.3 on 
the -log10 scale. Of the selected genes relating to innate immune processes discussed 
in the text, the most upregulated and downregulated genes are circled and labelled on 
the volcano plot. 
‘naked’ IONPs in EGTA buffer vs mouse serum-













Most of the genes shown in graph 4.13, except IL-10, were significantly downregulated 
in the serum deposited IONPs in EGTA buffer when compared to ‘naked’ IONPs in  
EGTA buffer. IL-1β showed the highest change in expression levels among all 
significant DEGs and was downregulated 9.34 fold. As mentioned previously, IL-1β is 
a potent pro-inflammatory cytokine that plays a crucial role in the host’s defence in 






































































































Figure 4.13. Bar chart and heatmap showing significant DEGs. Graph A shows the Log2 fold 
change of expression for selected DEGs relating to immune system processes. Graph B shows a 
corresponding heat map of the significant upregulated and downregulated DEGs, plotted using log2 
of expression values. The left column represents mouse serum deposited IONPs in EGTA buffer and 
the right column represents ‘naked’ IONPs in EGTA buffer. Most of the genes were downregulated in 
the serum deposited sample when compared to the ‘naked’ IONPs sample, with the exception of IL-
10 which was upregulated in the serum deposited sample. The dotted lines how the threshold value 
after which significant changes may occur within cells.  Heatmaps show in which sample the gene 
was more upregulated. Grey blocks indicate no expression or low expression below the detection limit. 
A B 
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The TNFAIP3 gene codes for the protein A20, also known as tumour necrosis factor 
α-induced protein 3 (TNFAIP3), which is an anti-inflammatory protein that closely 
regulates the activation of NF-κB during inflammation (Coornaert, Carpentier and 
Beyaert, 2009). The A20 protein is a negative regulator of NF-κB signalling and in fact 
a study carried out in mice showed that A20-deficient mice were unable to inhibit NF-
κB activation, which resulted in severe inflammation (Lee et al., 2000). NF-κB 
signalling is activated during inflammation reactions, which in turn regulates the 
expression of pro-inflammatory genes coding for cytokines and chemokines. As seen 
with other pro-inflammatory cytokines, overexpression of NF-κB can lead to 
autoimmune reactions (Lawrence, 2009). NF-κBID is a protein initially thought to be 
inhibiting NF-κB signalling, however is now reported to be able to both inhibit as well 
as promote NF-κB signalling depending on cell type (Schuster et al., 2013). 
 
TNFSF9 (tumour necrosis factor superfamily 9), also known as CD137L, is a ligand 
that is expressed by antigen presenting cells (APCs) and upon interaction with its 
receptor triggers a cell-mediated immune response, which causes pro-inflammatory 
cytokines to be secreted (Dharmadhikari et al., 2016). 
 
IL-27 is a cytokine secreted by APCs that has both pro-inflammatory and anti-
inflammatory properties and forms part of the IL-6 and IL-12 cytokine family (Kourko 
et al., 2019). Even though IL-27 is secreted when innate immunity is activated, it plays 
an important role in modulating the adaptive immune response, especially Th1 and 
Th2 responses (Fabbi, Carbotti and Ferrini, 2017). As pro-inflammatory cytokine, IL-
27 can promote an efficient Th1 response by encouraging clonal expansion and 
proliferation of CD4+ and CD8+ T cells respectively (Fabbi, Carbotti and Ferrini, 2017). 
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Although these mechanisms are yet to be fully understood, as an anti-inflammatory 
cytokine, IL-27 inhibits the expression of an important Th2 transcription factor, thus 
supressing Th2 immune responses (Villarino, Huang and Hunter, 2004, Kourko et al., 
2019). 
 
CSF-1 (colony-stimulating factor 1), also known as M-CSF (macrophage CSF) is an 
important part of innate immunity and a growth factor which plays a key role in the 
proliferation, survival and  differentiation of macrophages by binding to its receptor 
(Jones and Ricardo, 2013). CSF2 (granulocyte-macrophage colony-stimulating factor) 
and CSF3 (granulocyte colony-stimulating factor) are other growth factors also 
involved in the proliferation, differentiation and survival of immune cells, however 
CSF2 is for macrophages and neutrophils whereas CSF3 is only for granulocytes (He 
et al., 2008). CSF2 and CSF3 can also promote inflammatory responses by triggering 






























The ‘naked’ IONPs in DGVB++ buffer sample was compared to the ‘naked’ IONPs in 
EGTA buffer sample to look at the effects each of these pre-treatments - in the 
absence of serum proteins - could have on subsequent gene expression in 
macrophages. Hundreds of significant DEGs were identified and gene ontology 
enrichment analysis was performed to narrow down the genes relating to immune 
system processes (figure 4.15).  
 
Figure 4.14. Table showing summary of genes discussed in this comparison.  The table lists the 






The Gene Ontology analysis results (figure 4.15) revealed a large number of pathways 
the significant DEGs in this comparison are involved in. The most upregulated pathway 
was found to be ‘inflammatory response’, which again means one of the conditions 
investigated here elicited a significant inflammatory response in the cells, the common 






Figure 4.15. Gene Ontology Analysis Overview. Differentially expressed genes were clustered by 
their gene ontology and the enrichment of gene ontology terms was tested using Fisher exact test 
(GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly enriched with 




















From the graph (figure 4.16), it can be seen that there were more upregulated genes 
(220 genes) compared to downregulated genes (100 genes). Of 320 significant DEGs, 
80 were identified to be related to immune system processes through GO enrichment 
analysis. A few genes related to the innate immune system and inflammation were 
selected and are discussed below. 
 
Figure 4.16. Volcano plot showing global transcriptional change.  This graph shows 
all DEGs when the two ‘naked’ IONPs samples (DGVB++ and EGTA buffer) were 
compared against each other. Of 12,785 DEGs, 320 genes were significant (p value 
<0.05). The red dots on the right of the graph show genes that were significantly 
upregulated and the blue dots on the left show genes that were significantly 
downregulated. The x-axis shows log2 fold change of each gene and the y-axis shows 
the -log10 of its p-value. Significant p-value was considered at p<0.05, i.e. above 1.3 on 
the -log10 scale. Of the selected genes relating to innate immune processes discussed 
in the text, some genes are circled and labelled on the volcano plot. 
‘naked’ IONPs in DGVB
++
 buffer vs ‘naked’ 









From the above graphs (figure 4.17), it can be seen that most of the selected genes 
are significantly upregulated in the ‘naked’ IONPs in EGTA buffer when compared to 
‘naked ‘ IONPs in DGVB++ buffer. The downregulated gene in ‘naked’ IONPs in EGTA 
buffer sample is CD2 (T-cell surface antigen CD2). The CD2 gene codes for CD2 
protein, a glycoprotein, which participates in a pathway important for T cell activation 
(Binder et al., 2020, Altevogt, Michaelis and Kyewski, 1989). 
 
A number of the genes upregulated in the presence of ‘naked’ IONPs in EGTA buffer 
(TNFAIP3, TNFSF9, TNFRSF1B, NLRP3, NF-κB1, NF-κBID, CSF1, CSF2, IL-27) 
have been described in the section above. This is an indication that a greater 
inflammatory response is triggered in the EGTA buffer since a few of the genes 






















































































































Figure 4.17. Bar chart and heatmap showing significant DEGs. Graph A shows the Log2 fold 
change of expression for selected DEGs relating to immune system processes. Graph B shows 
a corresponding heat map of the significant upregulated and downregulated DEGs, plotted using 
log2 of expression values. The left column represents ‘naked’ IONPs in DGVB++ buffer and the 
right column represents ‘naked’ IONPs in EGTA buffer. The dotted lines show threshold values, 
following which significant changes may occur within cells. Heatmaps show in which sample the 
gene was more upregulated in. Grey blocks indicate no expression or expression below the 
detection limit. 
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and promote inflammation reactions. Upregulation of anti-inflammatory factors such 
as TNFAIP3, which encodes the A20 protein, a negative regulator of NF-κB, can also 
be seen, further indicating a balanced reaction between pro-inflammatory and anti- 
inflammatory responses. 
 
CD40 gene encodes the protein CD40, belonging to the TNF superfamily, which is a 
receptor expressed on B cells and macrophages. Upon activation by its ligand (CD40L 
found on T cells) it is a mediator of adaptive immunity, particularly in T-cell immunity 
(Ara, Ahmed and Xiang, 2018). CD40 receptor engagement with its ligand can also 
trigger the expression of other TNF receptors and consequently can cause the 
activation of NF-κB signalling (Michel, Zirlik and Wolf, 2017). 
 
NRROS (negative regulator of reactive oxygen species) reduces the amount of ROS 
(reactive oxygen species) secreted by phagocytes during inflammation reactions 
(Noubade et al., 2014). Production of ROS by phagocytes is an important part of the 
host’s immune response against pathogens, however unregulated production of ROS 
can be harmful and can lead to oxidative stress and autoimmune diseases (Di Dalmazi 
et al., 2016). Through interactions with the latent TGF-β complex, NRROS can also 
activate TGF-β, a cytokine with both pro-inflammatory and anti-inflammatory 
properties (Smith et al., 2020).  
 
IL-7R (IL-7 receptor) is expressed by activated macrophages after activation of the 
innate immune system and its expression can also be activated by TNFs during an 
inflammatory reaction (Al-Mossawi et al., 2019). IL-7R plays an important role in both 
the innate and adaptive arms of the immune system, particularly in the survival, 
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differentiation and development of T cells through propagating pro-inflammatory 
signalling of the IL-7 cytokine (Passtoors et al., 2015). 
CD247 forms part of the T-cell receptor complex and is important for optimal functions 
of T-cells during inflammation (Lundholm et al., 2010). In fact, downregulation of the 
CD247 component of the receptor complex is known to be seen in patients with 
chronic inflammations caused by suppressed activity of the immune system (Eldor et 
al., 2015). 
 















 Figure 4.18. Table showing summary of genes discussed in this comparison.  The table lists the 
significant DEGs identified in this comparison and the log2 fold change values. 
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Mouse serum deposited IONPs in DGVB++ buffer vs. Control 
To study the effects of mouse serum deposited IONPs in DGVB++ buffer on gene 
expression, the sample was compared to a control sample where the cells were not 
exposed to any IONPs. This will give us a good indication of the inflammation response 
triggered when serum proteins associated with the classical pathway are adsorbed 






The Gene Ontology analysis results revealed several pathways the significant DEGs 
in this comparison are involved in (figure 4.19). 
An overview of DEGs are shown in the volcano plot below.  
Figure 4.19. Gene Ontology Analysis Overview. Differentially expressed genes were clustered by 
their gene ontology and the enrichment of gene ontology terms was tested using Fisher exact test 
(GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly enriched with 
an adjusted p-value (P<0.05) in the differentially expressed gene sets. Up to 40 GO terms are shown 





















From the volcano plot (figure 4.20), it can be clearly seen that the number of 
upregulated significant DEGs greatly outnumbers the number of downregulated 
DEGs. Of 188 significant DEGs, 43 genes were downregulated and 145 genes were 
upregulated. GO enrichment analysis was performed to identify genes relating to 
immune system processes and 32 genes were identified. Of those, genes that were 
Figure 4.20. Volcano plot showing global transcriptional change.  This graph shows 
all DEGs when the control (no IONPs) sample was compared against mouse serum 
deposited IONPs in DGVB++ buffer. Of 13,119 DEGs, 188 genes were significant (p 
value <0.05). The red dots on the right of the graph show genes that were significantly 
upregulated and the blue dots on the left show genes that were significantly 
downregulated. The x-axis shows log2 fold change of each gene and the y-axis shows 
the -log10 of its p-value. Significant p-value was considered at p<0.05, i.e. above 1.3 on 
the -log10 scale. Of the selected genes relating to innate immune processes discussed 
in the text, some genes are circled and labelled on the volcano plot. 







the most relevant to innate immune processes and inflammation reactions were 







The downregulated TNF gene seen in the graph above codes for an important pro-
inflammatory cytokine (TNF-α) which is crucial during an inflammatory response.  
ACOD1 expression, which is usually upregulated in macrophages during pro-
inflammatory responses as discussed previously, is also downregulated in the mouse 
serum deposited sample. The two most upregulated genes are IL-10, an anti-
inflammatory cytokine, and CD2 which is a T-cell surface antigen important in the 
activation of T cells, a key part of adaptive immunity. Of all 32 genes identified relating 

































































Figure 4.21. Bar chart and heatmap showing significant DEGs. Graph A shows the Log2 fold 
change of expression for selected significant DEGs relating to immune system processes. Graph B 
shows a corresponding heat map of the significant upregulated and downregulated DEGs, plotted 
using log2 of expression values. The left column represents the control (no IONPs) sample and the 
right column represents mouse serum deposited IONPs in DGVB++ buffer. The dotted lines show the 
threshold value, following which significant changes may occur within cells. Heatmaps show in which 
sample the gene was more upregulated in. Grey blocks indicate no expression or expression below 
















Mouse serum deposited IONPs in EGTA buffer vs. Control 
The control sample (with no IONPs exposure) was compared to the mouse serum 
deposited IONPs in EGTA buffer to look at the effects of serum proteins associated 
with the alternative pathway adsorbed onto the IONPs. The results for Gene Ontology 
analysis are shown in the graph below (figure 4.23). 
 
Figure 4.22. Table showing summary of genes discussed in this comparison.  The table lists the 
















Figure 4.23. Gene Ontology Analysis Overview. Differentially expressed genes were clustered by their 
gene ontology and the enrichment of gene ontology terms was tested using Fisher exact test 
(GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly enriched with an 
adjusted p-value (P<0.05) in the differentially expressed gene sets. Up to 40 GO terms are shown. 
-log 10 (Adjusted Pvalue) 
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The above volcano plot (figure 4.24) shows that there were many more upregulated 
genes than downregulated genes when the two samples were compared. Of 183 
significant DEGs, 152 were upregulated whereas 31 genes were downregulated. 
Gene ontology enrichment analysis was carried out with the significant DEGs to 
Control (No NPs) vs mouse serum-deposited 
IONPs in EGTA buffer 
Figure 4.24. Volcano plot showing global transcriptional change.  This graph shows 
all DEGs when the control (no IONPs) sample was compared against mouse serum 
deposited IONPs in EGTA buffer sample. Of 12,192 DEGs, 183 genes were significant 
(p value <0.05). The red dots on the right of the graph show genes that were significantly 
upregulated and the blue dots on the left show genes that were significantly 
downregulated. The x-axis shows log2 fold change of each gene and the y-axis shows 
the -log10 of its p-value. Significant p-value was considered at p<0.05, i.e. above 1.3 on 
the -log10 scale. Of the selected genes relating to innate immune processes discussed 





identify those that relate to immune system processes. 36 genes were identified and 
those that were the most relevant to innate immune response and inflammation were 







A few common patterns are seen with serum deposited IONPs in EGTA buffer and 
serum deposited IONPs in DGVB++ buffer (figures 4.25 and 4.21) where pro-
inflammatory related genes such as TNF and ACOD1 are downregulated and the anti-
inflammatory cytokine IL-10 is upregulated. NRROS and CD74 are also 
downregulated in serum deposited IONPs in EGTA buffer compared to the control 
sample. NRROS, as described earlier, is a negative regulator of ROS production, thus 
regulating oxidative damage in cells. CD74 gene codes for the transmembrane protein 
CD74 that is important during antigen processing and presentation by chaperoning 


















































































IONPs in EGTA 
buffer
Figure 4.25. Bar chart and heatmap showing significant DEGs. Graph A shows the Log2 fold 
change of expression for selected significant DEGs relating to immune system processes. Graph B 
shows a corresponding heat map of the significant upregulated and downregulated DEGs, plotted 
using log2 of expression values. The left column represents the control (no IONPs) sample and the 
right column represents mouse serum deposited IONPs in EGTA buffer. The dotted lines show the 
threshold value, following which significant changes may occur within the cell. Heatmaps show which 





have also shown that CD74, through a series of binding and formation of complexes, 
is able to activate NF-κB signalling (Gil-Yarom et al., 2017).  
 
Amongst the upregulated genes are TCIM, IL-10, IL-6RA, RAB7B, CD24A and 
SERPINB9B, some of which have already been described previously. Of all 36 genes 
identified relating to immune system processes, TCIM (Transcriptional and Immune 
Response Regulator) showed the highest level of upregulation (5 fold) in the serum 
deposited sample compare to untreated cells.  TCIM is associated with Wnt/b-catenin 
signalling and plays a role in the proliferation of tumour cells. Overexpression of TCIM 
was shown to suppress the cytotoxic function of intratumoral CD8+ T cells (Tsukumo 
and Yasutomo, 2018; Dai et al., 2017).  
 
IL-6Rα (IL-6 receptor α-subunit) is an IL-6 receptor. IL-6 is an important cytokine which 
plays a role in various functions such as inflammation and immune responses. 
Aberrant IL-6 expression can give rise to inflammatory diseases and autoimmune 
diseases (Su, Lei and Zhang, 2017).  
 
The Rab superfamily of proteins are crucial players of intracellular trafficking, as 
described in chapter 3.  Rab7b expression is upregulated in activated monocytes 
following exposure to LPS (lipopolysaccharide) (Bucci, Bakke and Progida, 2010). 
Rab7b is part of the Rab GTPase protein family and acts in a similar manner to Rab7. 
It is thus important for lysosomes function as well as during the trafficking of receptors 


















‘naked’ IONPs in DGVB++ buffer vs. Control 
To look at the effects of IONPs incubated in two different buffers, first the ‘naked’ 
IONPs in DGVB++ buffer sample was compared to the control sample (from cells not 
exposed to IONPs). The results from Gene Ontology analysis are displayed in the 
graph below (figure 4.27).  
Figure 4.26. Table showing summary of genes discussed in this comparison.  The table lists the 
















Figure 4.27. Gene Ontology Analysis Overview. Significantly differentially expressed genes were 
clustered by their gene ontology and the enrichment of gene ontology terms was tested using Fisher exact 
test (GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly enriched with 
an adjusted p-value (P<0.05) in the differentially expressed gene sets. Up to 40 GO terms are shown in 
the above figure. 
 174 




















From the volcano plot (figure 4.28), it can be seen that there were more upregulated 
than downregulated significant DEGs when the ‘naked’ IONPs sample was compared 
to the control sample. Of 188 significant DEGs, 130 genes were upregulated and 58 
genes were downregulated. Gene ontology enrichment analysis was performed to 
Control (No NPs) vs ‘naked’ IONPs in DGVB
++
 buffer 
Figure 4.28. Volcano plot showing global transcriptional change.  This graph shows 
all DEGs when the control (no IONPs) sample was compared against ‘naked’ IONPs in 
DGVB++ buffer sample. Of 12,567 DEGs, 188 genes were significant (p value <0.05). 
The red dots on the right of the graph show genes that were significantly upregulated 
and the blue dots on the left show genes that were significantly downregulated. The x-
axis shows log2 fold change of each gene and the y-axis shows the -log10 of its p-value. 
Significant p-value was considered at p<0.05, i.e. above 1.3 on the -log10 scale. Of the 
selected genes relating to innate immune processes discussed in the text, some genes 




identify the list of genes related to immune system processes and 27 genes were 







Two upregulated genes in the graph (figure 4.29) are the anti-inflammatory cytokine 
IL-10 and CD24A, also known as CD24, which acts as signal transducer. CD24 
suppresses the immune response during inflammatory reactions by interacting with 
proteins (Siglec-10) on innate immune cells, which inhibits signalling cascades leading 
to decreased engulfment of foreign and unwanted material by macrophages (Barkal 
et al., 2019). Whilst this can be an effective protective mechanism against cell 
damage, it can be exploited by cancer cells as a way to evade immune surveillance. 
 
Amongst the downregulated genes are IFI44, MPEG1 and NRROS, the latter of which 
has been described previously as a negative regulator of ROS. IFI44 (Interferon-




















































‘naked’ IONPs in 
DGVB++ buffer
Figure 4.29. Bar chart and heatmap showing significant DEGs. Graph A shows the Log2 fold 
change of expression for selected significant DEGs relating to immune system processes. Graph B 
shows a corresponding heat map of the significant upregulated and downregulated DEGs, plotted 
using log2 of expression values. The dotted lines show the threshold value, following which significant 
changes may occur within the cell. The left column represents the control (no IONPs) sample and the 
right column represents ‘naked’ IONPs in DGVB++ buffer. Heatmaps show in which sample the gene 





immune activation, particularly during antiviral responses, which plays an important 
role in protecting against host damage and autoimmune diseases (DeDiego et al., 
2019). MPEG1 (macrophage-expressed gene 1) encodes a protein important for 
macrophages to protect the host against pathogens, particularly during intracellular 
defence against bacteria (McCormack et al., 2015). Downregulation of MPEG1 can be 
favourable for the growth and survival of pathogenic bacteria. 
 









‘naked’ IONPs in EGTA buffer vs. Control 
The final comparison was to look at the effects of ‘naked’ IONPs in EGTA buffer 
compared to the control sample (no exposure to IONPs). The results of the Gene 
Ontology analysis is shown below (figure 4.31). 
Figure 4.30. Table showing summary of genes discussed in this comparison.  The table lists the 






The Gene Ontology analysis results (figure 4.31) show ‘inflammatory responses’ as 
the third highest term/pathway suggesting that the presence of EGTA buffer triggers 
a higher inflammatory response in the mouse macrophages as this is also seen when 
the two ‘naked’ samples were compared (Figure 4.15). Furthermore, preliminary 
studies carried out by members of our lab showed that the IONPs, which have a starch 
coating on the surface, activated complement more via the alternative pathway than 




Figure 4.31. Gene Ontology Analysis Overview. Differentially expressed genes were clustered by their 
gene ontology and the enrichment of gene ontology terms was tested using Fisher exact test 
(GeneSCFv1.1-p2). The above figure shows gene ontology terms that are significantly enriched with an 

















These results show that the IONPs studied here are potent activators of the alternative 
pathway of the complement system (figure 4.32). 
 
To compare ‘naked’ IONPs in EGTA vs. control cells, an overview of all DEGs are 












































































Figure 4.32. Activation of the classical and alternative pathways 
with different nanoparticles. Human serum was incubated with E 
cells overnight at 4oC. The serum was then separated from the E 
cells via centrifugation. The absorbed serum that was obtained was 
diluted in DGVB++ buffer in the ratio of 1:1. The serum was then 
incubated with carbon nanotubes, iron nanoparticles (Pristine) and 
Zymosan for 1 hour at 37oC. The serum was spun down at maximum 
speed for 10 minutes and the supernatant was collected. 200μl of 
serum was inoculated in a 94 well plate and was serial diluted with 
100μl of DVGB buffer in the other wells up to the dilution of 1:4096. 
Complete lysis (100%) was carried out in neat serum. The graph 
shows that starch coated iron oxide nanoparticles activate the 
alternative pathway more than the classical pathway. Experiment 






















The volcano plot above shows that similar to some previous trends, the upregulated 
genes vastly outnumber the downregulated genes in the ‘naked’ IONPs sample 
compared to the control sample (figure 4.33). Of 201 significant DEGs, 21 genes were 
downregulated whereas 180 genes were upregulated. Gene ontology enrichment 
analysis was performed to identify the genes relating to immune system processes 
and 52 genes were identified, some of which are discussed below (figure 4.34). Of 
Control (No NPs) vs ‘naked’ IONPs in EGTA buffer 
Figure 4.33. Volcano plot showing global transcriptional change.  This graph shows 
all DEGs when the control (no IONPs) sample was compared against ‘naked’ IONPs in 
EGTA buffer sample. Of 13,114 DEGs, 201 genes were significant (p value <0.05). The 
red dots on the right of the graph show genes that were significantly upregulated and 
the blue dots on the left show genes that were significantly downregulated. The x-axis 
shows log2 fold change of each gene and the y-axis shows the -log10 of its p-value. 
Significant p-value was considered at p<0.05, i.e. above 1.3 on the -log10 scale. Of the 
selected genes relating to innate immune processes discussed in the text, some genes 







note, the number of significant DEGs relating to immune system processes in this case 








Of all 52 significant DEGs relating to immune system processes, 47 genes were 
upregulated and 5 genes were downregulated. LIF (leukaemia inhibitory factor), a 
member of the IL-6 family, was the most upregulated gene of all 13,144 DEGs (figures 
4.34 and 4.35). This is the only sample where significant upregulation of LIF was seen. 
LIF is a cytokine and, as its name suggests, plays an important role in the inhibition of 
leukaemia progression, however, upregulation of LIF can occur during inflammation, 
which can enhance the formation and progression of solid tumours by promoting 

















































































Figure 4.34. Bar chart and heatmap showing significant DEGs. Graph A shows the Log2 fold 
change of expression for selected significant DEGs relating to immune system processes. Graph B 
shows a corresponding heat map of the significant upregulated and downregulated DEGs, plotted 
using log2 of expression values. The dotted lines show the threshold value (2), following which 
significant changes may occur within the cells. The left column represents the control (no IONPs) 
sample and the right column represents ‘naked’ IONPs in EGTA buffer. Heatmaps show which 
sample the gene was more upregulated in. Grey blocks indicate no expression or expression below 
the detection limit. 
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molecule and is slightly downregulated in the ‘naked’ IONPs sample compared to the 
control sample. 
 
Other upregulated genes include IL-1RN, CD80 and CD14. IL-1RN (interleukin 1 
receptor antagonist) is an anti-inflammatory protein that counteracts the effects of the 
potent pro-inflammatory cytokine IL-1, including IL-1β (SHIIBA et al., 2015). CD80 (T-
lymphocyte activation antigen) is a ligand usually expressed on APCs and acts as co-
stimulatory molecule in T-cell activation during adaptive immune responses (LI et al., 
2016). CD14 (monocyte differentiation antigen) is mainly produced by monocytes and 
macrophages and when stimulated, can promote the release of pro-inflammatory 
cytokines and chemokines by enhancing specific signalling pathways (Marcos et al., 
2010).  
 











 Figure 4.35. Table showing summary of genes discussed in this comparison.  The table lists the 
significant DEGs identified in this comparison and the log2 fold change values. 
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5.3 Discussion 
Nanomaterials are very promising agents in the treatment as well as diagnosis of many 
diseases, including cancer. However, there still are a lot of roadblocks and gaps to be 
filled in the existing literature when it comes to the safety of using nanomaterials for 
therapeutic and diagnostic purposes. Depending on their size, shape and chemical 
properties, NPs can trigger many toxicity issues, ranging from acute localised 
inflammation to systemic damage (Hannon et al., 2019). Undesirable effects from the 
activation of the immune system by NPs include inflammation reactions, 
hypersensitivity and anaphylaxis (Zolnik et al., 2010). Of particular note, the effects of 
aberrant cytokine expression can vary from mild (example: fever, nausea) to more 
severe and fatal effects such as organ damage (Hannon et al., 2019).  
 
Other than triggering a pro-inflammatory response, NPs can also have the opposite 
effect of suppressing the immune system, which is more favourable for tumour growth 
as cancer cells are able to evade a suppressed immune surveillance (Ilinskaya and 
Dobrovolskaia, 2014). Hence, studying cytokine expression levels is an excellent way 
to assess the type of immune response triggered by NPs. The aim of this study was 
to further understand the immunotoxicity of IONPs by using cytokines as biomarkers 
of inflammation and transcriptome profiling to study gene expression changes at the 
mRNA level. 
 
From the bioinformatics results comparing the mouse serum deposited IONPs 
samples (figure 4.6), no significantly differentially expressed genes relating to the 
immune system, irrespective of the buffer used, were observed. In fact, out of more 
than 13,000 genes, only two were significantly differentially expressed. This indicates 
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that the inflammatory response triggered by both mouse serum deposited samples are 
quite similar, which also correlates to what was seen from the qPCR results in figures 
4.2-4.3.  It is important to note that the differences seen with the different treatments 
may relate to the differences in overall IONP uptake. The results from the previous 
chapter showed less IONP uptake in general when IONPs were coated with mouse 
serum compared to human serum. Thus, the differences seen in inflammatory 
responses from the qPCR results where mouse serum treatments seem to elicit a 
more suppressed immune response compared to human serum treatments could be 
linked to the differences in IONP uptake. 
 
When the mouse serum deposited IONPs in DGVB++ buffer was compared against its 
corresponding ‘naked’ IONPs sample, significant upregulation and downregulation of 
some genes were identified, including the upregulation of anti-inflammatory cytokine, 
IL-10. The other upregulated genes seen were those associated with inflammation 
responses.  
 
When the mouse serum deposited IONPs sample in EGTA buffer was compared to 
‘naked’ IONPs sample in EGTA, the only upregulated gene shown in the graph was of 
the anti-inflammatory cytokine IL-10. All other pro-inflammatory genes were 
significantly downregulated and of all 289 significantly differentially expressed genes, 
IL-1β was the most downregulated gene by almost 10-fold. Complement-dependent 
downregulation of IL-1β was also seen in a study carried out by Pondman et al., (2016) 
investigating the interactions of carbon nanotubes and immune cells. This indicates 
that the mouse serum deposited IONPs in EGTA sample might have more of an 
immunosuppressive effect than that elicited by IONPs without the presence of mouse 
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serum coating. The qPCR results in figure 4.3  support this pattern where common 
pro-inflammatory cytokines such as IL-1β and NF-κB1 were downregulated in the 
serum deposited sample. In fact, through gene ontology analysis results for this 
comparison showed ‘inflammatory response’ as the pathway identified with the most 
significant DEGs (figure 4.15).  
 
When the two ‘naked’ IONPs samples were compared against each other, most genes 
relating to a pro-inflammatory reaction were significantly upregulated in the ‘naked’ 
IONPs in EGTA sample compared to ‘naked’ IONPs in DGVB++ buffer. Gene ontology 
analysis for this comparison also revealed ‘inflammatory response’ as the pathway 
with the most significant DEGs. This confirms our qPCR results, where ‘naked’ IONPs 
in EGTA buffer triggered a marginally higher cytokine profile. These results so far 
strongly suggest IONPs in the EGTA veronal buffer, in the absence of serum proteins, 
trigger a much higher pro-inflammatory response.  
 
To look at the effects of each of the different IONP samples on gene expression, the 
samples were individually compared to a control sample, where the cells were not 
exposed to any IONPs or either of the veronal buffers. The first comparison included 
mouse serum deposited IONPs in DGVB++ buffer against the control sample. The most 
upregulated gene relating to the immune system was CD2 which is involved in the 
activation of T cells in humans. Anti-inflammatory cytokine IL-10 was also upregulated, 
however not many genes relating to a pro-inflammatory reaction were upregulated. 
Furthermore, ‘inflammatory response’ was not a significant pathway identified 
following gene ontology analysis, indicating that serum-deposited IONPs in DGVB++ 
do not have a significant effect on an inflammation response. However, ‘positive 
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regulation of B cell apoptosis’ was the second pathway with most significant DEGs 
identified. Apoptosis is crucial in protecting the host against diseased or damaged 
cells, but aberrant apoptosis signalling can play a role in autoimmune diseases, 
neurodegenerative diseases and cancer (Opferman, 2008). 
 
When the serum deposited IONPs in EGTA buffer was compared to the control 
sample, IL-10 was again upregulated as well as TCIM (an immune response 
regulator). Gene ontology analysis again revealed ‘positive regulation of B cell 
apoptotic process’ as the second most common pathway amongst the significant 
DEGs. Inflammatory response was also another pathway identified but had less than 
half of the number of associated genes compared to the B cell apoptotic pathway.  
 
The next comparison included ‘naked’ IONPs in DGVB++ buffer against the control 
sample and the anti-inflammatory cytokine IL-10 was again upregulated, which also 
confirms the results seen with qPCR. Most genes associated with pro-inflammatory 
responses were downregulated and furthermore, gene ontology analysis identified 
‘positive regulation of B cell apoptotic process’ and ‘negative regulation of 
inflammatory response’ amongst the 10 most common pathways identified.  
 
The last comparison included ‘naked’ IONPs in EGTA buffer against the control 
sample and as expected, most genes contributing to a pro-inflammatory response 
were upregulated. Of 52 significant DEGs relating to the immune system, LIF, a 
member of the IL-6 family, was the most upregulated by almost 10-fold. As mentioned 
previously, upregulation of LIF can promote metastasis and hence promote the 
progression of solid tumours. Gene ontology analysis results revealed that ‘positive 
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regulation of apoptotic process’, ‘inflammatory response’ and ‘positive regulation of 
macrophage chemotaxis’ were amongst the top 5 pathways identified.  
Changes in gene expression levels is an important part of studying a cell’s functionality 
and fate. Any significant differentially expressed gene could cause changes within a 
cell, for example, by affecting genetic interactions or forming a different variant of a 
protein, which can lead to protein malfunction and cause unwanted phenotypic 
changes. A recent study carried out in a modified E.coli strain showed that a change 
in gene expression can not only influence the type of genetic interaction but also the 
strength of the genetic interaction (Li et al., 2019). Furthermore, it is also well 
documented that gene networks regulate immune cell development and their function, 
which are crucial in the modulation of immune responses (Díaz-Muñoz and Turner, 
2018). Thus, for our purpose of establishing the biosafety of IONPs as drug delivery 
vehicles, it was important to study and identify changes in gene expression that may 
occur following the exposure of IONPs.   
 
The results presented in this chapter have significantly contributed to our 
understanding of the immune responses triggered by IONPs at the base level. The 
most common gene ontology pathways seen across most comparisons were the 
apoptotic pathway and inflammatory response. The bioinformatics results presented 
showed IL-10 as the gene that is the most consistently affected, which is also visible 
from the qPCR data (especially with ‘naked’ IONP samples) produced in this chapter. 
The qPCR results are based on 2 experimental repeats and should be repeated to 
validate the results. However, our results seen with IL-10 align with other studied from 
published literature. For example, a study investigating the interactions of carbon 
nanotubes and the immune system identified IL-10 as an important player in the 
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interactions between NPs and immune cells (Pondman et al., 2016). Even though it is 
not as straightforward to pinpoint the ‘safest’ opsonised method for IONPs from the 
presented results, they are all factors identified that can be further studied and tackled 
to reduced unwanted inflammatory responses triggered by IONPs.  
 
The route of administration of NPs is crucial in determining their fate and toxicity 
effects (Elsabahy and Wooley, 2013). In this study, we have mimicked intravenous 
administration by opsonisation with serum proteins, which the NPs will naturally 
encounter in the blood plasma. Furthermore, studies have shown that complement 
deposition on carbon nanotubes leads to enhanced uptake in human macrophages 
(Kouser et al., 2018), thus the presence of serum proteins on NPs may also influence 
the inflammatory response. In our study, the effects of IONPs exposure was studied 
after a 2 hour exposure in RAW 264.7 cells, which gives a good indication of the initial 
immune response, however a longer IONPs exposure time could be studied to 
observed cytokine levels over a prolonged period of time. Some studies have shown 
that cytokine expression levels can increase or decrease over time (Denner et al., 
2013), hence it could be beneficial to study cytokine expression levels after 24 hours 
of IONPs exposure to see whether the inflammatory responses are further increased 
or suppressed over time. A recent study carried out in mice showed that gold NPs can 
increase the expression of IL-1β and IL-6 over the course of a few days in a size 
dependent manner; small-sized gold NPs increased cytokine expression much more 
than larger gold NPs (Khan et al., 2019). This supports the argument that 
immunotoxicity of IONPs seen in our findings can heavily depend on size and other 
smaller IONPs may elicit different immune responses, better or worse.  
 
 188 
This study identified a number of genetic changes relating to the immune response, 
some of which were not validated using qPCR. For further studies, it is recommended 
that the significant changes in the identified genes are confirmed using qPCR to 
validate the bioinformatics results. IL-10 results were particularly eye-catching and in 
future work, it can be exploited as an immunomodulatory molecule to manage 
interactions between NPs and immune cells, thus potentially avoiding unwanted 
clearance of NPs. It is also important to note that RNA-sequencing for this study was 
carried out only once due to budget restraints. The data presented in this chapter 
focused solely on the immunotoxicity of IONPs and identifying genes relating to 
cytokine expression and promoters of inflammation reactions, however the RNA-
sequencing results also showed significant differences in other pathways that were 
not discussed here, including significant upregulation of proto-oncogenes. To fully 
understand the changes in gene expression and other toxicity issues in response to 
IONPs exposure, these other pathways should be explored as they all contribute 









5. Zebrafish (Danio rerio) Embryos: A Model to 





Zebrafish, as an animal model in the adult stage as well as embryonic stage, is 
becoming increasingly popular in the field of biomedical research, especially for 
nanoparticle toxicology studies. For example, embryo and adult zebrafish have been 
used in recent years to study the pathology and treatment of tuberculosis by 
fluorescently labelling the mycobacterium, drug-loaded NPs and/or macrophages to 
visually observe the pathogenesis and treatment efficacy (Fenaroli et al., 2014;  van 
Leeuwen, van der Sar and Bitter, 2014; Torraca et al., 2014). The use of embryos in 
particular is grabbing the attention of scientists as they are considered a very good 
replacement for animal experiments (Strahle et al., 2012).  
Along with their low maintenance costs compared to mammals, zebrafish possess 
unique characteristics which make them favourable for biomedical research. These 
include their small size, quick development, very high reproducibility, transparency of 
the embryo and acquiescent to genetic and chemical screens (Chakraborty et al., 
2016). Another fundamental advantage of using zebrafish in research is the fact that 
they share a striking amount (approximately 70%) of genetic identity with humans 
(Howe et al., 2013), and several zebrafish organ systems are remarkably similar to 
those in humans (Seth et al., 2013), thus scientific discoveries in zebrafish can be 
theoretically applicable to humans.  
The transparency of the embryo is also a major advantage as it eases the non-
intrusive visualisation of organs and biological processes in vivo (Seth, Stemple and 
Barroso, 2013). Zebrafish eggs also develop outside the mother’s body and are 
therefore an ideal model to study non-invasive early development and developmental 
toxicity. The major organ systems of zebrafish are all developed and start to function 
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within the first 5 days after fertilisation (Howe et al., 2013). Figure 5.1 shows a 




Figure 5.1. Embryonic development of zebrafish. The above images show the embryonic development 
of zebrafish from fertilisation to 3 days post fertilisation (dpf). Hatching of zebrafish embryos usually occur 
at 2-4 dpf and the protruding mouth stage is generally considered as the end of the embryonic stage. 
Thereafter, they enter the larval stage and begin to actively feed at 5dpf. In this chapter, microinjections 
are described that were carried out at the 1-cell stage, 16-cell stage and at the long pec stage (48 hpf). 




The life cycle of a zebrafish is characterised by four main stages: embryo (from 
fertilisation to hatching stage, which can be any time from 2-4 dpf), larva (embryo is 
hatched but is not at the juvenile stage yet), juvenile (development of most  adult 
characteristics, but sexual maturity is not reached) and adult (sexual maturity reached 
and they can breed) (Parichy et al., 2009).  
Zebrafish embryos have an increasing popularity in nanoparticle research, one of the 
main reasons being its transparency which allows for clear visualisation of 
fluorescently labelled NPs, thus the biodistribution of administered NPs can be directly 
studied at a whole organism level. Zebrafish embryos used in the toxicity studies of 
Silicon dioxide (SiO2) NPs showed that the chorion of zebrafish acts as a protective 
barrier before hatching. Vranic et al. (2019) observed the morphological effects using 
fluorescently labelled NPs visualised through fluorescence microscopy following NP 
exposure (Vranic et al., 2019). A different study recently carried out by Kocere et al. 
(2020) demonstrated the therapeutic capability of NPs in cancer treatment by inducing 
tumour formation in the embryos first through injection of melanoma cells into the 
embryos. Tumour formation, macrophage recruitment and accumulation of injected 
NPs in the tumour area were visualised and quantified through fluorescence 
microscopy, thus proposing zebrafish embryos as efficient animal models to study NP 
toxicity and its therapeutic capability in cancer (Kocere et al., 2020). Furthermore, 
behavioural studies in zebrafish embryos investigating toxicity of copper NPs (CuNPs) 
showed that CuNPs exposure to the embryos resulted in several side effects, including 
abnormal cardiac function, inhibition of the hatching stage, developmental 
abnormalities and a higher mortality rate (Sun et al., 2016). 
Other than visualisation and behavioural studies, zebrafish embryos are great models 
to study toxicity at the gene expression level due to their acquiescence to genetic 
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screening. A gene expression study carried out in zebrafish embryos to study the 
toxicity of silver NPs (Ag NPs) showed that acute toxicity seen with AgNPs was due 
to the dispersion of Ag+ ions in the media surrounding the embryos and was also size-
dependent on the AgNPs (Olasagasti et al., 2014). A more recent study by Qiang et 
al. also confirmed the size-dependent toxicity of AgNPs using zebrafish embryos as 
models and using mRNA expression levels to assess toxicity. The study compared 
two difference sizes of AgNPs and showed that the smaller sized AgNPs (4nm) 
displayed slightly higher toxicity compared to the larger sized ones (10nm) (Qiang et 
al., 2020). 
In this chapter, IONPs biodistribution and toxicity of IONPs were studied in zebrafish 
up to 5 dpf. Microinjections of zebrafish were carried out at 0.2 hpf (hours post 
fertilisation) and 1.5 hpf (for dextran microinjections only) and at 48 hpf in the duct of 
Cuvier for IONPs microinjections (this is described in more detail in chapter 2.9). The 
duct of Cuvier is a wide blood circulation vessel on the yolk sac and connects the heart 
to the trunk vasculature (Saraceni et al., 2016). The duct of Cuvier is one of the 
preferred sites of microinjections at 2-3 dpf for immediate systemic delivery of the 
injected material (Benard et al., 2012). At 2 dpf, when IONPs microinjections were 
carried out, the embryo develops significant craniofacial features as well as major 
sensory organs (eyes and ears) (von Hellfeld et al., 2020), making it easier to locate 
the duct of Cuvier. Figure 5.2. shows an overview of the normal development of 
zebrafish from 1 dpf to 5 dpf. The duct of Cuvier has been highlighted in the embryo 





Following administration of NPs, they will be subject to excretion. The biodistribution 
of NPs and the amount of time they remain in the embryo  depends on the surface 
charge of the administered particle (Paatero et al., 2017). A study carried out in mice 
showed that differently charged NPs of the same size had different residence times in 
Duct%of%Cuvier
Figure 5.2. Embryonic-larval anatomy of zebrafish. The above images show an overview of all major 
structures and organs that are formed by 5dpf. From 2 dpf (48h) onwards, embryos start to develop 
pigment cells and hatching usually starts at this stage. Alternatively, the embryos can be safely 
dechorionated manually at 2dpf for microinjections of IONPs in the duct of Cuvier (orange arrow). 
Images acquired and adapted from von Hellfeld et al., 2020.  
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mouse models where positively charged NPs stay in the kidneys for up to 4 days 
before excretion whereas neutral and negatively charged NPs stayed in the spleen 
and liver (Balogh et al., 2007). Other than surface charge, different sized NPs can also 
have different resident times in the body. In zebrafish embryos, the clearance of 
different sized NPs was shown to be mostly dependent on the MPS (Mononuclear 
Phagocytic System), which resulted in the NPs being trafficked to the digestive organs 
before elimination, mainly the liver, pancreas and gallbladder (van Pomeren et al., 
2019). The study also showed that the different sized NPs accumulated in these 
organs in different ratios, with the nanosphere accumulating the most in the liver, 
which is the main organ involved in clearance (Truong et al., 2015). 
A fundamental advantage of zebrafish embryos, particularly relevant to our studies, is 
the development of their immune system, where the embryos initially lack an adaptive 
immune system. After 1 dpf, zebrafish embryos already develop phagocytic activity 
against pathogens (Herbomel, Thisse and Thisse, 1999) and they rely solely on their 
innate immune response until their adaptive immune system develops around 3 weeks 
post fertilisation (Lam et al., 2004). This characteristic makes zebrafish embryos and 
larvae an ideal way of studying the innate immune response, in the absence of B- and 
T-cell responses. The complement system is a crucial part of the innate immune 
response, as well as bridging the innate and adaptive immune responses. The 
zebrafish complement system bears functional and structural similarity to the 
mammalian complement system as per a recent study, which investigated all known 
homologs of the mammalian complement system in zebrafish, including C3, factor H 
and C1 components (Zhang and Cui, 2014). The liver is the main site of production of 
complement components in zebrafish, however they can also be produced in 
extrahepatic sites (Zhang and Cui, 2014). Macrophages in zebrafish can arise from 
 196 
three known origins: the rostral blood island (RBI) produces primitive haematopoietic 
macrophages, the poster blood island (PBI) produces erythromyeloid precursors 
(EMPs) which can give rise to macrophages lineages and finally, in adult zebrafish, 
the ventral wall of the dorsal aorta (VDA) which can produce haematopoietic lineages 





The aim of this study is to use zebrafish embryos to study IONPs toxicity within innate 
immunity by investigating developmental abnormalities, mortality rate and the 
biodistribution of IONPs following microinjections. A high molecular weight dextran 
was also injected with the aim of labelling macrophages in zebrafish embryos to study 
the distribution of IONPs in relation to macrophages.  
Figure 5.3. Illustration on the known origins of tissue resident 
macrophages (TRMs). The above image shows the three major origins of 
TRMs from the larvae to adult stage. In the embryonic stage, mostly microglia 
and peripheral macrophages are generated. These macrophages will eventually 
be replaced by macrophages produced from the ventral wall of the dorsal aorta 
(VDA) in adult zebrafish, which tend to accumulate in the brain, epidermis, heart, 
intestine and liver. Image obtained from Lin, Wen and Xu, 2019. 
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5.2 Results  
As part of the preliminary studies, zebrafish embryos were injected at 2 dpf with 
different ‘naked’ IONPs concentrations (5 µg/ml, 50 µg/ml, 100 µg/ml, 500 µg/ml and 
1000 µg/ml) to test for lethal toxicity concentrations of injected IONPs. The IONPs 
were injected in the duct of Cuvier and the mortality rate and developmental defects 
were monitored until 5dpf. The graph below shows the survival rate of the embryos at 




Overall, the IONPs injected embryos showed a low mortality rate, at least 90.9% 
survived, however, 14.3% and 5% of zebrafish larvae injected with 500 µg/ml and 
1000 µg/ml of IONPs, respectively, showed signs of cardiotoxicity through severe 















































'naked' IONPs in PBS
Healthy Embryos
Pericardial Oedema
Figure 5.4. Bar chart showing survival rates of zebrafish larvae at 5dpf. The graph 
shows the survival rates of injected zebrafish embryos using different concentrations of 5 
µg/ml, 50 µg/ml, 100 µg/ml, 500 µg/ml and 1000 µg/ml IONPs, with the survival percentages 
of 100%, 95.2%, 95%, 100% and 90.9%, respectively. The control larvae were injected with 
PBS only at 2dpf. 14.3% of larvae at 500 µg/ml and 5% at 1000 µg/ml displayed 
characteristics of pericardial oedema. Number of injected embryos were 20-22 per 
concentration. The image on the right shows a larvae with severe pericardial oedema. 
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slower heartbeat than normal and were unresponsive to any external stimulus. 
Pericardial oedema in zebrafish embryos is a marker of toxicity and a defective 
cardiovascular system can lead to an overall defective growth and severe 
malformations of the larvae (Chahardehi, Arsad and Lim, 2020).  
‘naked’ IONPs microinjections were repeated, with slightly different concentrations 
with the aim of investigating the ideal concentrations for the visualisation of IONPs. 
The graph below shows the survival rates of injected embryos using 100 µg/ml, 300 





The above graph shows a survival rate of 100% in all concentrations injected, with 











































'naked' IONPs in PBS
Healthy Embryos
Pericardial Oedema
Figure 5.5. Bar chart showing survival rates of zebrafish larvae at 5dpf. The graph 
shows the survival rates of injected zebrafish embryos using different concentrations of 100 
µg/ml, 300 µg/ml, 500 µg/ml and 1000 µg/ml IONPs, with the survival percentages of 100% 
in all conditions. The control larvae were injected with PBS only at 2dpf. 3.33% of larvae at 
300 µg/ml displayed characteristics of pericardial oedema. Number of injected embryos were 
25-30 per concentration.  
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concentrations, conversely to what was seen previously (figure 5.5). This could be due 
to human error during microinjections, some embryos being slightly more developed 
than others or this batch of egg lay could have been healthier in general. These larvae 
were then imaged to determine the concentrations at which IONPs can be visualised 







500 µg/ml 300 µg/ml 1000 µg/ml Control
100µm
500 µg/ml 300 µg/ml 1000 µg/ml Control
100µm
Figure 5.6. Injected zebrafish larvae at 5dpf. The images above show zebrafish larvae imaged at 5 
dpf using a Leica DMi8 microscope (10X objective) with brightfield and fluorescence (568nm excitation 
and 603nm emission). At 300 µg/ml, only a few IONPs were seen, whereas at 500 µg/ml and 1000 
µg/ml a higher amount of IONPs were clearly visible in the pericardial area as well as the tail. The 
control larvae were injected with PBS only at 2dpf, along with the different IONPs concentrations. An 
arrow in the top left picture points to pericardial oedema in the larvae and yellow arrows show IONPs. 
Brightfield images are in the first and third row showing embryo morphology and the second and fourth 
row showing fluorescent images in black and white. Representative image of 2 imaged embryos, 22-
25 per group. 
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From the above images (figure 5.6), IONPs could hardly be seen at concentration 300 
µg/ml, whereas at higher concentrations of 500 µg/ml and 1000 µg/ml, IONPs were 
clearly visible under the microscope. Thus, IONP concentrations of 500 µg/ml and 
1000 µg/ml were deemed as the ideal dosage to be further studied. Since IONPs were 
incubated at 37C for 1 hour in serum, washed and sonicated on the day of 
microinjections, the time available to carry out the microinjections was limited, hence 
also limiting the number of embryos injected per experiment. To maximise the time 
available and to increase the amount of embryos injected, overnight incubation of 
IONPs instead was investigated and through western blotting, the level of C3 protein 





Since the levels of C3 protein adsorption were similar in IONPs incubated overnight 






















































Figure 5.7. Western blot 
showing levels of C3 
protein. The results show 
that incubating the IONPs in 
human serum overnight and 
for 1 hour results similar 
levels of C3 protein 
adsorption.  
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incubated at 37C overnight, followed by the washes and sonication on the day of 
injections. This allowed for greater time efficiency and more injected per condition. 
The next microinjections were carried out to investigate the effects of the deposition 
of human serum proteins on the surface of the IONPs. The graphs below show the 
mortality rate for serum-deposited IONPs and ‘naked’ IONPs (figure 5.8). Experiments 





Injection of embryos with serum-deposited IONPs resulted in a low mortality rate, 
however some larvae developed pericardial oedema and spinal curvature as shown 
in the above graph (figure 5.8). Spinal curvature in zebrafish larvae can be an 
indication of idiopathic scoliosis, which has been linked to severe defects in 
cerebrospinal fluid flow (Grimes et al., 2016). However, this was the only case of spinal 
curvature seen in all experiments carried out in this study. 
The larvae were also imaged under the microscope at 4 dpf and 5 dpf to study the  









































































Figure 5.8. Bar chart showing survival rates of zebrafish larvae at 5dpf. The graph shows the survival 
rates of injected zebrafish embryos using different concentrations of 500 µg/ml and 1000 µg/ml, comparing 
serum deposited IONPs and ‘naked’ IONPs. The control larvae were injected with PBS only at 2dpf. 28.3% 
of larvae injected with serum-deposited IONPs at 1000 µg/ml displayed characteristics of pericardial 
oedema. However, all 28.3% of these larvae with pericardial oedema were observed during one of the 
experimental repeats. In the same experimental repeat, 4.8% of larvae developed a spinal curvature. 
Number of injected embryos were 20-35 per concentration. The image on the right shows spinal curvature 
in an embryo. Image of embryo obtained from Buchan et al., 2014. A one-way ANOVA test was carried out 
in GraphPad prism to determine statistical significance. No statistical significance was found between the 





The above images (figure 5.9) show the localisation of serum deposited IONPs at 4 
dpf (2 days post microinjections, 500 µg/ml IONPs per injection). The IONPs are 
distributed around the bottom of the yolk sac, leading into the yolk sac extension, 
intestine and cloaca, where they may be excreted. The next images below show larvae 
injected with 1000 µg/ml of serum deposited IONPs (figure 5.10). 
4 dpf - 500 µg/ml 
4 dpf - 500 µg/ml 
Figure 5.9. Injected zebrafish larvae at 4dpf. The images above show zebrafish larvae imaged at 
4 dpf using the Leica DMi8 microscope (20X objective). Serum deposited IONPs injected at a 
concentration of 500 µg/ml were found to be distributed along the yolk sac (A) and around the 
intestine leading to the cloaca (B) (figure 5.2). Overlays of bright field and fluorescent images (right 
hand panels) show larvae morphology and IONP distribution. Fluorescence only images are on the 
left. Arrows indicate IONP accumulation. Diffuse red staining around the yolk sac close to the injection 
















4 dpf - 1000 µg/ml 
4 dpf - 1000 µg/ml 
4 dpf - control
Figure 5.10. Injected zebrafish larvae at 4dpf. The images above show zebrafish larvae imaged at 
4 dpf using the Leica DMi8 microscope (20X objective). Serum deposited IONPs injected at a 
concentration of 1000 µg/ml were found to be distributed along the yolk sac, heart, liver (A) and 
around the intestine leading to the cloaca (B) (figure 5.2). Control larvae was injected with PBS only 
(C). Overlays of bright field and fluorescent images (right hand panels) show larvae morphology and 
IONP distribution. Fluorescence only images are on the left. Arrows indicate IONP accumulation. 
Diffuse red staining around the yolk sac close to the injection site is seen also in the control animals 
indicating autofluorescence from the yolk sac proteins. Representative image of 2 imaged embryos, 














These images (figure 5.10) show that serum deposited IONPs at a higher 
concentration accumulate around the heart and the liver, where they may remain until 
excreted. IONPs were also noticed around the intestine and cloaca suggesting that 
they would be excreted shortly afterwards. The next images below (figure 5.11) show 





The above images (figure 5.11) show that serum-deposited IONPs accumulate in the 
pericardium and liver, likely stored until they are excreted. IONPs were also seen in 
Figure 5.11. Injected zebrafish larvae at 5dpf. The images above show zebrafish larvae imaged at 
5 dpf using the Leica DMi8 microscope (20X objective). Serum deposited IONPs injected at a 
concentration of 500 µg/ml were found to be distributed along the yolk sac, heart, liver (A) and in the 
caudal vein in the tail (B) (figure 5.2). Overlays of bright field and fluorescent images (right hand panels) 
show larvae morphology and IONP distribution. Fluorescence only images are on the left. Arrows 
indicate IONP accumulation. Diffuse red staining around the yolk sac close to the injection site is seen. 











the caudal vein in the tail, whose function is to return blood from the trunk and tail to 





5 dpf - 1000 µg/ml 
5 dpf - 1000 µg/ml 
Control
Figure 5.12. Injected zebrafish larvae at 5dpf. The images above show zebrafish larvae imaged at 
5 dpf using the Leica DMi8 microscope (20X objective). Serum deposited IONPs injected at a 
concentration of 1000 µg/ml were found to be distributed along the heart, liver, some seen in the 
ceratohyal (below eye) (A) and in the intestine as well as the pronephric duct (B) (figure 5.2). Control 
larvae were injected with PBS only (C). Overlays of bright field and fluorescent images (right hand 
panels) show larvae morphology and IONP distribution. Fluorescence only images are on the left. 
Arrows indicate IONP accumulation. Diffuse red staining around the yolk sac close to the injection site 
is seen also in the control animals indicating autofluorescence from the yolk sac proteins. 













Other than the same pattern seen in the heart and liver, some IONPs were also seen 
in the ceratohyal, which is a cartilage important in the support and structure of the 
lower jaw (figure 5.12) (Wu, Su and Shu, 2018). If the ceratohyal cartilage develops 
abnormally, it leads to the development of smaller heads in the larvae which can 
impact their feeding behaviour (Wu, Su and Shu, 2018).  Some IONPs were also seen 
at the pronephric duct, which is a duct of the embryonic kidney called the pronephrons 
(figure 5.12) (Kimmel et al., 1995). This provides strong evidence of IONPs excretion 
at 5 dpf. 
Zebrafish larvae injected with the same concentrations of ‘naked’ IONPs were also 
imaged to study the biodistribution of ‘naked’ IONPs at 4 dpf and 5 dpf. The images 
below (figure 5.13) show 4 dpf larvae injected with ‘naked’ IONPs at concentration 500 
µg/ml. 
 
4 dpf - 500 µg/ml 
4 dpf - 500 µg/ml 
Figure 5.13. Injected zebrafish larvae at 4dpf. The images above show zebrafish larvae imaged 
at 4 dpf using the Leica DMi8 microscope (20X objective). ‘Naked’ IONPs injected at a 
concentration of 500 µg/ml were found to be distributed around the yolk sac and very few in the 
ceratohyal (below eye) (A) and near the caudal vein in the tail (B) (figure 5.2). Overlays of bright 
field and fluorescent images (right hand panels) show larvae morphology and IONP distribution. 
Fluorescence only images are on the left. Arrows indicate IONP accumulation. Diffuse red staining 












The above images (figure 5.13) show a small amount of IONPs around the yolk sac 
and in the caudal vein in the tail. The images below (figure 5.14) show ‘naked’ IONPs 





4 dpf - control
Figure 5.14. Injected zebrafish larvae at 4dpf. The images above show zebrafish larvae imaged at 
4 dpf using the Leica DMi8 microscope (20X objective). ‘Naked’ IONPs injected at a concentration of 
1000 µg/ml were found to be distributed in the pericardium and liver (A) and near the caudal vein in 
the tail and the pronephric duct (B) (figure 5.2). Control larvae was injected with PBS only (C). Overlays 
of bright field and fluorescent images (right hand panels) show larvae morphology and IONP 
distribution. Fluorescence only images are on the left. Arrows indicate IONP accumulation. Diffuse red 
staining around the yolk sac close to the injection site is seen also in the control animals indicating 















The above images (figure 5.14) show that the ‘naked’ IONPs injected at a 
concentration of 1000 µg/ml accumulate in the heart and liver, similar to what was 
seen with the serum-deposited IONPs. IONPs were also seen in the caudal vein of 
the tail as well as the pronephric duct, once again demonstrating strong evidence of 
IONP excretion. Of note, ‘naked’ IONPs are visible in the pronephric duct at 4 dpf 
(figure 5.14) whereas serum-deposited IONPs were first visible in the pronephric duct 
at 5 dpf (figure 5.12 B). This could suggest that serum-deposited IONPs have a slightly 
higher residence time in the larvae before being excreted. The images below show 
‘naked’ IONPs localisation at 5dpf. 
 
 
5 dpf - 500 µg/ml 
5 dpf - 500 µg/ml 
Figure 5.15. Injected zebrafish larvae at 5dpf. The images above show zebrafish larvae imaged at 
5 dpf using the Leica DMi8 microscope (20X objective). ‘Naked’ IONPs injected at a concentration of 
500 µg/ml were found to be in the liver and pericardium (A) and near the causal vein in the tail and the 
pronephric duct (B) (figure 5.2). Overlays of bright field and fluorescent images (right hand panels) 
show larvae morphology and IONP distribution. Fluorescence only images are on the left. Arrows 
indicate IONP accumulation. Diffuse red staining around the yolk sac close to the injection site is also 











The images above (figure 5.15) show a few IONPs localised in the liver and heart, 
following the same pattern seen in other conditions. A few IONPs were also seen along 
the tail artery, however it is not clear whether these IONPs (figure 5.15 B) are in the 
tail artery or embedded in the muscle of that area.The images below (figure 5.16) show 




5 dpf - 1000 µg/ml 













Figure 5.15. Injected zebrafish larvae at 5dpf. The images above show zebrafish larvae 
imaged at 5 dpf using the Leica DMi8 microscope (20X objective). ‘Naked’ IONPs injected at 
a concentration of 1000 µg/ml were found to be accumulated in the heart (A) and a few in the 
intestine (B) (figure 5.2). Control larvae was injected with PBS only (C). Overlays of bright field 
and fluorescent images (right hand panels) show larvae morphology and IONP distribution. 
Fluorescence only images are on the left. Arrows indicate IONP accumulation. Diffuse red 
staining around the yolk sac close to the injection site is seen also in the control animals 
indicating autofluorescence from the yolk sac proteins. Representative image of 2 imaged 




The above images (figure 5.15) once again confirm the patterns previously seen where 
IONPs accumulate in the heart and along the excretory routes. The next question to 
be investigated was if macrophages are present or recruited at the sites where IONPs 
were seen to accumulate. With the aim of macrophage labelling, a high molecular 
weight dextran (MW = 2,000,000) fluorescently labelled with FITC was injected into 
the embryos at an early developmental stage. An earlier study showed that primitive 
macrophages from the ventral mesoderm can migrate to the yolk sac and to 
differentiate between ventral and dorsal macrophages, injection of a high molecular 
weight dextran into one of the blastomeres at the 16-cell stage (Herbomel, Thisse and 
Thisse, 1999) is a useful tool. Another study also successfully labelled macrophages 
using dextran in mouse models (Wang et al., 2002).  
In this study, to label macrophages in zebrafish embryos, two dextran injection 
methods were investigated; microinjection of dextran in the yolk sac at the 1-cell stage 
and microinjection of dextran in a blastomere at the 16-cell stage. The two injections 
methods were separately carried out and are discussed further below. Each 





































































Serum deposited IONPs + Dextran
Healthy Embryos
Pericardial Oedema
Figure 5.16. Dextran injected in yolk sac. The above graphs show the survival rates of zebrafish 
larvae at 5 dpf, following dextran microinjections at 0.2 hpf and IONPs microinjections at 2 dpf. 
Embryos injected with serum-deposited IONPs showed a better survival rate than those injected with 
‘naked’ IONPs. The control larvae were injected with dextran in the yolk sac at 0.2 hpf, followed by 
PBS microinjections at 2 dpf. Resultsof two independent experiments are shown. Error bars show 
standard deviation. A one-way ANOVA test was carried out in GraphPad prism to determine statistical 





The above graphs (figure 5.16) demonstrate a high survival rate in the larvae injected 
with dextran in the yolk sac and serum-deposited IONPs, with a low percentage of 
pericardial oedema seen. However, a lower survival rate was seen in the 
corresponding ‘naked’ IONPs injected larvae. This could suggest that the dextran 
microinjections into the yolk sac already exhibit a toxic effect on the embryos since a 
small percentage of control larvae, injected with only the dextran, also displayed 
characteristics of pericardial oedema, which was not seen in any control larvae 
(injected with PBS) prior to these experiments. One explanation for this could be the 
fact that up to 5 dpf, the embryos/larvae feed from the yolk sac, thereafter they 
independently feed. Thus, absorbing the dextran molecules along with their nutrients 
from the yolk sac could pose a certain level of toxicity, which is not translated to visible 
deformities, but when challenged with ‘naked’ IONPs (without deposition of serum 
proteins), may trigger a toxic effect in a dose-dependent manner. This effect is reduced 








































































































Serum deposited IONPs + Dextran
Healthy Embryos
Pericardial Oedema
Figure 5.17. Dextran injected in blastomeres. The above graphs show the survival rates of zebrafish 
larvae at 5 dpf, following dextran microinjections at 1.5 hpf and IONPs microinjections at 2 dpf. The 
serum-deposited IONPs showed a similar survival rate to the ‘naked’ IONPs. The control larvae were 
injected with dextran into a blastomere at 1.5 hpf, followed by PBS microinjections at 2 dpf. 
Representative image of 2 imaged embryos. A one-way ANOVA test was carried out in GraphPad 
prism to determine statistical significance. No statistical significance was found between the different 
concentrations for survival rate or embryos with pericardial oedema. 
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The results (figure 5.17) show the survival rate of zebrafish larvae at 5 dpf following 
dextran microinjections in one of the blastomeres at 1.5 hpf (16-cell stage) and IONPs 
microinjections at 2 dpf. The serum-deposited IONPs larvae showed a similar survival 
rate observed in the previous results with dextran injections into the yolk sac, but a 
noticeable difference is observed with the ‘naked’ IONPs injected larvae, which 
showed a better survival rate than of those that had received dextran microinjections 
into the yolk sac. This indicates that dextran microinjections into the blastomeres are 
less harmful to the embryos than those into the yolk sac allowing for a better survival 
rate following subsequent injections at 2 dpf. 
Confocal microscopy was used to obtain detailed information on IONP distribution in  
larvae injected with dextran and IONPs. The results (figures 5.18 - 5.25) show the 
same pattern of biodistribution of the IONPs as established previously, where they 
mostly accumulate in the pericardium, liver and excretory routes. In particular, the 






The above images (figure 5.18) show IONP localisation in 2 day old zebrafish 
embryos, on the same day of the IONPs microinjections (embryos were fixed 4 hours 
post injection, stained and imaged). The dextran 2,000,000 was injected at 1-cell stage 
(0.2 hpf) into the yolk sac. Dextran can be seen in the yolk sac and remained mostly 
contained within the yolk sac. Compared to 3 dpf (see images below figure 5.19), 
clusters of IONPs accumulation were not seen most likely because they had just been 
injected on the day through systemic delivery and IONPs being so small can only be 















Figure 5.18. Dextran injected in yolk sac. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 was injected into the yolk sac at the 1-cell stage followed by 
IONP injections (500ug/ml) (red) at 2dpf. Zebrafish embryos at 2 dpf, on the same day that IONPs 
microinjections were carried out, were fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) 
before imaging with a Nikon Eclipse TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows 
point to IONPs and the red arrow shows likely colocalisation of dextran and IONPs. Images were taken 
at the positions indicated in the grey insets and single sections of a z-stack where IONPs were visible 







The above images (figure 5.19) show accumulation of IONPs at 3 dpf mostly near the 
heart and liver. IONPs accumulate in clusters with no sign of successfully labelled 












Figure 5.19. Dextran injected in yolk sac. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 (green) was injected into the yolk sac at the 1-cell stage 
followed by IONPs (500ug/ml, red) injections at 2dpf. Zebrafish embryos at 3 dpf, one day after IONP 
microinjections were carried out, were fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) 
before imaging with a Nikon Eclipse TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows 
point to IONP accumulations. Images were taken at the positions indicated in the grey insets and single 
sections of a z-stack where IONPs were visible are displayed. Scale bar 10um. Representative image 






At 4 dpf, similar IONP localisation patterns were observed in the pericardium area, for 
both concentrations of IONPs used independent of serum deposition. The next images 












Figure 5.20. Dextran injected in yolk sac. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 (green) was injected into the yolk sac at the 1-cell stage 
followed by IONPs injections (500ug/ml and 100ug/ml (red)) at 2dpf. Zebrafish embryos at 4 dpf were 
fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) before imaging with a Nikon Eclipse 
TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows point to IONP clusters. Images were 
taken at the positions indicated in the grey insets and single sections of a z-stack where IONPs were 






IONP accumulation was again seen in the same area, with a small cluster seen near 
the cloaca (figure 5.21, bottom left), which indicates that these IONPs were very likely 
to be excreted shortly after. Injecting Dextran 2,000,000 into the yolk sac labelled 
some  macrophages in and around the yolk sac, as expected as this shows that some 
primitive macrophages might have migrated to the yolk sac to differentiate, as stated 
by Herbomel, Thisse and Thisse (1999). Very little (figure 5.18) to almost no 
colocalisation was seen between IONPs and dextran, suggesting that the yolk sac 
macrophages are not recruited to sites of IONPs accumulation and remain in the yolk 
Figure 5.21. Dextran injected in yolk sac. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 (green) was injected into the yolk sac at the 1-cell stage 
followed by IONPs injections (500ug/ml and 100ug/ml (red)) at 2dpf. Zebrafish embryos at 5 dpf were 
fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) before imaging with a Nikon Eclipse 
TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows point to IONP clusters. Images were 
taken at the positions indicated in the grey insets and single sections of a z-stack where IONPs were 
visible are displayed. Scale bar 10um. Representative image of 2 imaged embryos, 30 per group. 
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sac. Instead, the IONPs remain in the heart or liver until they are excreted at a later 
stage. The images below show zebrafish larvae with Dextran 2,000,000 injected into 





The images above (figure 5.22) show IONPs localisation following IONPs 
microinjections on the same day. A few clusters can be seen accumulating in the 
pericardium and excretory routes in the tail. 
Figure 5.22. Dextran injected in blastomere. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 (green) was injected into the blastomere at the 16-cell stage 
followed by IONPs injections (500ug/ml and 100ug/ml (red)) at 2dpf. Zebrafish embryos at 2 dpf, on the 
day of the IONP injections, were fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) before 
imaging with a Nikon Eclipse TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows point 
to IONP clusters. Images were taken at the positions indicated in the grey insets and single sections of 
a z-stack where IONPs were visible are displayed. Scale bar 10um. Representative image of 2 imaged 








From 3 dpf, more IONPs start to be visible in the tail showing that the embryo is likely 
processing the IONPs to be excreted. IONPs were still seen in the pericardium and 
liver at this stage, where they may remain for longer before excretion. Some 
colocalisation between IONPs and dextran was also seen, suggesting successful 













Figure 5.23. Dextran injected in blastomere. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 (green) was injected into the blastomere at the 16-cell stage 
followed by IONPs injections (500ug/ml and 100ug/ml (red)) at 2dpf. Zebrafish embryos at 3 dpf were 
fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) before imaging with a Nikon Eclipse 
TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows point to IONP clusters and red arrows 
indicated colocalization of IONPs with dextran 2,000,000. Images were taken at the positions indicated 
in the grey insets and single sections of a z-stack where IONPs were visible are displayed. The top left 
image does not show colocalisation however, shows the recruitment of macrophages around the 
IONPs. The top right image shows significant accumulation of IONPs in the caudal vein in the tail IONPs 
were still seen accumulated near the heart and liver. Scale bar 10um. Representative image of 2 







The above images (figure 5.24) show 4 day old zebrafish larvae imaged following 
IONPs microinjections at day 2 dpf. Colocalisation between IONPs and dextran can 
be seen in the pericardium in figure 5.24 (bottom left). Less IONP accumulation is 
seen here compared to the 3 dpf zebrafish larvae (figure 5.23). 
Figure 5.24. Dextran injected in blastomere. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 (green) was injected into the blastomere at the 16-cell stage 
followed by IONPs injections (500ug/ml and 100ug/ml (red)) at 2dpf. Zebrafish embryos at 4 dpf were 
fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) before imaging with a Nikon Eclipse 
TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows point to IONP clusters and red arrows 
indicated colocalization of IONPs with dextran 70,000. Images were taken at the positions indicated in 
the grey insets and single sections of a z-stack where IONPs were visible are displayed. Scale bar 








The above images (figure 5.25) show strong colocalisation between IONPs and 
dextran, suggesting that macrophages may have been recruited to the sites of IONP 
accumulation in the pericardium. The results overall show that macrophage labelling 
was much more successful by injecting dextran into the blastomere compared to the 
yolk sac. Although colocalisation between dextran and IONPs was seen in some 
cases, overall no significant colocalisation between macrophages and IONPs could 
be observed, suggesting phagocytosis by macrophages was not a major route of 
clearance for IONPs.  
Figure 5.25. Dextran injected in blastomere. The above images show the localisation of IONPs using 
confocal microscopy. Dextran 2,000,000 (green) was injected into the blastomere at the 16-cell stage 
followed by IONPs injections (500ug/ml and 100ug/ml (red)) at 2dpf. Zebrafish embryos at 5 dpf were 
fixed and stained with Hoechst 33342 to reveal cell nuclei (blue) before imaging with a Nikon Eclipse 
TE2000-S Confocal Microscope with a x60 oil lens. Yellow arrows point to IONP clusters and red arrows 
indicated colocalization of IONPs with dextran 70,000. Images were taken at the positions indicated in 
the grey insets and single sections of a z-stack where IONPs were visible are displayed. Scale bar 




The aim of this study was to investigate the biosafety and biodistribution of IONPs 
using zebrafish embryos as an animal model of innate immunity. The data obtained 
suggests that although the survival rates are relatively high, there are some toxicity 
issues to look out for such as pericardial oedema, which was seen at least once in 
most experiments conducted. Pericardial oedema is a typical manifestation of 
defective cardiac function in zebrafish embryos (Miura and Yelon, 2011). Hence it is 
important to highlight the developmental defects relating to cardiac function in 
response to IONPs, even if the overall risk of developing pericardial oedema was 
relatively low.  
To investigate the effect of serum proteins on the biodistribution of IONPs, serum-
deposited and ‘naked’ IONPs were studied. Even though the sites of IONP 
accumulation were very similar for both, there were some signs of different residence 
times in the zebrafish embryos. In some cases, ‘naked’ IONPs were seen near the 
cloaca and other excretory routes a day earlier (at 4 dpf) than serum-deposited IONPs 
(at 5dpf). This suggests that serum deposition on IONPs may play a role in their uptake 
and distribution. Despite the slightly different clearance times, both types of IONPs 
accumulate in the pericardium and the liver where they may remain before being 
excreted. Additionally, it is important to note that the resolution of the microscopy 
would not allow for individual IONPs to be visualised and hence IONPs would only be 
seen if they are in small or large clusters. Different microscopy techniques such as 
TEM or SEM can be used to image samples at a much higher magnification where 
NPs can be seen. The residence time of IONPs in zebrafish larvae could be further 
studied by taking samples of the surrounding medium of the embryos/larvae at regular 
time points to measure the presence of IONPs in the medium either through 
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microscopy or by isolating the IONPs in a magnetic field before quantification. The 
accumulation of IONPs in the pericardium as seen in our results is quite new and at 
the time of writing, there were no published literature that reported similar observations 
with IONPs in zebrafish embryos. The mortality rate seen in our studies may not 
represent a true assessment of cardiotoxicity as zebrafish embryos do not need a 
functioning cardiovascular system to survive (Miura and Yelon, 2011). Exposure to 
certain chemicals including NPs can cause cardiotoxicity in zebrafish. The heart rate 
may be affected, thus inadequately pumping blood around the body and if severe, it 
can lead to cardiac muscle dysfunction in zebrafish (Zakaria et al., 2018). Furthermore, 
gold and silver NPs were shown to change the heart morphology in zebrafish at high 
concentrations (Zakaria et al., 2018). Thus, it is important to study any effects of 
cardiotoxicity following exposure to IONPs beyond 5dpf. However studies carried out 
in different animal models have shown that the accumulation of NPs in the pericardial 
space did not pose a safety concern and did not affect heart rate or cardiac function 
in mice (Kermorgant et al., 2019).  
Functional innate immunity, consisting of immune cells, chemokines and cytokines 
similar to those present in humans, is established in zebrafish embryos at 2 dpf (Cha 
et al., 2018). Thus, inflammation in response to IONPs in zebrafish embryos/larvae 
can be studied by generating cytokine profiles using qPCR. For example, in different 
fish, gilthead sea bream (S. aurata), gold NP exposure after 4 days resulted in 
upregulation of pro-inflammatory cytokines such as TNF- and IL-1 (Teles et al., 
2017). Another study showed that palmitate (a fatty acid) triggers an inflammatory 
response in zebrafish embryos which was characterised by the upregulation of NF-
B, IL-1, TNF- and COX-2 (Cha et al., 2018). Taken together, these results 
demonstrate that exposure to NP can generate an inflammatory response in fish, 
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which can be measured using cytokines as biomarkers. To further study the effects of 
serum proteins adsorbed on IONPs, cytokine expression levels could be studied at 4 
dpf and 5 dpf to identify any inflammatory responses triggered.  
As mentioned in section 5.1, zebrafish and humans have a lot in common, including 
metabolism of drugs by the liver, hence zebrafish are promising models in the study 
of drug toxicity (Vliegenthart et al., 2014). When designing nanotherapeutics, 
circulation time is an important factor to be considered. For instance, if 
nanotherapeutics designed for the treatment of cancer have a low circulation time, it 
is deemed undesirable as there is a decreased chance of nanotherapeutic 
accumulation at the target tumour sites (Dal et al., 2020). Reduced nanoparticle 
circulation times in zebrafish embryos can be a direct consequence of uptake of NPs 
by macrophages (Dal et al., 2020). Hence the next subject of investigation was to label 
macrophages in zebrafish embryos using a high molecular weight dextran and 
investigating colocalisation between dextran and IONPs, which would give a good 
indication of IONP uptake by macrophages. One study demonstrated the successful 
labelling of dextran coated NPs (13nm) in mouse models to study tumour associated 
macrophages and the same group also showed that dextran coated IONPs have 
higher macrophage avidity in vitro (Keliher et al., 2011). Our study does not employ 
the use of dextran coated IONPs, however due to the fact that macrophages readily 
internalise dextran molecules, we aimed to use dextran as a fluorescent imaging probe 
in vivo. Another study successfully labelled tumour-associated macrophages in mice 
by injecting Texas red-dextran and macrophages were successfully visualised through 
microscopy due to their ability to phagocytose the injected dextran (Wyckoff et al., 
2007). Although only a handful of published literature have employed this method of 
macrophage labelling, other researchers have used other fluorescent imaging probes 
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for macrophage labelling such as GFP (green fluorescent protein), mCherry and 
EGFP, amongst others, where GFP seems to be the most commonly used (Li and Liu, 
2018). 
Our results demonstrate some successful labelling of macrophages with dextran when 
it was injected into one of the blastomeres at the 16-cell stage (1.5 hpf). However, the 
majority of IONPs did not colocalise with dextran indicating absence of phagocytosis 
of IONPs at the time points investigated. However, we cannot rule out that the IONP 
concentration in tissue macrophages was too low for detection. Although it is not clear 
if Kupffer cells (liver macrophages) of the embryos were also successfully labelled by 
dextran, different methods of macrophage labelling can be carried out to confirm our 
results. A study has shown that murine Kupffer cells have high dextran-endocytic 
activity using a dextran of molecular weight 40,000 (Movita et al., 2012). Furthermore, 
to reinforce our results, the experiment can be repeated using other methods of 
macrophage tracking to rule out the possibility of dextran uptake by other innate 
immune cells and investigate whether Kupffer cells are labelled by those methods. For 
example, large doses of live fluorescent bacteria can be injected into the embryos and 
imaged to visualise phagocytosis by macrophages (Herbomel, Thisse and Thisse, 
1999). Alternatively, a transgenic zebrafish strain, such as MPEG1.4:mCherry 
zebrafish, which expresses the macrophage-expressed gene 1 (MPEG1) labelled with 
mCherry can be used and macrophages can be visualised using fluorescence 
microscopy (van Pomeren et al., 2019). Taking our study forward, the IONPs used in 
could be pre-coated with the dextran prior to injecting into embryos to observe 
differences in biodistribution and macrophage labelling. To further study whether IONP 
uptake occurs at different time points to those studied here, the embryos/larvae can 
be imaged at more regular time points. In our study, confocal microscopy was mainly 
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used to obtain images of the cross-section (by taking a z-stack) that were analysed to 
establish where IONPs accumulated in the embryos. However, one disadvantage of 
this technique was that it is time consuming and therefore allows fewer embryos/larvae 
to be analysed.  
As mentioned previously, nanoparticle size and shape can greatly influence the 
bioavailability and toxic effects induced by IONPs. For example, gold NPs of size 60nm 
were found to be phagocytosed and efficiently cleared from the body by macrophages 
in zebrafish embryos (van Pomeren et al., 2019). This is different to what our results 
suggest and one of the main reasons for this difference could be the size of IONPs 
used (100 nm). Another study also showed faster clearance of nanospheres compared 
to rod-shaped NPs, the nanospheres were found to accumulate mostly in the liver 
compared to NPs of different shapes (Truong et al., 2015). 
In this study, we have successfully shown the biodistribution of IONPs in zebrafish 
embryos and larvae up to 5 dpf, as well as any developmental defects induced by 
IONPs toxicity. Due to a limited amount of IONPs available, only a few concentrations, 
up to 1000 µg/ml, were studied. Higher IONPs doses to further study dose-dependent 
toxicity of IONPs can add to our current findings. Furthermore, some initial 
experiments consisted of 1hour incubation time of IONPs with serum compared to 
other experiments where IONPs were incubated with serum overnight. Although, 
experiments were carried out to ensure that the protein amount remains unaffected 
on the surface of the IONPs, protein corona is a dynamic structure that is subject to 
change over time, which may influence their biodistribution in vivo. Another limitation 
to this study was that the zebrafish larvae were only monitored and imaged up to 5 dpf 
due to the lack of a project license. However, this study has a promising scope for 
further studies of IONP related toxicity and developmental defects. Coupled with 
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behavioural studies (swimming, feeding, response to stimuli) beyond 5 dpf into the 









6. General Discussion 
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Recent decades have seen a sharp increase in NP research especially for therapeutic 
and diagnostic purposes with growing optimism of breakthrough discoveries in the 
field of targeted therapy. NPs, in conjunction with therapeutic drugs, can change 
pharmacokinetic properties resulting in a greater therapeutic efficiency, controlled 
drug release and reduced side effects (Abdifetah and Na-Bangchang, 2019). NPs as 
drug delivery carriers are of interest in the treatment of diseases such as cancer, 
where patients can benefit greatly from targeted therapy. Despite being such 
promising agents, many NPs based drug delivery strategies are still being investigated 
due to toxicity concerns. Before the design and administration of NP-based drug 
carriers, it is vital to investigate and understand the biosafety of NPs so that strategies 
to overcome any toxicity issues can be developed. 
 
Administered NPs will inevitably come into contact with serum proteins and cells of 
the innate immune system such as macrophages and understanding these 
interactions and effects is crucial to determine NP toxicity. In this thesis we studied the 
toxicity of IONPs on a cellular level as well as a whole organism level. We first 
investigated the intracellular uptake and fate of 100nm IONPs in macrophages, which 
seemed to localise in the late endosomes/lysosomes for likely degradation after 24 
hours and also showed evidence of endocytosis by macropinocytosis. To study the 
immunotoxicity of IONPs, cytokines were used as biomarkers of inflammation. 
Transcriptome analysis was also used to identify differentially expressed genes that 
relate to the innate immune system to identify changes in gene expression in response 
to IONP exposure that can lead to unwanted pathologies. Finally, we used zebrafish 
embryos as a model organism to further study toxic effects of IONPs on the innate 
immune response in a physiological setting.  
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We first set out to investigate the intracellular uptake and fate of IONPs in 
macrophages. Our results show that serum deposition on IONPs, forming a ‘protein 
corona’, enhances the uptake of IONPs compared to ‘naked’ IONPs without adsorbed 
serum proteins. This suggests that endocytosis of serum deposited IONPs could be 
receptor-mediated. Studies have shown that the presence of a protein corona on NPs 
can result in receptor mediated endocytosis. For example, nanoceria (CeO2 NPs) 
deposited with a protein corona were shown to be taken up after interaction with 
specific receptors through clathrin-mediated endocytosis (Mazzolini et al., 2016). 
Although serum deposition may play a role in uptake patterns seen, the intracellular 
fate of IONPs did not seem to depend on the presence of a protein corona since there 
were no obvious differences in the localisation of serum-deposited IONPs and ‘naked’ 
IONPs in our results. Although, differences in uptake and colocalisation of serum-
deposited IONPs with Rab 7, seen between human serum and mouse serum samples, 
show evidence that the IONPs with different serum coatings may be trafficked 
differently. Recent studies have shown the formation of an intracellular protein corona 
whereby intracellular proteins adsorb on the surface of NPs (Qin et al., 2020) which 
can affect the intracellular trafficking of NPs, thus possibly resulting in a similar 
intracellular fate irrespective of the presence of an extracellular protein corona. Our 
results also show differences in uptake patterns when human serum or mouse serum 
proteins are adsorbed to the IONP surface. This indicates that specific differences 
between the two sera played a role in mediating the uptake of IONPs into the cells. A 
study has shown that different serum compositions in the protein corona can affect the 
endocytic pathways of NPs, irrespective of size and cell type (Francia et al., 2019). 
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We also used different sized dextrans as markers of endocytosis, which showed 
strong evidence of IONP uptake by macropinocytosis at 24 hours. However, this result 
differed when mouse serum was adsorbed onto the IONPs, again suggesting that the 
different serum compositions can affect endocytosis. Furthermore, studies have 
shown that dextran coated superparamagnetic iron oxide nanoworms (SPOI NW) 
activated complement in human serum via the alternative and lectin pathways 
whereas the same nanoworms activated complement via the lectin pathway in mouse 
serum (Wang et al., 2016). This could explain the differences seen in our results using 
dextran as endocytic markers. When IONP surface was deposited with human serum, 
strong colocalisation with dextran and uptake of IONPs was seen. For these 
experiments, veronal buffers were not used so we were unable to distinguish between 
the classical or complement pathways. Hence, as the existing literature above 
suggests, it is most likely that proteins associated with the alternative pathway were 
adsorbed onto the IONPs resulting in their uptake and the colocalisation seen. On the 
other hand, when IONP surfaces were deposited with mouse serum, different veronal 
buffers (DGVB++ and EGTA) were used to favour adsorption of complement proteins 
of the classical and alternative pathways respectively. Based on the study carried out 
by Wang et al. (2016), and assuming that the IONPs are likely to activate complement 
in mouse serum via the lectin pathway could explain the decrease in IONP uptake 
observed. Although the lectin pathway can also be activated using DGVB++, it is 
believed that the classical pathway will be preferably activated with this buffer since 
lectin pathway activation requires the presence of higher serum concentrations (Okroj 
et al., 2012). To further study this effect seen, a cytokine profile associated with 
different uptake mechanisms could be investigated to link the use of different sera with 
different endocytic pathways which can provide further insight on the uptake and 
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intracellular trafficking of these IONPs and cellular responses. Furthermore, cellular 
fractionation techniques can also be investigated to isolate and separate organelles 
following treatment with IONPs to confirm our results that suggest accumulation in late 
endosomes/lysosomes. 
 
We have seen that the presence and composition of a protein coating on IONPs can 
have different effects on the uptake of IONPs. However, to see how this translates on 
an immunotoxic level and what cytokines the macrophages may secrete as an 
inflammation response upon exposure to IONPs, we used common pro-inflammatory 
and anti-inflammatory cytokines as biomarkers of inflammation reactions. 
Upregulation of pro-inflammatory cytokines such as IL-1β and IL-16 was most altered 
when the cells were exposed to ‘naked’ IONPs in EGTA buffer. Furthermore, through 
gene ontology analysis, the ‘naked’ IONPs in EGTA buffer sample showed 
upregulation of a significant number of genes involved in inflammatory responses. 
These results strongly suggest that the hydrophilic starch coating on the IONPs in 
conjunction with EGTA buffer stimulates a significant inflammatory response that is 
not seen with the other samples. This effect could be due to possibly the calcium 
chelating agent EGTA removing bound ions from the starch, which could alter its 
structural properties so that is a ‘red flag’ for the cell triggering an inflammatory 
response. EGTA is a commonly used metal-chelating agent and clinically used in 
patients with metal poisoning due to its affinity to bind metal ions (Finnegan and 
Percival, 2015). This raises the question whether it is able to bind to the iron part of 
the IONPs causing a displacement in the ions, resulting in cytotoxicity in the absence 
of a protein corona on the IONPs. Additionally EGTA is known to have a high binding 
affinity for Fe3+ (García-Casal, Leets and Layrisse, 2004), which does make our 
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hypothesis stronger, however the reactions with the hydrophilic starch coating is still 
unclear and not well characterised. Nevertheless, our data does provide evidence that 
there are some interactions between the starch coating on IONPs and components of 
EGTA buffer, which needs further investigating.  
 
Unlike the ‘naked’ IONPs in EGTA buffer, for both mouse serum deposited IONPs 
samples less genes associated with inflammatory responses were identified in the 
gene ontology analysis. Instead, upregulation of IL-10, an anti-inflammatory cytokine, 
was observed suggesting a suppressed macrophage activity. Hence, this could be a 
plausible explanation of why lower IONP uptake was seen in experiments with these 
IONPs (chapter 3). IL-10 was also upregulated by the ‘naked’ IONPs in DGVB++, which 
was also associated with lower IONP uptake (chapter 3.3.1).  
 
Gene ontology investigation identified other pathways that were upregulated in 
addition to the innate immunity response related ones. However, analysis of these 
pathways is beyond the scope of this thesis. Therefore, the data presented here is 
only part of the genotoxic effects exhibited by IONPs and other pathways should be 
explored to fully understand the effects of IONPs on a cellular level, as this will 
contribute to the understanding of the biosafety of IONPs to be used in a physiological 
setting. Furthermore, due to costs, RNA-seq was not carried out on the samples that 
were exposed to human serum deposited IONP but it would be beneficial to sequence 
these samples to fully understand the differences observed between human serum 
and mouse serum complement activation, as laid out in chapter 3.  
 
 233 
As part of the immunotoxicity studies, zebrafish embryos up to 5dpf were used to 
assess the toxicity of IONPs in a whole organism model. We have successfully 
demonstrated the biodistribution of IONPs in the larvae through microscopy and also 
successfully labelled macrophages using a high molecular weight dextran. Low 
colocalisation of IONPs and dextran suggested that the IONPs were not phagocytosed 
at the time points investigated. They were rather either cleared from the body, 
accumulated in the liver for likely clearance at a later stage or accumulated in the 
pericardium. The results showed a low mortality rate overall, although some larvae 
displayed symptoms of pericardial oedema, which is an indication of abnormal cardiac 
function. One of the main limitations of this project was that the embryos were only 
studied up to 5dpf, and although some toxicity was seen in the cardiovascular system, 
it may not translate into a true mortality rate as a result of IONPs toxicity since 
zebrafish embryos do not need a functioning cardiovascular system to survive (Miura 
and Yelon, 2011). Thus, for further studies of IONP toxicity in zebrafish embryos, it is 
important to study the larvae beyond 5dpf. Additionally, at 5df, the larvae still retained 
IONPs, hence it would be beneficial to study the residence times of IONPs beyond 
5dpf. Moreover, IONP toxicity can also be assessed at a molecular level through qPCR 
reactions. For instance, a study used specific biomarker genes for metal toxicity, 
oxidative stress and inflammation reactions to assess toxicity of silver NPs in zebrafish 
embryos (Olasagasti et al., 2014). 
 
The IONPs studied in this thesis had a 100nm diameter and a hydrophilic starch 
coating around the magnetite core. It is well known that different sizes, shapes and 
chemical properties of NPs influence their uptake in cells and their immunotoxicity 
(Hoshyar et al., 2016). For instance, a study showed that different shapes of gold 
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nanomaterials were internalised in different amounts in RAW264.7 cells because they 
were internalised through different endocytic pathways (Xie et al., 2017). Furthermore, 
in the development of therapeutic and diagnostic approaches, the size of NPs can 
greatly influence their half-life in blood circulation, specific targeting, tumour 
penetration as well as cellular uptake as discussed previously (Hoshyar et al., 2016). 
The positive uptake of IONPs seen in macrophages could be exploited in future to 
target tumour-associated macrophages in the tumour microenvironment to increase 
the efficacy of new cancer immunotherapies. Our results also show the accumulation 
of IONPs in lysosomes which can be exploited to make the IONPs a favourable drug 
delivery vehicle for targeted drug delivery to lysosomes where the low acidic pH 
feature can be employed to release their content.  
 Additionally, the cytokine profiles produced in chapter 4, in particular IL-10, could be 
studied as an immunomodulatory molecule when designing new drug delivery vehicles 
in order to suppress/avoid unwanted recognition by immune cells. To further asses 
toxicity of IONPs in vitro, techniques such as dynamic light scattering (DLS) and zeta 
potential (ZP) analysis can be useful. Furthermore, the in vitro work carried out in 
mouse macrophages should be carried out in primary human cells and mammalian in 
vivo models such as rodents to link the relevance of this study to humans and further 
assess the biosafety of IONPs and identify other toxicity issues that may arise.  
Overall, we believe that the results and data generated within this thesis have 
contributed greatly to the study and understanding of IONP toxicity at a cellular level 
as well as in an organism model and provides a good building foundation to further 
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